Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,40327,-0.113247660202908,0.00244925185610445,-0.118048193840873,-0.108447126564943,0
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,40406,-0.0963404420178699,0.00252104545065588,-0.101281691101155,-0.0913991929345844,8.17595648756237e-306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,40351,-0.147240800145576,0.00419305061546041,-0.155459179351879,-0.139022420939274,3.05826170367174e-260
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,40304,-0.066909007751657,0.00253540687930823,-0.0718784052351012,-0.0619396102682129,3.09266440334887e-150
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37937,-0.0778739970972994,0.00297480463164525,-0.0837046141753241,-0.0720433800192747,2.21358624799193e-147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40511,-0.0388630946384646,0.00213301990326419,-0.0430438136488624,-0.0346823756280668,1.9742160417864e-73
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,40456,0.0503680825721179,0.00281358668505554,0.044853452669409,0.0558827124748267,5.6227641299708e-71
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,40406,-0.0608048573591692,0.00339979524423578,-0.0674684560378713,-0.054141258680467,7.60417938079793e-71
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,40223,0.0823748332371159,0.00493328926592314,0.0727055862759066,0.0920440801983253,4.6409633722615e-62
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,37877,-0.0464096805510549,0.00295466919280918,-0.0522008321689609,-0.040618528933149,4.17264548516204e-55
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40531,-0.0358504856617329,0.00236106356389612,-0.0404781702469693,-0.0312228010764965,1.03017311732471e-51
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,40345,-0.04027313559056,0.00265579036715567,-0.0454784847101851,-0.0350677864709349,1.39964452839734e-51
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,40370,-0.0249393256864619,0.00166128815561915,-0.0281954504714755,-0.0216832009014484,1.35899717855816e-50
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40484,-0.040538115624664,0.00272242822247947,-0.0458740749407238,-0.0352021563086043,8.18555664138759e-50
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,40398,-0.0517439541672781,0.00347957415350667,-0.0585639195081512,-0.044923988826405,1.09815078048022e-49
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFP,Properdin,38008,-0.0265284729042329,0.00180134067523205,-0.0300591006276877,-0.0229978451807781,1.02738203956417e-48
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,40121,-0.0636476954005425,0.00440998325195655,-0.0722912625743773,-0.0550041282267076,6.44775963809822e-47
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,40304,-0.0362634656415638,0.00251924510505254,-0.0412011860474668,-0.0313257452356608,1.10221635926305e-46
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,37693,-0.0365567972722657,0.00253899289444927,-0.0415332233453863,-0.0315803711991452,1.19567604161757e-46
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,37666,-0.133479765546328,0.00939689007155262,-0.151897670086572,-0.115061861006085,1.85101810269094e-45
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37895,0.0633064863261477,0.00449943309668458,0.0544875974566459,0.0721253751956495,1.20582895809938e-44
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40466,-0.0729228377438044,0.00523263659087332,-0.0831788054619161,-0.0626668700256927,6.89171388126602e-44
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,40275,-0.0897038288443509,0.00645124141714413,-0.102348262021953,-0.0770593956667484,1.06919720125241e-43
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,38008,0.0312546821177265,0.00227739371210295,0.0267909904420047,0.0357183737934483,1.4063974326973e-42
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,40450,-0.0492827104616827,0.00362150066755213,-0.0563808517700849,-0.0421845691532806,6.11349751116668e-42
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37666,-0.0474202925301471,0.00350111911419621,-0.0542824859939717,-0.0405580990663225,1.61969061716234e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,40327,-0.0311464692082495,0.0023073069065383,-0.0356687907450646,-0.0266241476714345,2.67656108844443e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,40511,-0.0455430577617288,0.00339093785608889,-0.0521892959596631,-0.0388968195637946,6.63364660217467e-41
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40484,-0.0642487017588076,0.00479473378004557,-0.073646379967697,-0.0548510235499183,1.00350491195622e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,40354,-0.0294331208078555,0.00219996599728712,-0.0337450541625382,-0.0251211874531727,1.33175416660589e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,40417,-0.0451524628781924,0.00338992254995308,-0.0517967110761005,-0.0385082146802844,2.91978621585609e-40
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,40353,0.107027377326818,0.00826745237181136,0.0908231706780673,0.123231583975568,3.87624315917406e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,40417,-0.0723180214461346,0.00558699895163994,-0.0832685393913489,-0.0613675035009203,3.95236883071449e-38
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,40419,-0.0487827788383749,0.00381597922128611,-0.0562620981120957,-0.0413034595646542,3.07432434941195e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,40372,-0.0419411109090677,0.00329913038499731,-0.0484074064636624,-0.0354748153544729,7.58553373198633e-37
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,40223,-0.0378226332456939,0.00298777603746925,-0.0436786742791336,-0.0319665922122541,1.49991833127629e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40466,-0.0482137434716474,0.00381636979161926,-0.0556938282632211,-0.0407336586800737,2.0612078198013e-36
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37937,-0.0775847847640508,0.00620745966416287,-0.08975140570581,-0.0654181638222916,1.19661594340853e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,40199,-0.0530637333344474,0.00426012473110731,-0.0614135778074177,-0.0447138888614771,1.90759884361068e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,40354,-0.0346736087441964,0.00278671540721331,-0.0401355709423345,-0.0292116465460583,2.24555052842689e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRN,Agrin,40417,-0.0340930405899636,0.00274734714138157,-0.0394778409870715,-0.0287082401928557,3.37533115031196e-35
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,40374,-0.0334450742545109,0.00274330730440093,-0.0388219565711368,-0.0280681919378851,4.89188251001703e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,40037,-0.054842845324991,0.00451090790415234,-0.0636842248171296,-0.0460014658328524,7.4190775115713e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,40327,-0.0336601404576082,0.00277384061611067,-0.0390968680651851,-0.0282234128500313,9.73793728941746e-34
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,40511,-0.0536489824714745,0.00442257086614348,-0.0623172213691157,-0.0449807435738333,1.01966942954583e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39956,-0.0546688514598242,0.00452782874438652,-0.0635433957988217,-0.0457943071208266,2.04747151871815e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,40009,-0.0395923445330721,0.00329877623453086,-0.0460579459527526,-0.0331267431133916,4.84547184457775e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,40327,-0.0357603360919199,0.0029818392414088,-0.0416047410050811,-0.0299159311787586,5.38772201799382e-33
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,40391,-0.0301524106618611,0.00253005813540723,-0.0351113246072593,-0.025193496716463,1.3171351968783e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),37730,-0.172330430140998,0.0145551183426172,-0.200858462092528,-0.143802398189468,3.52562432162196e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,40531,-0.0258620610230259,0.00219361426951326,-0.0301615449912719,-0.0215625770547799,5.97180704078424e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,40354,-0.0439716667542935,0.00373274932710605,-0.0512878554354214,-0.0366554780731657,6.71904556190786e-32
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FST,Follistatin,40391,-0.0505213180374098,0.00430573222549996,-0.0589605531993898,-0.0420820828754299,1.15847854468094e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,37145,0.107552784642516,0.00916701910495142,0.0895854271968108,0.12552014208822,1.26368071260618e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,40300,-0.0400341130382256,0.00341552400944878,-0.0467285400967453,-0.033339685979706,1.33993924746307e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,38008,-0.0261336709245519,0.00223132510877924,-0.0305070681377592,-0.0217602737113446,1.56634825894143e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,40327,-0.04702542814198,0.0040243357031546,-0.054913126120163,-0.039137730163797,2.03873331976604e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,40256,0.0593763865352714,0.00510535805821635,0.0493698847411673,0.0693828883293754,3.87524317785472e-31
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40511,-0.0278102990160509,0.0024098231953707,-0.0325335524789775,-0.0230870455531243,1.09085152566434e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,40336,-0.0321099983857156,0.00278470559394193,-0.0375680213498418,-0.0266519754215894,1.22146806708467e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,40367,-0.0268351873214577,0.0023289494868145,-0.0313999283156141,-0.0222704463273013,1.34477479119535e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9,Complement component C9,37982,-0.0457746033944042,0.00402488301397478,-0.0536633741017948,-0.0378858326870136,7.79424146036152e-30
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,40466,-0.0210407882446538,0.00185624121131838,-0.0246790210188378,-0.0174025554704698,1.14002897666678e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,40354,-0.037515707820141,0.00331937143175369,-0.0440216758263782,-0.0310097398139037,1.66106932390329e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,40039,-0.0378683159069179,0.0033590014447429,-0.044451958738614,-0.0312846730752218,2.29965017498012e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37982,-0.0240155828645324,0.00213848811502815,-0.0282070195699876,-0.0198241461590772,3.90066479067342e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,40278,-0.0297905946178075,0.00267334320821552,-0.0350303473059099,-0.0245508419297051,9.84565025585745e-29
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,40286,-0.0262302058287069,0.0023663748986231,-0.0308683006300081,-0.0215921110274056,1.89721995775996e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,40465,-0.0306233814632685,0.00276723914204297,-0.0360471701816728,-0.0251995927448643,2.31358923220093e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,40327,-0.0266385458118122,0.00240730318695046,-0.0313568600582351,-0.0219202315653893,2.3358763383268e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,40300,-0.0281997474578496,0.00255258155050985,-0.0332028072968489,-0.0231966876188503,2.85730355769361e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFH,Complement factor H,37296,-0.021125263354238,0.00191343140271537,-0.0248755889035601,-0.0173749378049159,3.26286605342183e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,40354,-0.0543630272535737,0.0049301418321096,-0.0640261052445085,-0.0446999492626389,3.59506731939323e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40531,-0.0141744445604777,0.00128661460108926,-0.0166962091786126,-0.0116526799423427,3.99561652038251e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40484,-0.0316537892151574,0.00287340317877644,-0.0372856594455592,-0.0260219189847556,4.03023297046133e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37623,-0.0235983149056652,0.00214152470804054,-0.0277957033334247,-0.0194009264779057,4.08783831772786e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,40406,-0.030292024825985,0.00275568180630065,-0.0356931611663343,-0.0248908884856358,5.22983424291673e-28
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,40466,-0.0268472660928643,0.00246950048025412,-0.0316874870341623,-0.0220070451515662,1.96418733554425e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40531,-0.0217122965280682,0.00200697000714755,-0.0256459577420774,-0.017778635314059,3.49230845929107e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,40531,-0.0173543375483362,0.00160779163202186,-0.020505609147099,-0.0142030659495733,4.55464013988477e-27
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,40431,-0.0354699077218084,0.00331154564515619,-0.0419605371863145,-0.0289792782573022,1.11354614776553e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,40223,-0.0363209652452645,0.00339095704092437,-0.0429672410454763,-0.0296746894450527,1.11489180063784e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,40253,-0.0372333696509568,0.00347790604714748,-0.0440500655033659,-0.0304166737985478,1.18137648708635e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37593,0.107379250625472,0.0100461132548325,0.0876888686460006,0.127069632604944,1.47903844691225e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37955,-0.0800290917239182,0.00750194142986311,-0.0947328969264498,-0.0653252865213865,1.83564928567067e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40511,-0.0365230678209098,0.00343023794399379,-0.0432463341911376,-0.029799801450682,2.19613339144197e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,40341,-0.0456468052924065,0.00428982591178425,-0.0540548640795036,-0.0372387465053094,2.36315276801254e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,40484,-0.0304227902097767,0.00286193026019756,-0.036032173519764,-0.0248134068997895,2.63938912121192e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37968,-0.0644850992230084,0.00607936425184461,-0.0764006531566238,-0.052569545289393,3.49632983598653e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,40372,-0.0197810140646365,0.00187264411166018,-0.0234513965234904,-0.0161106316057825,5.38344023464587e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40531,-0.0188910901645243,0.00179374648319962,-0.0224068332715955,-0.015375347057453,7.49572569532822e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,40511,-0.0352244036273877,0.00334572128403924,-0.0417820173441046,-0.0286667899106708,7.7750124592472e-26
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40484,-0.0281590706882476,0.00269054935489472,-0.0334325474238413,-0.022885593952654,1.49734302497116e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37985,-0.0626727531041631,0.00599762147477278,-0.0744280911947177,-0.0509174150136085,1.83917896899038e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,38008,0.0318016702404011,0.00304899702776412,0.0258256360659834,0.0377777044148188,2.25153521922141e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,40409,-0.0512307369984377,0.00492126899575033,-0.0608764242301084,-0.0415850497667671,2.68809297982235e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,40300,-0.0252919796578862,0.0024301819849136,-0.0300551363483169,-0.0205288229674556,2.76621370520044e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37780,-0.0357410864723755,0.00346019268403195,-0.0425230641330781,-0.0289591088116729,6.45385959120276e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,40398,-0.036392846456241,0.00353567204181829,-0.0433227636582048,-0.0294629292542771,9.05404244457803e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37875,-0.0743917770616145,0.00723080789284412,-0.088564160531589,-0.06021939359164,9.84410398927975e-25
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37896,-0.0739583640093373,0.00721183580714682,-0.0880935621913451,-0.0598231658273295,1.38229891500264e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,40320,-0.0189985477413206,0.00185584124019051,-0.022635996572094,-0.0153610989105472,1.61076916016202e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,40386,-0.0196197136906941,0.0019187186851156,-0.0233804023135207,-0.0158590250678675,1.81559085585159e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37982,-0.0239053990989152,0.00234058591104012,-0.0284929474845538,-0.0193178507132766,2.11702206782186e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2,Complement C2,40367,-0.0202659021036037,0.00199044908831543,-0.0241671823167019,-0.0163646218905054,2.84438229481725e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,40290,0.0537448076993012,0.00528660793666705,0.0433830561434338,0.0641065592551686,3.32959824223368e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,40219,-0.0239140450542346,0.00235498801301058,-0.0285298215597353,-0.0192982685487339,3.74958488677181e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,40336,-0.0277063906783746,0.00272887443283997,-0.0330549845667409,-0.0223577967900082,3.80595778783979e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40495,-0.0985093631022565,0.00971578183711339,-0.117552295502999,-0.0794664307015143,4.37871726191515e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37896,-0.0863615472221719,0.00851877533660109,-0.10305834688191,-0.0696647475624338,4.58279171495473e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,40367,-0.0211999424146059,0.00209456562263317,-0.025305291034967,-0.0170945937942449,5.24885117038528e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,40336,-0.0509562608309069,0.0050394569381409,-0.0608335964296631,-0.0410789252321508,5.80806556658849e-24
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37953,-0.0121959265636774,0.00121992044029049,-0.0145869706266468,-0.00980488250070807,1.88925731502193e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,40039,-0.0347470918953892,0.00347838505849892,-0.0415647266100471,-0.0279294571807313,1.99409172294272e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,40327,-0.0226261978771147,0.002266035958573,-0.0270676283559178,-0.0181847673983116,2.08014379070332e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37589,-0.0319464706835426,0.00319870494909265,-0.0382159323837642,-0.025677008983321,2.0990687876166e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,40352,-0.0328380247500797,0.00330498120577388,-0.0393157879133965,-0.0263602615867629,3.39421935483978e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,40354,-0.0319951438164287,0.00322941240307309,-0.038324792126452,-0.0256654955064055,4.50808648392285e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,40043,-0.0341859150701636,0.00345305619600541,-0.0409539052143342,-0.0274179249259929,4.85877799470571e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,40442,-0.0304430965163227,0.00307572065457682,-0.0364715089992933,-0.0244146840333521,4.95261632237407e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,40349,-0.0321411688807396,0.00326068208190827,-0.0385321057612798,-0.0257502320001994,7.42022092575491e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,40417,-0.0353751705628098,0.00359576724910219,-0.0424228743710501,-0.0283274667545695,8.96462439365483e-23
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40448,-0.0226742736682103,0.00230738290888012,-0.0271967441696153,-0.0181518031668052,1.00066242386123e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,40261,-0.0314193684918285,0.00320441248424618,-0.037700016960951,-0.025138720022706,1.24271423110218e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,40406,0.0325145974325116,0.00332057610734759,0.0260062682621103,0.0390229266029128,1.41286035877833e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37988,-0.0157172484068287,0.0016050300253721,-0.018863107256558,-0.0125713895570994,1.4410391822421e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,40448,-0.0420779143089962,0.00430353556811772,-0.0505128440225069,-0.0336429845954855,1.62589997550644e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,40223,-0.0281540795701763,0.00288199851043944,-0.0338027966506376,-0.022505362489715,1.77237447240882e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37623,-0.073480933117563,0.00754555570878806,-0.0882702223067876,-0.0586916439283384,2.46179586277715e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,37982,-0.0194392859596545,0.00199932754472542,-0.0233579679473163,-0.0155206039719926,2.8479619085137e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,40300,-0.035664985685999,0.00367271143531191,-0.0428635000992103,-0.0284664712727877,3.12773602407899e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,40072,-0.0275202802115304,0.00283944776222087,-0.0330855978254833,-0.0219549625975775,3.75995882237162e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,40406,-0.0297294034268884,0.00306951916502621,-0.0357456609903397,-0.023713145863437,4.00373697980079e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40466,-0.035871698516621,0.00370395122458233,-0.0431314429168024,-0.0286119541164396,4.02704201929289e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,40327,0.030184361859036,0.00312202667948652,0.0240651895672425,0.0363035341508296,4.73413129860042e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37623,-0.0361319253087988,0.00373761677037061,-0.0434576541787252,-0.0288061964388724,4.92337335599867e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,40155,-0.0367853571163432,0.00380908986373281,-0.0442511732492596,-0.0293195409834269,5.2724644466992e-22
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,40039,-0.0349196740738322,0.0036415049802029,-0.0420570238350299,-0.0277823243126345,1.01758123841546e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOST,Sclerostin,40325,-0.0307352128730731,0.00320678031998434,-0.0370205023002425,-0.0244499234459038,1.06419050931303e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40497,-0.0404637489028064,0.00422194379223492,-0.0487387587355869,-0.032188739070026,1.0656730050245e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_E,,40336,-0.0228472507869996,0.00239024387197636,-0.0275321287760733,-0.0181623727979259,1.36513965604168e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,37926,-0.0508444582597824,0.00532108664035078,-0.06127378807487,-0.0404151284446949,1.44254747080876e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,40452,-0.0207023882821726,0.00217009516078202,-0.0249557747973053,-0.0164490017670398,1.63177697374158e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40466,-0.0628058740588618,0.00658440050836775,-0.0757112990552626,-0.049900449062461,1.65151731799986e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,40268,-0.0213509914198413,0.00224346319141815,-0.0257481792750208,-0.0169538035646617,2.0344847821481e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,40374,-0.0234790328460981,0.00246841042001866,-0.0283171172693346,-0.0186409484228615,2.13585040042891e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,40466,-0.0231326975355673,0.0024417322496788,-0.0279184927449378,-0.0183469023261969,3.06457510580751e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,40354,-0.0243292687855667,0.0025738559350991,-0.0293740264183609,-0.0192845111527724,3.76089487295616e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,40037,-0.0394047454700042,0.00417130862968366,-0.0475805103841841,-0.0312289805558242,3.98590388186812e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,40006,-0.0241072478893494,0.00255549299796626,-0.0291160141653632,-0.0190984816133355,4.51522559310334e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,40417,-0.0527582019139298,0.00562382642155831,-0.0637809017001841,-0.0417355021276755,7.38103469786315e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,40406,-0.0227725782736565,0.00243130540781886,-0.0275379368729814,-0.0180072196743315,8.48623423686864e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,40336,-0.0261001628879251,0.00278659138068008,-0.0315618819940581,-0.0206384437817922,8.49557490256252e-21
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,40286,-0.0318315691187717,0.00340819422992999,-0.0385116298094345,-0.0251515084281089,1.09172457507513e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,40484,-0.0355615260612877,0.00381380876571272,-0.0430365912420846,-0.0280864608804908,1.25847071681861e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40511,-0.0202121781315173,0.0021718753013972,-0.0244690537222558,-0.0159553025407788,1.4905836913696e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,40167,-0.0539966761963433,0.00583230230644137,-0.0654279887169684,-0.0425653636757182,2.34197509621598e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,40173,-0.0334268962955298,0.00361788278187226,-0.0405179465479994,-0.0263358460430602,2.79096315950047e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37993,0.0380050561325549,0.00411832981493654,0.0299331296952793,0.0460769825698306,3.15252147029727e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,40354,-0.0185620569643217,0.00201250055188938,-0.0225065580460248,-0.0146175558826185,3.2329597411187e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37985,-0.0206444813539993,0.00224193505503275,-0.0250386740618635,-0.0162502886461351,3.79251035748597e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,40466,-0.0284195444890873,0.00308967933688428,-0.0344753159893805,-0.0223637729887942,4.07872226996031e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,40417,-0.0206206033371093,0.00224745272353086,-0.0250256106752298,-0.0162155959989888,5.05228921067434e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,40177,-0.0218940309114319,0.00238647842521722,-0.0265715286248577,-0.0172165331980062,5.10320571467914e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37896,-0.0772904436961655,0.00843089218072464,-0.0938149923703858,-0.0607658950219452,5.53333953837185e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,40300,-0.029565708533348,0.00322938898332215,-0.0358953109406594,-0.0232361061260366,6.07505397301533e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,37666,-0.0428387672707389,0.00468496649014405,-0.0520213015914212,-0.0336562329500565,6.89489973411678e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,40354,0.0276078983223432,0.00302285660932184,0.0216830993680724,0.033532697276614,7.44595926575388e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,40327,-0.0188412372567761,0.00206357307410626,-0.0228858404820243,-0.0147966340315278,7.6312727315605e-20
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,40406,-0.0435907390212905,0.0048013745675051,-0.0530014331736005,-0.0341800448689805,1.22374178406459e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,40406,-0.0205730895724193,0.00226702252424749,-0.0250164537199444,-0.0161297254248942,1.26774015538882e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40531,-0.0206579671615538,0.00227776870821279,-0.0251223938296508,-0.0161935404934567,1.33254572200312e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2,Brorin,40162,-0.0292158426989425,0.00322479410793439,-0.0355364391504939,-0.0228952462473911,1.45863790890284e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37896,-0.0710570242389751,0.00787549563384957,-0.0864929956813203,-0.05562105279663,2.08389640062008e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,40352,-0.0209867877100051,0.00232948511274882,-0.0255525785309928,-0.0164209968890174,2.30729327151143e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,40300,-0.0586686732443538,0.00651621427349235,-0.0714404532203988,-0.0458968932683088,2.43065222151463e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,39956,-0.0340461173213574,0.0037835421267371,-0.0414618598897621,-0.0266303747529527,2.54958760973989e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,40229,-0.0220746061327091,0.00245477588639366,-0.0268859668700407,-0.0172632453953775,2.68608094860594e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,40429,-0.0251390479354708,0.00280215231424083,-0.0306312664713828,-0.0196468293995588,3.24891975633387e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37666,-0.0282269565439197,0.00315668454362997,-0.0344140582494344,-0.022039854838405,4.32561042117147e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,40398,-0.0328312558489667,0.00368212039130885,-0.0400482118159321,-0.0256142998820014,5.33013889430788e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40497,-0.0280905245628481,0.00315197047248823,-0.034268386688925,-0.0219126624367711,5.53887376439641e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40511,-0.0196672937292153,0.00221058679472098,-0.0240000438468684,-0.0153345436115621,6.34661604070546e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40466,-0.0394588015264923,0.00443936929389575,-0.048159965342528,-0.0307576377104567,6.8497768372233e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40484,-0.04473142389308,0.00504008805069891,-0.0546099964724498,-0.0348528513137101,7.71127691561196e-19
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,40511,-0.0192734590214814,0.00217939456948912,-0.02354507237768,-0.0150018456652827,1.02255431126847e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,40298,-0.0200059736905455,0.00226478674976876,-0.0244449557200922,-0.0155669916609987,1.11925986885789e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,40010,-0.0354171978150136,0.00400966206180055,-0.0432761354561427,-0.0275582601738845,1.12656882717997e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39975,-0.0396773127434022,0.00449840043148724,-0.0484941775891172,-0.0308604478976872,1.26095460367823e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",40484,-0.0539662503867848,0.00613456486705775,-0.065989997526218,-0.0419425032473516,1.54493181918765e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,40307,-0.0148267346351513,0.00168787930091839,-0.0181349780649513,-0.0115184912053512,1.73288177391021e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,40398,-0.0222601057010763,0.00253425153916595,-0.0272272387178416,-0.0172929726843111,1.74021138560002e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",40272,-0.0759916837087709,0.00865930064590594,-0.0929639129747465,-0.0590194544427952,1.86877431645152e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,37896,-0.0515497748369022,0.00588527530178684,-0.0630849144284044,-0.0400146352454,2.20092731033855e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,40300,-0.0235647450006758,0.00269280618599086,-0.0288426451252179,-0.0182868448761337,2.32456218503563e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPS,Colipase,40306,-0.0496601864177358,0.00568823673443308,-0.0608091304172246,-0.0385112424182469,2.78872363733104e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39530,-0.0275993450269646,0.00316207564776422,-0.0337970132965825,-0.0214016767573467,2.85424426367971e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,40466,-0.0299219162297084,0.00343060211651206,-0.0366458963780721,-0.0231979360813448,2.99637142300115e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,40268,-0.0243781766331563,0.00279658983732879,-0.0298594927143208,-0.0188968605519919,3.13325669333278e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,40484,-0.0796231432288498,0.00913819720059011,-0.0975340097420064,-0.0617122767156932,3.23801359382142e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C3,Complement C3,37355,-0.0339985024487775,0.00390234149230122,-0.0416470917736879,-0.0263499131238671,3.33663712302665e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,40406,-0.0181943322741164,0.0020960879392641,-0.022302664635074,-0.0140859999131587,4.32956392724256e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37896,-0.100110109780229,0.0115321945246651,-0.122713211048573,-0.0775070085118853,4.37330565046336e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRN,Progranulin,40257,-0.0174487923345166,0.00201295483510901,-0.0213941838113302,-0.0135034008577029,4.80807022705437e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,40203,-0.0289662218219313,0.00334359817189325,-0.035519674238842,-0.0224127694050205,5.0269419983523e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40511,-0.0233651088808177,0.00270196884009674,-0.0286609678074074,-0.0180692499542281,5.75759407620508e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,40354,-0.0324706960682237,0.00375667374133348,-0.0398337766012373,-0.02510761553521,5.96548844465308e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,40327,-0.0260239298629128,0.00301247224430398,-0.0319283754617486,-0.020119484264077,6.21803390343036e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,40327,-0.0280941359409546,0.00325604651263634,-0.0344759871057218,-0.0217122847761873,6.80914625142434e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,40187,-0.0523666524711186,0.00607670273256071,-0.0642769898269376,-0.0404563151152996,7.47813072401344e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MENT,Protein MENT,37666,0.0154873817037912,0.00179938886490683,0.0119605795285738,0.0190141838790086,8.33853222831083e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,37807,-0.0712580876835352,0.00828219356361236,-0.0874911870682155,-0.055024988298855,8.56751554799526e-18
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,40336,-0.0286548048316566,0.00334116725316639,-0.0352034926478627,-0.0221061170154505,1.06912099553832e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,37054,-0.0175192022761441,0.00204247001364444,-0.0215224435028872,-0.013515961049401,1.08254999479832e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40511,-0.0314297962872544,0.00366787822128837,-0.0386188376009796,-0.0242407549735292,1.13823763543009e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40484,-0.0448309656600643,0.00523180344843847,-0.0550853004190037,-0.0345766309011249,1.13839883068228e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",40039,-0.0512207265571911,0.00598398748700698,-0.0629493420317248,-0.0394921110826574,1.23664610328703e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,40466,-0.0184274778714024,0.00215301176341011,-0.0226473809276862,-0.0142075748151186,1.24123943888864e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",40327,-0.017133208118033,0.00200182438238923,-0.0210567839075159,-0.0132096323285501,1.2436029914517e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,40300,-0.0204007677858696,0.00238699126485904,-0.0250792706649933,-0.0157222649067459,1.3812489093277e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,40352,-0.0181151148121485,0.00212335630577463,-0.0222768931714668,-0.0139533364528303,1.5751929815528e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,40308,-0.038970186786052,0.0045720277051393,-0.0479313610881251,-0.030009012483979,1.68415090804388e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,40406,-0.0287556711088125,0.00338010850479221,-0.0353806837782052,-0.0221306584394197,1.93610478571333e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,40484,-0.0201758763421333,0.00237257811452827,-0.0248261294466087,-0.0155256232376578,1.99508390360243e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,40466,-0.0240436263482716,0.00282770562372669,-0.0295859293707759,-0.0185013233257673,2.01078578418876e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,40223,-0.0342211078548252,0.0040289042041631,-0.0421177600949849,-0.0263244556146655,2.17441334970467e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37623,-0.0684563313843882,0.00806669439949076,-0.08426705240739,-0.0526456103613863,2.35957773540053e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37955,-0.0799925959100049,0.00942728235813525,-0.09847006933195,-0.0615151224880598,2.37539416765494e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,40104,-0.0146010771438831,0.00172166096405588,-0.0179755326334327,-0.0112266216543336,2.43389706942164e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,37937,-0.0648217595557741,0.0076539806464638,-0.0798235616228431,-0.049819957488705,2.72842711459464e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,40379,-0.0398571644882732,0.0047145864180279,-0.0490977538676079,-0.0306165751089385,3.05566011328507e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,40398,-0.0193332486677588,0.00228770573414455,-0.0238171519066821,-0.0148493454288355,3.13662392593552e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37623,-0.0368745292278535,0.00436322333680907,-0.0454264469679993,-0.0283226114877077,3.18346258379625e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,37985,-0.0483778670563659,0.00572481687231886,-0.0595985081261108,-0.0371572259866209,3.19296809413735e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,37666,-0.0755734734896061,0.00895298056397677,-0.0931213153950006,-0.0580256315842116,3.46709679961741e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,40414,-0.0222358878647897,0.00263913651987104,-0.0274085954437369,-0.0170631802858424,3.89678168460909e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPN,Asporin,37985,-0.0190225201504303,0.0022593702296814,-0.0234508858006058,-0.0145941545002548,4.16204814486546e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37955,-0.0245274526579805,0.00291436691053952,-0.030239611802638,-0.0188152935133231,4.28272237533224e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,40223,-0.023378602305644,0.00278325321637479,-0.0288337786097386,-0.0179234260015494,4.85172351310604e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39975,-0.0250660583705247,0.00298850885338694,-0.0309235357231631,-0.0192085810178863,5.3896199905572e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",40300,-0.0241127411255119,0.00288309102899669,-0.0297635995423454,-0.0184618827086783,6.58971784110217e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,40300,-0.0267880586565969,0.00320667008502905,-0.0330731320232538,-0.0205029852899399,7.14860152141661e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37985,-0.0235361159947594,0.00281811593995436,-0.02905962323707,-0.0180126087524489,7.37679790948684e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37955,-0.0533708811808934,0.00639844370309543,-0.0659118308389604,-0.0408299315228263,8.05972917828753e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,40417,0.0432337632326294,0.00518770354270814,0.0330658642889214,0.0534016621763373,8.45286535647892e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,40391,-0.0203179950587689,0.00243812123316431,-0.0250967126757709,-0.0155392774417668,8.48447251405552e-17
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,40327,-0.0237196113386123,0.00285664761714547,-0.0293186406682174,-0.0181205820090072,1.09338153679883e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39975,-0.0747704974838175,0.00901554444481326,-0.0924409645956515,-0.0571000303719835,1.18895324729364e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,40354,0.0466418592520454,0.00562788169546313,0.0356112111289376,0.0576725073751531,1.2465069321628e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,38008,-0.0142393622561934,0.00171952888534185,-0.0176096388714634,-0.0108690856409234,1.33543041183121e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,40327,-0.0520862623410164,0.00629363749963992,-0.0644217918403106,-0.0397507328417221,1.37391802974104e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,40391,-0.0355289160896882,0.00429928401087736,-0.0439555127510078,-0.0271023194283686,1.51961014783302e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37666,-0.0277223228679058,0.00335455814664919,-0.0342972568353382,-0.0211473889004734,1.54116310579676e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39954,-0.0321428223583076,0.00389254387324629,-0.0397722083498703,-0.0245134363667449,1.6060378304042e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,40300,-0.0589118628395317,0.00713598254742575,-0.0728983886324862,-0.0449253370465772,1.62936115726423e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,40336,0.0235575688952749,0.00285445530110788,0.0179628365051034,0.0291523012854463,1.6660867316696e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,40300,0.0934042131231473,0.011339054124445,0.0711796670392351,0.11562875920706,1.89630005119188e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37896,-0.0619279491326044,0.00751831356724609,-0.0766638437244067,-0.047192054540802,1.92875768764961e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,40511,-0.0240661213303319,0.00292257588757609,-0.029794370069981,-0.0183378725906827,1.93960942032964e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40511,-0.0530895886387572,0.00644860686570921,-0.0657288580955473,-0.0404503191819672,1.96945439264892e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37623,0.0351050721320245,0.00427451205711684,0.0267270285000755,0.0434831157639735,2.36401556885118e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,37593,-0.0260547836358721,0.00317371127569079,-0.032275257736226,-0.0198343095355181,2.425757792197e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELL,L-selectin,38008,-0.0157613221806591,0.00192087632535623,-0.0195262397783573,-0.0119964045829609,2.50665705882599e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37896,-0.0790117623566938,0.0096307341546063,-0.0978880012997221,-0.0601355234136655,2.53245408963714e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,40437,-0.0189374964872302,0.00231093993394824,-0.0234669387577687,-0.0144080542166916,2.70049461783502e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37623,-0.0312870018178451,0.00381815179118653,-0.0387705793285707,-0.0238034243071195,2.75238284247188e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,40485,-0.0182800990871091,0.00223289887937101,-0.0226565808906762,-0.0139036172835419,2.88479462779352e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37896,-0.0765325745158186,0.00937391130968727,-0.0949054406828057,-0.0581597083488316,3.51562559143877e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,39660,-0.0152573838217594,0.00186917285046877,-0.0189209626086782,-0.0115938050348406,3.53288705559065e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,37666,-0.0200363600615162,0.00245645043033918,-0.024851002904981,-0.0152217172180514,3.75420548942226e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,40300,-0.0593738247577902,0.00729311345369056,-0.0736683271270237,-0.0450793223885567,4.20664977765309e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,40509,-0.0283148883655139,0.00348219878290954,-0.0351399979800166,-0.0214897787510112,4.55376756577379e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37750,-0.00913503994907415,0.00112466349482779,-0.0113393803989366,-0.00693069949921169,4.96846959301133e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFI,Complement factor I,38008,-0.013521320801138,0.00166475885706674,-0.0167842481609888,-0.0102583934412872,4.97585172989953e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,40391,-0.0307741157690106,0.00379007857166224,-0.0382026697694686,-0.0233455617685526,5.01444140970825e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,40437,-0.0328070895738875,0.00404596553484723,-0.0407371820221881,-0.0248769971255869,5.48926920394286e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,40301,-0.0241368109834145,0.00299068830313257,-0.0299985600575544,-0.0182750619092747,7.49007736916445e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,40288,-0.0316903080857385,0.00393404837010954,-0.0394010428911532,-0.0239795732803238,8.48253433907859e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,40336,-0.0411144801687468,0.00510530390166516,-0.0511208758160105,-0.0311080845214831,8.62746275658845e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,37985,-0.0647508654852934,0.00804945654135433,-0.0805278003063479,-0.0489739306642389,9.40459531250802e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37896,-0.0594516571761943,0.00739289922581698,-0.0739417396587956,-0.044961574693593,9.59516099662983e-16
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASN,Vasorin,40111,-0.0183274585760919,0.00228357948757876,-0.0228032743717463,-0.0138516427804375,1.08010525179757e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,40300,-0.0187748016835588,0.00234179383727444,-0.0233647176046167,-0.0141848857625009,1.1561120225315e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,40039,-0.0563561856957398,0.00703727494636663,-0.0701492445906184,-0.0425631268008612,1.24527858870599e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37623,-0.0573584260838926,0.00716907490650533,-0.0714098129006431,-0.0433070392671422,1.33886153355101e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40511,-0.0359286092351745,0.00450757366170434,-0.044763453612115,-0.027093764858234,1.68284552202758e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37896,-0.0192815120091385,0.00242135121065819,-0.0240273603820285,-0.0145356636362484,1.81158344946261e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,40348,-0.0355613884266706,0.00448239481764201,-0.0443468822692489,-0.0267758945840923,2.2703317972525e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40511,-0.0367471268909806,0.00464270002215601,-0.0458468189344064,-0.0276474348475548,2.63226620100786e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39975,-0.0326773653681304,0.00412965417891344,-0.0407714875588007,-0.02458324317746,2.68432189886443e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37955,-0.0548935179230394,0.0069553916023014,-0.0685260854635501,-0.0412609503825286,3.1961120924165e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,37985,0.0519271345246128,0.0065829291654725,0.0390245933602867,0.0648296756889389,3.30116801874686e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,40300,-0.0185875304398347,0.00235784068255162,-0.0232088981776359,-0.0139661627020336,3.39521430152664e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,40300,-0.0441955501362734,0.00561043782549439,-0.0551920082742424,-0.0331990919983044,3.55887564037793e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,40354,-0.0181587997871152,0.00230632221195565,-0.0226791913225482,-0.0136384082516821,3.67018949326804e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,40391,0.0554005601411182,0.00704544416233341,0.0415914895829447,0.0692096306992916,3.97914606441188e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,40300,-0.0488312887671586,0.00621588249611032,-0.0610144184595348,-0.0366481590747823,4.22272232175631e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,40374,-0.0156257506845588,0.00199174934229227,-0.0195295793954517,-0.011721921973666,4.59419315303375e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,40327,-0.0153772599999824,0.00196327154075745,-0.019225272219867,-0.0115292477800978,5.08493437771953e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,40325,-0.066988322734554,0.00856124707539204,-0.0837683670023224,-0.0502082784667856,5.41202179448833e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,37937,-0.0197953947045739,0.00252978106534379,-0.0247537655926477,-0.0148370238165,5.45550949207638e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYY,Peptide YY,37557,0.0615945582136853,0.00787661314297466,0.046156396453455,0.0770327199739157,5.68798421082881e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,40245,-0.0185760203710831,0.00238187370026858,-0.0232444928236095,-0.0139075479185567,6.63263037528663e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,40406,-0.0177602338881116,0.00228155232195353,-0.0222320764391405,-0.0132883913370827,7.43947764662542e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,37954,-0.0233465428851867,0.00300330576643539,-0.0292330221874,-0.0174600635829733,8.17776962369369e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,40336,-0.0309041415551305,0.00397729534468151,-0.0386996404307063,-0.0231086426795547,8.3173287503992e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,40336,-0.0243091588132808,0.00312947318805397,-0.0304429262618665,-0.018175391364695,8.47100726974151e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39860,-0.0244414244032734,0.00314760027445863,-0.0306107209412124,-0.0182721278653345,8.66941235869451e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37896,-0.0173044411312474,0.00222983310561858,-0.0216749140182598,-0.012933968244235,9.07376635953411e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,37593,-0.0587510692845207,0.00757045031812997,-0.0735891519080554,-0.043912986660986,9.07700170888039e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,40417,-0.0848818555325616,0.0109537973371544,-0.106351298313384,-0.0634124127517391,9.81059537083702e-15
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,40327,-0.0188328809454088,0.00243854923413963,-0.0236124374443225,-0.0140533244464952,1.20390881891247e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,40446,-0.0221754165478637,0.00287374222267745,-0.0278079513043115,-0.0165428817914159,1.26533409684913e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,40398,-0.0240046954348963,0.00311967921450135,-0.0301192666953189,-0.0178901241744736,1.5020773618186e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,40350,-0.0252894054671465,0.00328872717988315,-0.0317353107397175,-0.0188435001945756,1.56053076124302e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,40511,-0.0291476290821854,0.003797394003606,-0.0365905213292531,-0.0217047368351176,1.73955359320588e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,40465,-0.0384302823275433,0.00500825594821545,-0.0482464639860456,-0.0286141006690411,1.77129969357908e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40466,-0.0426287231966706,0.0055566534093536,-0.0535197638790036,-0.0317376825143375,1.79529402745006e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40466,-0.0331506577907439,0.0043243994569334,-0.0416264807263334,-0.0246748348551545,1.87652303157368e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37985,-0.0391184987503306,0.00511391905613781,-0.0491417801003607,-0.0290952174003005,2.15496693637174e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37937,-0.0244654418475055,0.00320058572105147,-0.0307385898607664,-0.0181922938342446,2.24686150427357e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,40300,-0.0228187687846251,0.00298590750428648,-0.0286711474930266,-0.0169663900762236,2.25805995642845e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,38008,-0.0161599209191348,0.00212153362621343,-0.0203181268265131,-0.0120017150117564,2.76605060692601e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,40039,-0.0352297962443697,0.00462746100561561,-0.0442996198153763,-0.0261599726733631,2.82672222350684e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37593,-0.0530894213565984,0.0069761062376147,-0.0667625895823232,-0.0394162531308736,2.92333148614997e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",40300,-0.020447030618477,0.00268800502968323,-0.0257155204766561,-0.0151785407602978,2.96775513191252e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,37666,-0.0324911690282929,0.00428235922405916,-0.0408845931074488,-0.0240977449491369,3.48697844201129e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,40286,-0.0271955959807762,0.00358587813533669,-0.0342239171260361,-0.0201672748355163,3.53394169678945e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,40037,-0.0216548224886677,0.00285704409619943,-0.0272546289172186,-0.0160550160601169,3.6651068892997e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,40291,-0.0301402274530983,0.00397837278915233,-0.0379378381198369,-0.0223426167863597,3.75964682519405e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,40391,-0.052152141011975,0.00688864982420619,-0.0656538946674191,-0.0386503873565309,3.91390988687213e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",40336,-0.0517071848102996,0.00683528480372708,-0.0651043430256047,-0.0383100265949945,4.09862736844387e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,40039,-0.0238772868137771,0.00316466091896592,-0.0300800222149503,-0.0176745514126039,4.77312194704769e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,37993,-0.0143496130874814,0.00190415881469238,-0.0180817643642785,-0.0106174618106844,5.15586928354446e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,40368,-0.0167945509994386,0.00223108174317158,-0.0211674712160549,-0.0124216307828223,5.44703085139644e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37937,-0.0222305625369936,0.00295337564407221,-0.0280191787993751,-0.016441946274612,5.51365528801587e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDK,Midkine,40347,-0.031664380508917,0.0042082179841478,-0.0399124877578467,-0.0234162732599873,5.57866989518819e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37810,-0.0192588019794959,0.00256455334997798,-0.0242853265454527,-0.014232277413539,6.3060675997523e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37593,-0.0551186365786803,0.0073397857793411,-0.0695046167061889,-0.0407326564511718,6.31448378234333e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,37710,-0.0238594354396038,0.00318537482892388,-0.0301027701042946,-0.0176161007749131,7.3055345380563e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,37976,-0.0138766953985411,0.00185300060177451,-0.0175085765780191,-0.010244814219063,7.38234588867322e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37666,-0.0392907396321209,0.00524734611503162,-0.0495755380175828,-0.0290059412466589,7.45096343036418e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,37570,-0.016948706473829,0.00226778381990025,-0.0213935627608335,-0.0125038501868245,8.29162277869662e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,40354,-0.0488741214267262,0.00655280526317688,-0.0617176197425529,-0.0360306231108995,9.20223108972007e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RETN,Resistin,40278,-0.0256441830554274,0.00343897039398673,-0.0323845650276414,-0.0189038010832134,9.3141693236584e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",40300,-0.0431517995340916,0.00579197851817979,-0.054504077429724,-0.0317995216384592,9.79476676009851e-14
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,40223,-0.0155378132436031,0.00208996729880673,-0.0196341491492643,-0.0114414773379419,1.10370693561003e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37982,-0.0444502385368808,0.0059804328064947,-0.0561718868376104,-0.0327285902361512,1.12860922740451e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40466,-0.0505807368282497,0.00681107814986344,-0.063930450001982,-0.0372310236545173,1.17343630475773e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,37993,-0.0171067716845006,0.00231168096188449,-0.0216376663697943,-0.012575876999207,1.44048079023571e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,40398,0.0281171024784895,0.00380017929455641,0.020668751061159,0.0355654538958201,1.4416494963027e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,40336,-0.0545228175170821,0.00737547577697417,-0.0689787500399515,-0.0400668849942128,1.5132913291919e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39975,-0.028754232792011,0.0038903578179977,-0.0363793341152865,-0.0211291314687355,1.52976283442802e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,40374,-0.0205210280964162,0.00277701549156163,-0.025963978459877,-0.0150780777329554,1.5457841355315e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40511,-0.0279771770208196,0.00378892748750569,-0.0354034748963307,-0.0205508791453084,1.61217006149855e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,37937,-0.0167181003498317,0.00226440183454142,-0.0211563279455328,-0.0122798727541305,1.63817575085044e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39975,-0.0491986678336091,0.00666993623539149,-0.0622717428549765,-0.0361255928122418,1.71124260329945e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,40198,-0.0180283418437181,0.00244657150340503,-0.022823621990392,-0.0132330616970443,1.80685663162669e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37896,-0.0324018884456231,0.0043966982280959,-0.0410194169726911,-0.0237843599185552,1.81131262307848e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,40484,-0.0406949246538671,0.0055314409541336,-0.0515365489239689,-0.0298533003837652,1.97160090478939e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40531,-0.0299422785758185,0.00407232361616957,-0.0379240328635109,-0.0219605242881262,2.03701344472141e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,40484,-0.0344120775220792,0.00468074209756133,-0.0435863320332994,-0.025237823010859,2.04926033615749e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELN,Elastin,37985,-0.0213741261852249,0.00290936190059386,-0.0270764755103888,-0.0156717768600609,2.14831649441135e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,37666,-0.0218908245715193,0.00298083158822803,-0.0277332544844462,-0.0160483946585923,2.19662707888979e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,40354,0.0279643408744405,0.00380939522058319,0.0204979262420975,0.0354307555067836,2.22444135165709e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40531,-0.0153891540810819,0.00209700493623949,-0.0194992837561113,-0.0112790244060525,2.26088743356925e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,40345,-0.0566490679360626,0.00772860254514245,-0.0717971289245418,-0.0415010069475834,2.41592729862263e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,40328,-0.0550140991080696,0.00751338187158123,-0.0697403275763688,-0.0402878706397704,2.55732488151557e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAX,Protein max,39956,-0.0634210332900341,0.00867047369738633,-0.0804151617369113,-0.0464269048431569,2.70781215735985e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPTC,Opticin,40300,-0.0274066533359524,0.00375293586534695,-0.0347624076320325,-0.0200508990398724,2.95402184216091e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40511,-0.0444241710324863,0.00609136045613419,-0.0563632375265093,-0.0324851045384633,3.17311790239692e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37623,-0.0390408389316365,0.00536469032939686,-0.0495556319772543,-0.0285260458860186,3.59666129914961e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,40325,0.029321633504496,0.00404256312853976,0.021398209772558,0.0372450572364339,4.25742475574584e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,40336,-0.0225093689126192,0.00310489626146158,-0.0285949655850839,-0.0164237722401546,4.37134474905139e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,39956,-0.0265711856921241,0.0036709376138565,-0.0337662234152829,-0.0193761479689654,4.75808049896221e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37666,0.0150497714042078,0.00207905488260419,0.0109748238343036,0.019124718974112,4.77833964217964e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,40300,-0.018120236985369,0.00250386072760618,-0.0230278040114771,-0.0132126699592609,4.80027798546405e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,40198,-0.0145511005940002,0.00201133171505459,-0.0184933107555072,-0.0106088904324932,4.8855722841445e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37945,-0.0118968831633122,0.0016451204905725,-0.0151213193248343,-0.0086724470017901,5.02978868306422e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,40417,-0.015521190815187,0.0021481770859347,-0.019731617903619,-0.011310763726755,5.22652972891924e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,40271,-0.0361603695754454,0.00500869084088752,-0.0459774036235849,-0.0263433355273058,5.45417662877064e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37896,-0.0178764477539535,0.00247665344134273,-0.0227306884989853,-0.0130222070089218,5.55943677531569e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37937,-0.0189923385148297,0.00263519775002833,-0.0241573261048852,-0.0138273509247742,6.0160332738682e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,40427,-0.0166310820936356,0.0023193080650024,-0.0211769259010403,-0.0120852382862308,7.78795414512172e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39831,-0.0718460208840043,0.0100269258665805,-0.0914987955825022,-0.0521932461855065,8.1135550171996e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40531,-0.017199122231053,0.00240636846255471,-0.0219156044176603,-0.0124826400444458,9.2279527075249e-13
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,37709,-0.0761701277365921,0.0106836270275435,-0.0971100367105774,-0.0552302187626068,1.05864705585222e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,40374,-0.014264061661264,0.0020016118623946,-0.0181872209115574,-0.0103409024109705,1.07533777433419e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,40485,-0.0189137910996139,0.00265934680076356,-0.0241261108291105,-0.0137014713701174,1.19036960754441e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40497,-0.0313836264627839,0.00441279922263089,-0.0400327129391405,-0.0227345399864274,1.19239832377121e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37623,-0.045858069262778,0.00645005117715044,-0.0585001695699929,-0.0332159689555632,1.22272277502609e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37993,-0.0152562118056754,0.00214664080780295,-0.0194636277889692,-0.0110487958223816,1.24512164183286e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37895,-0.0468766699445389,0.00660164404479858,-0.0598158922723441,-0.0339374476167337,1.30308632998743e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37993,-0.0131358982295906,0.00185340575790661,-0.0167685735150876,-0.00950322294409368,1.43378947708247e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,37929,-0.0274109608032792,0.00387046039922598,-0.0349970631857621,-0.0198248584207963,1.49033406153714e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,40327,-0.0169928641028406,0.00240174156800809,-0.0217002775761365,-0.0122854506295448,1.5544085491373e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,40300,-0.0532646956715388,0.00753556305935149,-0.0680343992678677,-0.0384949920752099,1.63216042506363e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,38008,-0.0382207558073607,0.00540764571356449,-0.0488197414059471,-0.0276217702087743,1.64973701030668e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37895,-0.0240880877654602,0.00340833011044398,-0.0307684147819304,-0.01740776074899,1.65626164791723e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37896,-0.0323052249009336,0.00458112877762746,-0.0412842373050834,-0.0233262124967837,1.8524097150516e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,40350,-0.0292400866976831,0.0041475119397378,-0.0373692100995692,-0.0211109632957971,1.8623685189505e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB2,Calretinin,39956,-0.018442277630435,0.00261623735237401,-0.023570102841088,-0.0133144524197819,1.87592803150867e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,40286,-0.0169936497467468,0.00241279441110423,-0.0217227267925111,-0.0122645727009825,1.95688185036081e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37985,-0.0524395470676804,0.00745108760285486,-0.0670436787692759,-0.0378354153660849,2.04645652283394e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37623,-0.0182156636303971,0.00258825755769403,-0.0232886484434774,-0.0131426788173168,2.04951312965429e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,37985,-0.037750313518167,0.00536667379974699,-0.0482689941656711,-0.0272316328706629,2.10020255517082e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40466,0.0769658884566127,0.0109636340661325,0.055477165686993,0.0984546112262324,2.30597976115946e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37603,-0.0328689428696666,0.00468374460240269,-0.0420490822903759,-0.0236888034489573,2.36665544141941e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,40004,-0.0301668367665168,0.00430139515667351,-0.0385975712735969,-0.0217361022594368,2.42406729918627e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37895,-0.0319111781070891,0.00455548261953855,-0.0408399240413846,-0.0229824321727935,2.58726728414304e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,37896,-0.0657824241318515,0.00939281365717932,-0.0841923388999229,-0.04737250936378,2.61540281550209e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40484,-0.0165885846607623,0.00237125983008012,-0.0212362539277193,-0.0119409153938053,2.74406370345707e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,40354,-0.0173619374518324,0.00248264980498989,-0.0222279310696126,-0.0124959438340522,2.79167886919971e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,40406,-0.0139107390356132,0.00198943397342309,-0.0178100296235224,-0.0100114484477039,2.81121979648751e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,40466,-0.0345709120652555,0.00494431509137648,-0.0442617696443534,-0.0248800544861576,2.81595455294973e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37955,-0.0273062382235048,0.00392000311311669,-0.0349894443252136,-0.0196230321217961,3.41490041827767e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,40354,-0.0149650669285024,0.0021489002018875,-0.0191769113242019,-0.0107532225328029,3.4355318623042e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37937,-0.0618138693229593,0.0088752890030984,-0.0792094357690321,-0.0444183028768864,3.44314777465521e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,40210,-0.0544103601044409,0.0078268780599473,-0.0697510411019376,-0.0390696791069441,3.74988370940685e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,40306,-0.0109378371520332,0.0015753099797157,-0.0140254447122759,-0.0078502295917904,3.97934803351561e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40531,-0.0182156516564235,0.0026242815004936,-0.023359243397391,-0.0130720599154561,4.03652732647428e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,40427,-0.0397740749900267,0.00573155790595741,-0.0510079284857033,-0.0285402214943502,4.08648096207381e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,40288,0.0232471418717574,0.00335144534167169,0.0166783090020809,0.0298159747414339,4.17630456547997e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,37895,-0.0217716341222892,0.0031391806082179,-0.0279244281143963,-0.0156188401301821,4.23435090269073e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,40465,-0.0115054454980941,0.00166091110086535,-0.0147608312557902,-0.00825005974039798,4.45625957459003e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,40166,-0.0336401108830446,0.00485659942103161,-0.0431590457482665,-0.0241211760178226,4.47544257937455e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37993,-0.0346527451984791,0.00500262322302872,-0.0444578867156154,-0.0248476036813428,4.49536152175483e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,40187,-0.0179169922529735,0.00259286872098342,-0.022999014946101,-0.012834969559846,5.02882115986149e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,40336,-0.0223215181609623,0.00323133734750141,-0.0286549393620651,-0.0159880969598596,5.10814137640474e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,40162,-0.0160663873744133,0.00233811824624437,-0.0206490991370523,-0.0114836756117743,6.59164655331738e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLN,Promotilin,40336,-0.0505791414896997,0.00736306631754905,-0.0650107514720958,-0.0361475315073035,6.69105657845988e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37985,-0.0569786078994775,0.00831104583687371,-0.07326825773975,-0.040688958059205,7.40046753192355e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,40039,-0.0231825094359242,0.00338203462781626,-0.0298112973064441,-0.0165537215654043,7.41928554041272e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,40336,-0.0380624946333983,0.00555601179396329,-0.0489522777495664,-0.0271727115172303,7.61951495036189e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,40039,-0.0163400726379487,0.00238793048372206,-0.0210204163860439,-0.0116597288898534,8.05671651640376e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,40336,-0.0307356683530634,0.0044928132257718,-0.0395415822755761,-0.0219297544305506,8.14715990789056e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",40037,-0.0528090145249166,0.00773629031289166,-0.0679721435381842,-0.0376458855116489,9.04477108395874e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,40223,0.0292551129132278,0.00428769587978671,0.0208512289888459,0.0376589968376098,9.23789499723687e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,40223,-0.019692783513457,0.00288753618365139,-0.0253523544334137,-0.0140332125935003,9.43963895878001e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,40300,-0.0135847671676678,0.00199223689262635,-0.0174895514772155,-0.0096799828581202,9.50866884737356e-12
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,40336,-0.0343468638083747,0.00504444570334903,-0.0442339773869388,-0.0244597502298106,1.01908767400407e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37955,-0.042171071360607,0.00619856133389238,-0.0543202515750361,-0.0300218911461779,1.0650985185946e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40466,-0.0195972873463326,0.00288389909619779,-0.0252497295748803,-0.013944845117785,1.11810240811238e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37741,-0.0313525808960985,0.0046131766598316,-0.0403944071493684,-0.0223107546428285,1.1190974087128e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,40037,-0.0411939145827717,0.00606215801665055,-0.0530757442954068,-0.0293120848701366,1.12038978050819e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,37593,-0.0283271453751163,0.00417001807237998,-0.0365003807969811,-0.0201539099532516,1.14513285074655e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,40354,-0.0473387327182571,0.00697455021906666,-0.0610088511476278,-0.0336686142888865,1.18246330295935e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,39975,-0.0302028178803834,0.00445019712564175,-0.0389252042466413,-0.0214804315141256,1.187586631176e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,40330,-0.0252985754150615,0.00373766923327554,-0.0326244071122816,-0.0179727437178414,1.34639792140957e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,40367,-0.019001800816927,0.00280879135600406,-0.0245070318746949,-0.013496569759159,1.37844853648902e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,40511,-0.0192364296494229,0.00284444358342428,-0.0248115390729345,-0.0136613202259113,1.40009478125877e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,40092,-0.0234919143416955,0.0034737716720992,-0.0303005068190099,-0.016683321864381,1.40286871901972e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,40300,-0.0412385349684996,0.00610490873928537,-0.0532041560974989,-0.0292729138395002,1.47826185810736e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37623,-0.038289620884427,0.00567713686372028,-0.0494168091373188,-0.0271624326315353,1.59931228888653e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,37666,-0.0172752279894249,0.00256257194447927,-0.0222978690006043,-0.0122525869782455,1.63423107825795e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37955,-0.0352545376384244,0.00523081997459852,-0.0455069447886375,-0.0250021304882113,1.65072353038901e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,40336,-0.0314511343600376,0.00466962083220168,-0.0406035911911529,-0.0222986775289223,1.69246421149665e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,39975,-0.0410716935093633,0.0061108521017474,-0.0530489636287882,-0.0290944233899384,1.86630655106711e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,40284,-0.0153546991969724,0.0022846223519576,-0.0198325590068093,-0.0108768393871354,1.86781916900509e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FN1,Fibronectin,38008,-0.0146024298992891,0.00217350036981498,-0.0188624906241265,-0.0103423691744518,1.91072792537548e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,40354,-0.0196067107614797,0.00292197005633859,-0.0253337720719033,-0.0138796494510561,2.01059218084059e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,40180,-0.0323130875173771,0.00481770132903043,-0.0417557821222768,-0.0228703929124775,2.05215405351322e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,40379,-0.0170566101233436,0.00254443711809978,-0.0220437068748192,-0.0120695133718681,2.10333187175059e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,40354,-0.018930353705717,0.0028243714994167,-0.0244661218445737,-0.0133945855668603,2.11769393127734e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,37931,-0.041877757790141,0.00625616005444493,-0.0541398314968531,-0.029615684083429,2.2598361141875e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37666,-0.0695945213046221,0.0103967302261135,-0.0899721125478046,-0.0492169300614396,2.26094831727989e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",40417,-0.0614156361154133,0.0091819458557132,-0.0794122499926112,-0.0434190222382155,2.32578107459546e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37666,-0.0148251479961263,0.00222050894334306,-0.0191773455250787,-0.0104729504671739,2.54555627032254e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37937,-0.0357984939268241,0.00536374137378766,-0.0463114270194479,-0.0252855608342003,2.58361648829365e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,40485,-0.0116094880570454,0.00173973685475805,-0.0150193722923711,-0.00819960382171959,2.58610293784675e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37666,-0.0394739225215718,0.00591470793382893,-0.0510667500718765,-0.0278810949712671,2.59103520279716e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37937,-0.0450072009742688,0.00674913583353659,-0.0582355072080005,-0.0317788947405371,2.68338031628281e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,37937,-0.0252912078756842,0.00379439374647899,-0.032728219618783,-0.0178541961325854,2.741798103371e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,40327,-0.0258338843517582,0.00388332512332524,-0.0334452015934756,-0.0182225671100407,2.97541822262649e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37552,-0.0466273704874235,0.00701121780894442,-0.0603693573929546,-0.0328853835818925,3.03906175188932e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,40259,-0.0147478955294163,0.00221843621237123,-0.0190960305056639,-0.0103997605531687,3.07081704761013e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,40333,-0.051790925789752,0.0077964328966345,-0.0670719342671556,-0.0365099173123483,3.17562542772554e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37982,-0.0217009155462941,0.00326976999572134,-0.0281096647379079,-0.0152921663546802,3.32703023571984e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,37332,-0.0271529723579739,0.00409444808523824,-0.0351780906050408,-0.0191278541109069,3.45192073212838e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,38008,-0.0102938521819083,0.0015523301389078,-0.0133364192541676,-0.00725128510964899,3.45522727713722e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,37955,0.0295658950025362,0.0044590237632686,0.0208262084265297,0.0383055815785426,3.47094186593083e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",40300,-0.0330645265994789,0.00499115453638957,-0.0428471894908025,-0.0232818637081554,3.59341790548648e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,40352,-0.0211376101572892,0.00319333535229059,-0.0273965474477787,-0.0148786728667996,3.72477492288654e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,40300,-0.0401788813795197,0.00607680447084132,-0.0520894181423687,-0.0282683446166707,3.91692130626928e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,37896,-0.018519964710868,0.00280078301126985,-0.0240094994129569,-0.0130304300087791,3.92360414386407e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37557,-0.0372208401143419,0.00564416868953031,-0.0482834107458213,-0.0261582694828625,4.42862265459844e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,40012,-0.0306619671583138,0.00465166034907638,-0.0397792214425035,-0.0215447128741241,4.49052035838376e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,40300,-0.0490198139416614,0.00744226352062933,-0.0636066504420949,-0.034432977441228,4.6392489725412e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,37955,-0.041611973285459,0.00631774655640603,-0.0539947565360148,-0.0292291900349031,4.66922053342954e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,40365,-0.0154770227113556,0.00235325552518461,-0.0200894035407174,-0.0108646418819938,4.95472411976787e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,40350,-0.0198325165012061,0.0030173077371753,-0.0257464396660697,-0.0139185933363425,5.08738556629766e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37623,-0.0392934483283689,0.00598293808054661,-0.0510200069662403,-0.0275668896904976,5.3058060107101e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37937,-0.0573305133187773,0.00873192602956607,-0.0744450883367268,-0.0402159383008278,5.37136801080222e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,37896,-0.0417045641949676,0.00635397264261906,-0.054158350574501,-0.0292507778154342,5.44718051209662e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,40336,-0.0608458110955643,0.00927182845931065,-0.0790185948758132,-0.0426730273153155,5.45728036725352e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37985,-0.0293750376465747,0.00448628979945152,-0.0381681656534996,-0.0205819096396497,6.05241691462508e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40531,-0.0225472191559316,0.00345157556610749,-0.0293123072655022,-0.0157821310463609,6.66478592115998e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,40223,-0.0224152231791321,0.00343174685315588,-0.0291414470113176,-0.0156889993469466,6.70062460005662e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37896,-0.079688844278747,0.0122008669470005,-0.103602543494868,-0.055775145062626,6.74976427798354e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,40037,-0.0304409244111873,0.00466162983864465,-0.0395777188949308,-0.0213041299274438,6.77576543090401e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,40336,-0.023363304968968,0.00357813664999763,-0.0303764528029633,-0.0163501571349726,6.80089558041375e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,40223,-0.0273784455632844,0.00419428026993125,-0.0355992348923497,-0.0191576562342192,6.88867681754642e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,40466,-0.0125901193753027,0.00193280669766531,-0.0163784205027267,-0.0088018182478787,7.54039514299277e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,40171,-0.0144250604465156,0.00221456739714913,-0.0187656125449278,-0.0100845083481033,7.55408688659792e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,40307,-0.0363226927804004,0.00558776864496608,-0.0472747193245339,-0.0253706662362668,8.25023459980092e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,40039,-0.0185087979368787,0.00285238173384161,-0.0240994661352083,-0.0129181297385492,8.90781588722445e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,40417,-0.0111137448214156,0.00171335792165133,-0.0144719263478522,-0.00775556329497902,9.04191154734014e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,40300,-0.0275237765639062,0.00424366951397596,-0.0358413688112991,-0.0192061843165134,9.08491401395879e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,40511,-0.0239917758614951,0.00370427586112234,-0.0312521565492949,-0.0167313951736953,9.64235149776892e-11
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,40304,-0.020921036178352,0.00324072762897974,-0.0272728623311523,-0.0145692100255517,1.10879066134245e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,40391,-0.0307829550160059,0.00477561659705542,-0.0401431635462345,-0.0214227464857773,1.182485631244e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,40063,-0.0159775619005829,0.00248372569235675,-0.0208456642576021,-0.0111094595435637,1.28834331708868e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39975,-0.0418324713663029,0.00650636240206159,-0.0545849416743436,-0.0290800010582621,1.31788304794088e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37666,-0.0136524699879932,0.00212360602364516,-0.0178147377943377,-0.00949020218164866,1.32940940951005e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37937,-0.0165153393932625,0.00257108979077256,-0.0215546753831767,-0.0114760034033483,1.37665344158925e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37955,-0.0526230900705608,0.00819985287558858,-0.0686948017067144,-0.0365513784344072,1.43095125819397e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37937,-0.0482266480316602,0.00753121768132431,-0.0629878346870559,-0.0334654613762646,1.56821208591033e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,39975,-0.0202159117228275,0.00315835927917698,-0.0264062959100144,-0.0140255275356407,1.5903769233386e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,40283,-0.0576508556157644,0.00902895405694575,-0.075347605567378,-0.0399541056641507,1.76046725654582e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37666,-0.0470975662032369,0.00738906098809671,-0.0615801257399065,-0.0326150066665674,1.90330820273895e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,37666,-0.0286917605564838,0.0045016266621975,-0.0375149488143909,-0.0198685722985767,1.90721646013932e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,40352,-0.0266487018003816,0.00418269395680041,-0.0348467819557104,-0.0184506216450528,1.92735349978811e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37896,-0.0402049348839106,0.0063199825691171,-0.0525921007193801,-0.0278177690484411,2.06187581795977e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,40273,-0.0135110350027089,0.00212666048812644,-0.0176792895594368,-0.0093427804459811,2.16686748077317e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,40327,-0.0221956870137413,0.00349707442681976,-0.029049952890308,-0.0153414211371745,2.25612529734022e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37666,-0.0458171721013448,0.00723711539422683,-0.0600019182740294,-0.0316324259286602,2.5168142256632e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,37666,-0.0237979484307336,0.00376379722874588,-0.0311749909990755,-0.0164209058623917,2.65035047718109e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,40198,-0.0273605010275233,0.0043287821061791,-0.0358449139556343,-0.0188760880994122,2.67559766595646e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COCH,Cochlin,37985,-0.0243985678248954,0.00386163827868159,-0.0319673788511113,-0.0168297567986794,2.72931231927089e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37955,-0.0357364273146818,0.00565611376864595,-0.0468224103012279,-0.0246504443281358,2.72943427047543e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,37896,0.0357969073717016,0.00566730788765405,0.0246889839118997,0.0469048308315036,2.76182089670021e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,40300,-0.0440816809580036,0.00698046169711657,-0.0577633858843521,-0.0303999760316552,2.77341201939063e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37593,-0.0168891394113304,0.00267497076881139,-0.0221320821182007,-0.0116461967044601,2.81088115397367e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,40465,-0.0319328499807368,0.00507610446392075,-0.0418820147300215,-0.0219836852314521,3.23996278683321e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,37666,-0.0226238309173109,0.00359600639403167,-0.029672003449613,-0.0155756583850088,3.24589896212165e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNLY,Granulysin,40327,-0.0265114343497834,0.00421746492676737,-0.0347776656062474,-0.0182452030933193,3.3402716064917e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,40354,0.0219688613421782,0.00349716850805455,0.0151144110663913,0.0288233116179651,3.43156991826857e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,40336,-0.0217057435604547,0.00345529273409149,-0.028478117319274,-0.0149333698016354,3.43204167905064e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37567,-0.0620898829706084,0.00988586232293448,-0.08146617312356,-0.0427135928176568,3.47752033514007e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37985,-0.0155430279733164,0.00247536910715756,-0.0203947514233453,-0.0106913045232876,3.51001219016963e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,40511,-0.0462712992031974,0.00737353721391631,-0.0607234321424733,-0.0318191662639214,3.57863036394495e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,37593,-0.0431886566971856,0.00690636631489438,-0.0567251346743786,-0.0296521787199926,4.1390388225173e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,40395,0.0332843392552863,0.00532473174814827,0.0228478650289157,0.0437208134816569,4.184855262559e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,37896,-0.0304450812173614,0.00487983067185762,-0.0400095493342023,-0.0208806131005204,4.53692983632533e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,40300,-0.0427393260779943,0.00685305035228339,-0.0561713047684697,-0.0293073473875188,4.58695503903285e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37955,-0.037537728530082,0.00602258465264857,-0.0493419944492732,-0.0257334626108908,4.71716810505196e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39975,-0.0273451715026178,0.00438830526498882,-0.0359462498219959,-0.0187440931832397,4.7429320042381e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,40417,-0.0244606078081677,0.00393249341882412,-0.0321682949090629,-0.0167529207072724,5.09124885665161e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,40327,-0.0615003299231945,0.00989998893389595,-0.0809043082336306,-0.0420963516127585,5.35630901635772e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,40223,-0.0288890560536368,0.0046511436716356,-0.0380052976500426,-0.0197728144572311,5.39092167322221e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,40304,-0.0592078823483288,0.00953279071722016,-0.0778921521540803,-0.0405236125425772,5.39715962008387e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,40400,-0.0263384985887749,0.00424300670169034,-0.034654791724088,-0.0180222054534618,5.51627281894684e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39975,-0.0347148621398505,0.0055935154075916,-0.04567815233873,-0.0237515719409709,5.56352148433012e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,37985,-0.0470571024563921,0.00758386673619098,-0.0619214812593264,-0.0321927236534578,5.63288326994264e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,40382,-0.0156629573315631,0.00253015085488687,-0.0206220530071414,-0.0107038616559848,6.14337001152518e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37666,-0.035505087526566,0.00573994303852127,-0.0467553758820677,-0.0242547991710643,6.36850747690768e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,37593,-0.0223134254795826,0.0036095377982664,-0.0293881195641847,-0.0152387313949805,6.52520708628364e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,40531,-0.0165707610265289,0.00268311000935934,-0.0218296566448732,-0.0113118654081846,6.73466523949984e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,40223,-0.0379064717647294,0.00614134008296069,-0.0499434983273323,-0.0258694452021264,6.89300337175076e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37666,-0.0606944860732364,0.00983973461609681,-0.0799803659207861,-0.0414086062256866,7.10396932781266e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,37536,-0.0239608602067756,0.00388540245803304,-0.0315762490245204,-0.0163454713890308,7.16954848147085e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,40039,-0.0471400846588267,0.00765602839767583,-0.0621459003182713,-0.0321342689993821,7.58331144705057e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,40162,-0.0164936385476177,0.00267981425128763,-0.0217460744801414,-0.0112412026150939,7.70123890973028e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,37955,-0.052522367210845,0.00853705107152007,-0.0692549873110243,-0.0357897471106656,7.85324052755872e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37993,-0.0182184987182101,0.00296146959647991,-0.0240229791273107,-0.0124140183091095,7.87441883613133e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,37567,-0.0209792758223468,0.00341135610088476,-0.0276655337800809,-0.0142930178646127,7.98171715124605e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,40369,-0.0150710310825993,0.00245499245394142,-0.0198828162923245,-0.0102592458728741,8.50487673432235e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,37976,-0.0139186883926883,0.00226901965704104,-0.0183659669204888,-0.00947140986488787,8.79585485593109e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,40177,-0.0151969415028811,0.00247789165391963,-0.0200536091445636,-0.0103402738611986,8.82927845750037e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,40417,-0.0167127151015768,0.00272712903604323,-0.0220578880122215,-0.0113675421909321,9.08985550122255e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,37972,-0.0170510166432619,0.00278408467378159,-0.0225078226038738,-0.01159421068265,9.35131807733415e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,40300,-0.0114963546809729,0.00187786456919242,-0.0151769692365901,-0.00781574012535576,9.45642366180171e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,37479,-0.0277131193756271,0.00453156369559161,-0.0365949842189866,-0.0188312545322675,9.89619189700898e-10
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,37666,0.0162356380483944,0.00265721905703184,0.011027488696612,0.0214437874001768,1.02423709929737e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,40039,-0.0249626686965484,0.00408620269950242,-0.0329716259875731,-0.0169537114055236,1.02630948567401e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,40037,-0.0207167191684434,0.00339216838968924,-0.0273653692122343,-0.0140680691246524,1.03788082911618e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,40286,-0.0175136177141958,0.00286782266299973,-0.0231345501336752,-0.0118926852947163,1.03932359294751e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,40327,-0.0296330478511656,0.00485394820857298,-0.0391467863399686,-0.0201193093623625,1.0523407469315e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37939,-0.0112146049326527,0.00183685068070974,-0.0148148322668438,-0.00761437759846165,1.05394656859235e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37593,-0.0203699355575745,0.00333936160519033,-0.0269150843037475,-0.0138247868114014,1.09081168299692e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37985,-0.0453606916591609,0.00743810220130402,-0.0599393719737168,-0.030782011344605,1.10036576398584e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,40300,0.0466435748684279,0.00765529488283504,0.0316391968980712,0.0616479528387846,1.13389605602443e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,37961,-0.022484052727221,0.00369131364047022,-0.0297190274625427,-0.0152490779918994,1.15202473308182e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,40492,-0.0150849299374047,0.00248150000448004,-0.0199486699461855,-0.0102211899286238,1.23706259298789e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37985,-0.0138271293418496,0.00227543524270016,-0.0182869824175419,-0.00936727626615728,1.25977081546623e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,40327,0.0204944481937349,0.00337397096399024,0.013881465104314,0.0271074312831557,1.27385222837761e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,40223,-0.0290295172050109,0.00477920151233919,-0.0383967521691958,-0.0196622822408261,1.27519598906544e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C5,Complement C5,38008,-0.00771277370563364,0.00126972128459464,-0.0102014274234391,-0.00522411998782815,1.27795654492415e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,40371,-0.0151018220310481,0.00248761686632277,-0.0199775510890407,-0.0102260929730554,1.30163908661233e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,40327,-0.0609463528812024,0.0100424218322337,-0.0806294996723804,-0.0412632060900245,1.31724972621653e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37623,-0.0423246265205293,0.00698301651072846,-0.0560113388815571,-0.0286379141595016,1.38902899517898e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGMN,Legumain,40417,-0.0178757568370106,0.00295135254430045,-0.0236604078238395,-0.0120911058501817,1.41968361084377e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,39941,-0.0284277592563501,0.00469701538160418,-0.0376339094042943,-0.0192216091084059,1.460814208857e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37593,-0.013440890588658,0.00222098168494477,-0.0177940146911498,-0.0090877664861663,1.47152784092471e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37623,-0.0309146238947277,0.00511383089453187,-0.0409377324480102,-0.0208915153414452,1.53167054390418e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37955,-0.0400877656672723,0.00663210107742992,-0.053086683779035,-0.0270888475555097,1.53818376777537e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,40336,-0.0361384200961719,0.00598281818188458,-0.0478647437326656,-0.0244120964596781,1.57192551933569e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40511,-0.0378767081109965,0.00627512256623424,-0.0501759483408156,-0.0255774678811774,1.61444660977419e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,40336,-0.0244662788157984,0.00405580404033678,-0.0324156547348585,-0.0165169028967384,1.65114277278639e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,40336,-0.0613676561482801,0.0101750280298043,-0.0813107110866965,-0.0414246012098637,1.66351439587269e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,38008,-0.015890053343028,0.00263467990919798,-0.021054025965056,-0.0107260807209999,1.67069860201309e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,40037,-0.0423996850211492,0.00703157105963092,-0.0561815642980258,-0.0286178057442726,1.67762992717035e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,40037,-0.0336446033923996,0.00558259958151072,-0.0445864985721606,-0.0227027082126386,1.71120719509409e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37557,-0.0288481313358315,0.00478955871507283,-0.0382356664173743,-0.0194605962542888,1.75658031055006e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37623,-0.0381313719161766,0.00633164378472767,-0.0505413937342429,-0.0257213500981104,1.76480978100536e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,40300,-0.0524956788363459,0.00871785143413671,-0.0695826676472539,-0.035408690025438,1.7648123889937e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39975,-0.041127239632105,0.00683891179044828,-0.0545315067413837,-0.0277229725228264,1.85390503811653e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,40336,-0.0214219667890868,0.00356347369709642,-0.0284063752353958,-0.0144375583427779,1.87789991818958e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37985,-0.0321272629196697,0.0053459250072853,-0.0426052759339489,-0.0216492499053905,1.90674261549697e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37896,-0.0106989196578142,0.00178085756563932,-0.0141894004864673,-0.00720843882916112,1.92993800281103e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,39956,-0.0188145107352403,0.00313583562502619,-0.0249607485602916,-0.012668272910189,2.01907936843461e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,40417,-0.0140941556878855,0.00235012921433176,-0.0187004089479758,-0.00948790242779527,2.05099503402111e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,40417,-0.0381916928941909,0.00636840084929063,-0.0506737585588006,-0.0257096272295813,2.0525273006259e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37955,-0.0424055642399987,0.00707700711166834,-0.0562764981788687,-0.0285346303011288,2.12526974637811e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37623,-0.0508993055205823,0.00850703140557502,-0.0675730870755093,-0.0342255239656552,2.24468748290627e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37955,-0.0303022042790395,0.00507157674993883,-0.0402424947089196,-0.0203619138491594,2.36014980951821e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,37220,-0.0536055801431927,0.00897537114924545,-0.0711973075957138,-0.0360138526906716,2.39829963774713e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLU,Clusterin,38008,-0.0164046704141241,0.00274894814516346,-0.0217926087786444,-0.0110167320496037,2.46750074579547e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,40300,-0.01638918797473,0.00274878320414764,-0.0217768030548594,-0.0110015728946006,2.53926912925643e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,40336,-0.0263584202672872,0.00442238751049568,-0.0350262997878588,-0.0176905407467157,2.57221829302837e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37937,-0.0131519865709236,0.00220692107555533,-0.0174775518790121,-0.00882642126283516,2.59437873791657e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37985,-0.0483041675798294,0.00811124358827021,-0.064202205012839,-0.0324061301468197,2.66175230023954e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,40374,-0.0146833515293374,0.00246807072747512,-0.0195207701551887,-0.0098459329034862,2.74895048330853e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,37985,-0.0149057528461326,0.00250620016797191,-0.0198179051753575,-0.00999360051690765,2.78897573699554e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,40300,-0.0335860092011181,0.00565116353305523,-0.0446622897259064,-0.0225097286763299,2.85367770742195e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,40202,-0.0222134026296395,0.00373865174343564,-0.0295411600467734,-0.0148856452125057,2.88282933770553e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37973,-0.0237985427419828,0.00400509830658206,-0.0316485354228837,-0.015948550061082,2.88381834019943e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,37397,-0.0390119743390025,0.00656541652599838,-0.0518801907299593,-0.0261437579480457,2.88730227248985e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37955,0.0222934257741461,0.00375224192316842,0.014939031604736,0.0296478199435562,2.89623291469715e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,40466,-0.0287287560836831,0.00483679919258502,-0.0382088825011497,-0.0192486296662164,2.91594780638654e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,40417,-0.0585809417002017,0.0098706117706279,-0.0779273407706323,-0.039234542629771,3.00139038072402e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,40354,0.016700784424239,0.00281479929279698,0.0111837778103569,0.0222177910381211,3.03242552417406e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40484,-0.0153676616842248,0.00259228855065858,-0.0204485472435156,-0.010286776124934,3.12516910060144e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37914,-0.0293691954029231,0.00495497032370002,-0.0390809372373752,-0.0196574535684711,3.15644979554085e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,40336,-0.0196559001021608,0.00331670006526987,-0.0261566322300897,-0.0131551679742318,3.16164882450667e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,40398,-0.0136091913223648,0.00229959888392641,-0.0181164051348605,-0.00910197750986898,3.32413639867656e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",40177,-0.0201357102621387,0.0034046082554776,-0.0268087424428748,-0.0134626780814026,3.402996553324e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37982,-0.0132707316168622,0.00224457773461524,-0.017670103976708,-0.0088713592570163,3.4538663796975e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37666,0.0149748669746566,0.00253308460923061,0.0100100211405646,0.0199397128087486,3.46923052080769e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,40111,-0.0332881182743487,0.00563202653544122,-0.0443268902838135,-0.0222493462648839,3.48144965527462e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,40336,-0.0268849507904566,0.004549780824084,-0.0358025212056613,-0.017967380375252,3.51091652883655e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,40300,-0.0418743663112987,0.0070958721919295,-0.0557822758074806,-0.0279664568151169,3.68161616000195e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,40485,-0.023989385382604,0.00406845287850217,-0.0319635530244683,-0.0160152177407398,3.78891810149369e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,40300,-0.0598931983257268,0.0101690897241514,-0.0798246141850636,-0.0399617824663901,3.9465404252881e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,40354,-0.0373731869831878,0.00634692383224284,-0.0498131576943838,-0.0249332162719918,3.9782474054976e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,40417,-0.0510846423868952,0.00868011855514961,-0.0680976747549885,-0.034071610018802,4.05419877544055e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,37666,-0.0278383042421319,0.00473354504983228,-0.0371160525398031,-0.0185605559444606,4.17478807142015e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,40429,-0.0353143330444428,0.0060069161047531,-0.0470878886097589,-0.0235407774791267,4.2111614323289e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,37593,-0.00823461481151417,0.00140096154486063,-0.010980499439441,-0.00548873018358734,4.2576001028595e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,37805,-0.0520082294987137,0.00885092560941899,-0.0693560436931749,-0.0346604153042525,4.30261165180853e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFB,Complement factor B,37765,-0.0159720971350167,0.00271975131740538,-0.0213028097171312,-0.0106413845529021,4.39163683184209e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,40336,-0.0188998279699877,0.00321875861703506,-0.0252085948593765,-0.012591061080599,4.39753880226255e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,40333,0.0222085003914249,0.00378253759883872,0.014794726697701,0.0296222740851488,4.40954797102105e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,37869,-0.0277310794021638,0.00472592387815468,-0.0369938902033469,-0.0184682686009806,4.51859722691678e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,40336,0.015978054147891,0.00272493962953636,0.0106371724739997,0.0213189358217823,4.61824657632448e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSG,Basigin,40497,-0.00984578588351319,0.00167936507675597,-0.0131373414339549,-0.00655423033307149,4.64053212213477e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40531,-0.0167045003171167,0.00285095390391161,-0.0222923699687835,-0.0111166306654499,4.73999731825294e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,40406,-0.0148722338414057,0.00254276462858559,-0.0198560525134334,-0.00988841516937791,5.0468247562597e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,40265,-0.0382534495788163,0.00654696693232488,-0.0510855047661731,-0.0254213943914595,5.22997203685406e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,37896,-0.0137330368970467,0.00235270924135675,-0.0183443470101059,-0.00912172678398748,5.43370628141311e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37937,-0.022129906606882,0.0037929641507151,-0.0295641163422836,-0.0146956968714804,5.52028637594982e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39918,-0.0367403111380389,0.00630162390071823,-0.0490914939834466,-0.0243891282926311,5.64330640962939e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,40398,-0.048523998619864,0.00832705995813462,-0.0648450361378079,-0.0322029611019202,5.7429227822551e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37895,-0.0417684694897788,0.00718703301279501,-0.055855054194857,-0.0276818847847005,6.32652515804575e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,40406,-0.0103235821876258,0.00177654436192264,-0.0138056091369942,-0.00684155523825747,6.32672211814627e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,40300,-0.0371241635519971,0.00639210268896877,-0.0496526848223759,-0.0245956422816183,6.45048993127826e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37896,-0.0225303399599351,0.00387984836855995,-0.0301348427623126,-0.0149258371575576,6.50334686435585e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,37896,-0.0168959367781761,0.00291280573994153,-0.0226050360284615,-0.0111868375278907,6.75765391206908e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,37593,-0.0145922067396147,0.00251616173811646,-0.019523883746323,-0.00966052973290648,6.80872586267774e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,37567,-0.038038302252922,0.0065591144852487,-0.0508941666440094,-0.0251824378618345,6.81255174113319e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,37993,-0.0119521047690898,0.0020611323971875,-0.0159919242675772,-0.00791228527060226,6.82793419956229e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40511,-0.0481523946918715,0.00830575451018762,-0.0644316735318392,-0.0318731158519038,6.85847999163661e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,40336,-0.0255077471263349,0.00440551017496268,-0.0341425470692618,-0.0168729471834081,7.17305772258206e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,40446,-0.0205354407638894,0.00355354407779857,-0.0275003871563746,-0.0135704943714042,7.66071521649245e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40512,-0.013058219169484,0.00226089601913173,-0.0174895753669822,-0.00862686297198579,7.80587317052348e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,40223,-0.0321052107668824,0.00555868449499954,-0.0430002323770815,-0.0212101891566833,7.80840704917392e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37709,-0.0334912721923333,0.00580944763698817,-0.0448777895608301,-0.0221047548238365,8.34933444786128e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,39975,-0.0389212478542412,0.00676264437854561,-0.0521760308361906,-0.0256664648722918,8.81049610661822e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,40369,-0.0223970065947325,0.00389178528207117,-0.030024905747592,-0.014769107441873,8.82650830590918e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,40300,-0.0262874218424267,0.00456955404241164,-0.0352437477655535,-0.0173310959192999,8.94326476010685e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,40417,-0.0183171649097441,0.00318474376165196,-0.024559262682582,-0.0120750671369063,9.00552128221298e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37985,-0.0337499675184312,0.0058699646350781,-0.0452550982031843,-0.0222448368336781,9.13844425562817e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,40198,-0.0423800027199007,0.00738110321195951,-0.0568469650153413,-0.0279130404244601,9.54643700116084e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,40058,-0.0202423169946563,0.00352553742314449,-0.0271523703440195,-0.0133322636452931,9.55157809588264e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,40336,-0.0124005835128239,0.00216146134151165,-0.0166370477421868,-0.00816411928346112,9.80485793807961e-09
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,40406,-0.0453057885140401,0.00791856650854939,-0.060826178870797,-0.0297853981572833,1.07505084810416e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,40354,-0.0167376170947217,0.0029300339100642,-0.0224804835584475,-0.0109947506309958,1.13365733781275e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBIN,Erbin,40300,-0.048624312547936,0.00852077745330872,-0.0653250363564211,-0.0319235887394509,1.17344469247968e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,40037,-0.0224890886465484,0.00394521101821408,-0.030221702242248,-0.0147564750508488,1.21725344037552e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39975,-0.0270814705531783,0.00475565419386199,-0.0364025527731478,-0.0177603883332088,1.25912455647942e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37593,-0.0361916850433277,0.00636349271676209,-0.0486641307681814,-0.023719239318474,1.3174214073158e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,40037,-0.0180577079242957,0.00317538125671726,-0.0242814551874616,-0.0118339606611299,1.31775743600094e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,37985,0.0118148103593529,0.0020779926848329,0.00774194469708038,0.0158876760216253,1.329821289686e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,40307,-0.0418999448271657,0.00737562175956069,-0.0563561634759046,-0.0274437261784267,1.36364455297324e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,40323,-0.017164443758176,0.00302148211218011,-0.023086548698049,-0.011242338818303,1.36415240859426e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40484,-0.0159605194850482,0.00281010326110117,-0.0214683218768065,-0.0104527170932899,1.37278712825955e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,40352,0.0249478523404587,0.00439350065544476,0.016336591055787,0.0335591136251304,1.38373670600675e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",40288,-0.0272850333150181,0.00480884353040994,-0.0367103666346216,-0.0178596999954146,1.42000987818646e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37623,-0.0251966845394629,0.0044406194267173,-0.0339002986158288,-0.016493070463097,1.42325873959504e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37666,-0.028800872390361,0.00507635275157874,-0.0387505237834554,-0.0188512209972667,1.42815355862648e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39975,-0.0225661744446803,0.00397963261077714,-0.0303662543618035,-0.0147660945275571,1.44987233783474e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",40187,-0.044857172694919,0.00791205791092781,-0.0603648062003375,-0.0293495391895005,1.4575441613012e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37955,-0.028141490521901,0.00496483657420143,-0.0378725702073358,-0.0184104108364662,1.47291974007105e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,40300,-0.00998881487784225,0.00176942138893348,-0.0134568808001519,-0.00652074895553263,1.67774147818347e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37896,-0.0359787032014881,0.00637360694345669,-0.0484709728106632,-0.023486433592313,1.68569060318791e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,40306,-0.0190320005796292,0.00337381218134062,-0.0256446724550568,-0.0124193287042016,1.71856680544954e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37896,-0.0300261888511383,0.005323217090569,-0.0404596943486536,-0.0195926833536231,1.72865735859331e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,40354,-0.0393564193518212,0.00697870856731901,-0.0530346881437665,-0.025678150559876,1.73446766421204e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39892,-0.0267720200987667,0.00475758150346058,-0.0360968798455494,-0.0174471603519839,1.86304831205401e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37709,-0.0521384928945055,0.00926723974194935,-0.0703022827887262,-0.0339747030002848,1.88052157343224e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,40037,-0.0349304582135755,0.00621577149413786,-0.0471133703420857,-0.0227475460850653,1.94621051253392e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37955,-0.0357746778227865,0.006369345372715,-0.0482585947533079,-0.0232907608922651,1.98485849468317e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39975,-0.0373997800927648,0.00667028854503679,-0.0504735456410369,-0.0243260145444927,2.09466838386073e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,40039,0.02049640761047,0.00365565714670947,0.0133313196029194,0.0276614956180205,2.09641557580482e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,37878,-0.021406657246974,0.00382028861352671,-0.0288944229294864,-0.0139188915644617,2.14305502887293e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,40324,-0.0452189115582671,0.00807504554162092,-0.0610460008198441,-0.0293918222966901,2.18114644359935e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,40039,-0.0308437235075145,0.00550980830879351,-0.0416429477927498,-0.0200444992222792,2.20537338660227e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,40354,-0.022729694960754,0.00406112751044027,-0.030689504881217,-0.0147698850402911,2.2183123668355e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,40142,-0.0215662301838562,0.00385345071842047,-0.0291189935919603,-0.014013466775752,2.22251667082667e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,40149,-0.0163361515317029,0.00292140233999573,-0.0220621001180945,-0.0106102029453113,2.28359793868269e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37895,0.0178960490785341,0.00320108043722414,0.0116219314215747,0.0241701667354934,2.30655842670342e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37896,-0.0272500104218774,0.00487523861793332,-0.0368054781130267,-0.0176945427307281,2.32192071539399e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,40345,-0.0229317416102344,0.00410538206159648,-0.0309782904509635,-0.0148851927695053,2.36474239765329e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,40511,-0.0253233401157835,0.0045348511468839,-0.0342116483636759,-0.016435031867891,2.38636254610884e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,39956,-0.0285336745703399,0.00511014216617198,-0.038549553216037,-0.0185177959246428,2.39359896684822e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37557,0.0369740925030012,0.00662586541815886,0.0239873962834098,0.0499607887225926,2.44914056193851e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,40398,-0.0215744181642166,0.00386881117737678,-0.0291572880718751,-0.0139915482565581,2.49392463602447e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39920,-0.0218152728103166,0.00391224502197652,-0.0294832730533906,-0.0141472725672427,2.50012138387642e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,37912,-0.0136508051871372,0.00244815100779225,-0.01844918116241,-0.0088524292118644,2.50899223777316e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,40223,-0.0135774760502771,0.00243555813566496,-0.0183511699961804,-0.00880378210437374,2.5203959442203e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,40406,-0.0258489955523552,0.00463895567286123,-0.0349413486711632,-0.0167566424335472,2.5567252345547e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,40300,-0.0143736705381959,0.00258107497709754,-0.019432577493307,-0.00931476358308469,2.60562753569214e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,40398,-0.026961235235638,0.00484485075638707,-0.0364571427181566,-0.0174653277531193,2.66486943470691e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37955,-0.0330652942226348,0.00594427629140163,-0.044716075753782,-0.0214145126914876,2.70924397940834e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37557,0.0259577651629184,0.00466661414933412,0.0168112014302235,0.0351043288956133,2.71237982643502e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,40419,-0.00971315486624449,0.00174780566165057,-0.0131388539630796,-0.00628745576940937,2.78294148843699e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40511,-0.0320306629111218,0.00576412256232171,-0.0433283431332723,-0.0207329826889712,2.78970930919224e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,40327,-0.0246839315297023,0.0044431620448307,-0.0333925291375705,-0.0159753339218342,2.8128608068552e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,38008,-0.0115677408134926,0.00208266166747163,-0.015649757681737,-0.00748572394524822,2.83962497782675e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37623,-0.0217678213011385,0.00391983215557241,-0.0294506923260604,-0.0140849502762165,2.85830422730378e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,40265,-0.0185310279047063,0.00333843251772144,-0.0250743556394403,-0.0119877001699722,2.88909296670635e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37855,-0.0497920875284604,0.00897056953740489,-0.067374403821774,-0.0322097712351468,2.9008871118964e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELP,P-selectin,40398,-0.0265950788010031,0.00479247240663926,-0.0359883247180161,-0.0172018328839902,2.91310085706216e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,37937,-0.0180062024415614,0.00324482346830982,-0.0243660564394486,-0.0116463484436741,2.9237610663861e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,40406,-0.0330659632491791,0.00595961767888019,-0.0447468138997843,-0.0213851125985739,2.92988397219841e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37874,-0.032364943396788,0.00583386785381024,-0.0437993243902561,-0.0209305624033199,2.94815587372473e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37570,-0.0164108755333664,0.00295819004525072,-0.0222089280220578,-0.010612823044675,2.95214081389114e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,40417,-0.00942567696031818,0.00170431041505604,-0.012766125373828,-0.00608522854680835,3.24344601898104e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,37879,-0.0405639725952879,0.00734255267586882,-0.0549553758399907,-0.026172569350585,3.36563496876559e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,40327,-0.0410965540030647,0.00744477058462737,-0.0556883043489344,-0.0265048036571951,3.43938983357484e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,37937,-0.0305567158552178,0.00554399711718427,-0.041422950204899,-0.0196904815055366,3.61958620244105e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,40417,-0.0572144728906531,0.0103851968513888,-0.0775694587193751,-0.0368594870619311,3.6597275169155e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,40371,-0.0309456231028367,0.00562226614601689,-0.0419652647490298,-0.0199259814566436,3.76751366950708e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,40267,-0.0106156955615708,0.00192922778132486,-0.0143969820129675,-0.00683440911017406,3.80127092318262e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,40140,-0.0164878719274499,0.00299644018803702,-0.0223608946960024,-0.0106148491588973,3.80336973738071e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39975,-0.0201932139714672,0.00367389154529627,-0.0273940414002479,-0.0129923865426865,3.93710322079802e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37896,-0.0262865094417352,0.00478315045746342,-0.0356614843383634,-0.0169115345451069,3.96367189091593e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,40136,-0.0675727862553196,0.0123196260558071,-0.0917192533247014,-0.0434263191859378,4.19936879804043e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,40263,-0.0170309980310003,0.00311013001608317,-0.0231268528625233,-0.0109351431994773,4.41741343738482e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,40460,-0.0120057861836878,0.00219357205870319,-0.016305187418746,-0.0077063849486295,4.48707708019351e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37937,-0.0282450115761343,0.00516063705102899,-0.0383598601961512,-0.0181301629561175,4.49968337222135e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,37985,-0.0337648123466393,0.00618130238695735,-0.0458801650250757,-0.0216494596682029,4.78008611555126e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,40406,-0.0413568660276905,0.00757361842101471,-0.0562011581328793,-0.0265125739225016,4.81490375068964e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37976,-0.00843271388849778,0.00154572734400189,-0.0114623394827415,-0.00540308829425408,4.96944512455136e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,39946,-0.0501098074298615,0.00920158763861286,-0.0681449192015427,-0.0320746956581803,5.23649322893513e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,40453,-0.0135497770699402,0.00248967485801296,-0.0184295397916456,-0.00867001434823478,5.3344270715869e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,40336,-0.0377251502396144,0.00693230360912824,-0.0513124653135058,-0.0241378351657231,5.34854877430097e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,40039,-0.0221121644908641,0.00406732775464883,-0.0300841268899758,-0.0141402020917524,5.51441292619283e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,40039,-0.0246974779323779,0.00454739711943065,-0.033610376286462,-0.0157845795782938,5.68391483748724e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,37557,-0.0268589483448469,0.00494753358248084,-0.0365561141665093,-0.0171617825231844,5.7759136393384e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EZR,Ezrin,40466,-0.0106561183519122,0.00196322076500394,-0.0145040310513199,-0.00680820565250445,5.78582383909505e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37666,-0.0129754144320508,0.0023914658709909,-0.017662687539193,-0.00828814132490868,5.87399442199223e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,40336,-0.0230795710325535,0.00425612770096914,-0.031421581326453,-0.014737560738654,5.95735821158222e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37955,-0.0340294343996285,0.00627675186538364,-0.0463318680557805,-0.0217270007434766,6.01156936437051e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37895,-0.0305040682095343,0.00562780037165343,-0.0415345569379751,-0.0194735794810936,6.05435458641517e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,40336,-0.0372003052392924,0.00686383131877117,-0.0506534146240839,-0.0237471958545009,6.05498694125896e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,37993,-0.0211460223768216,0.00390282328983022,-0.0287955560248888,-0.0134964887287543,6.12538982417782e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37895,-0.0275793708840003,0.0050932202208149,-0.0375620825167975,-0.0175966592512031,6.23705354293095e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40531,-0.0190094406176994,0.00351752059761053,-0.025903780989016,-0.0121151002463828,6.60195442375143e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,39898,-0.0191771316693261,0.00355132996717396,-0.0261377384049871,-0.0122165249336652,6.76314198153182e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,40406,-0.0326386437760847,0.00604653580317539,-0.0444898539503085,-0.0207874336018609,6.83858157591549e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,40406,-0.0122002449372963,0.00226126482053337,-0.0166323239855417,-0.00776816588905086,6.93774842020649e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,37623,-0.0312094113077414,0.00579002843322261,-0.0425578670368577,-0.0198609555786251,7.15921619343548e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,40223,-0.0355077204176925,0.00659793049586643,-0.0484396641895907,-0.0225757766457943,7.48626225912748e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,40417,-0.0118239194255859,0.00219743337677121,-0.0161308888440575,-0.00751695000711437,7.52070847437992e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37937,-0.023670893957151,0.00440034259727038,-0.032295565447801,-0.0150462224665011,7.60119712442318e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,40300,-0.051877459669794,0.00964705009777658,-0.0707856778614361,-0.0329692414781519,7.65780310880304e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37666,-0.0367342139568195,0.00683538466779325,-0.0501315679056943,-0.0233368600079448,7.82618230966049e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,40300,-0.0247341816304075,0.00460297881033536,-0.0337560200986648,-0.0157123431621502,7.83071216488021e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37946,-0.0302304725827013,0.0056263265772998,-0.0412580726742089,-0.0192028724911937,7.87064718200826e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,40300,-0.0267088724914372,0.00497209091617617,-0.0364541706871425,-0.0169635742957319,7.90730011036869e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,40304,-0.017393444302335,0.00324373412703271,-0.0237511631913192,-0.0110357254133509,8.33817575434774e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,40354,-0.012478079508331,0.00232827836286871,-0.0170415050995537,-0.00791465391710831,8.46820620302812e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37623,-0.0396765768022375,0.00740253703094224,-0.0541855493828843,-0.0251676042215907,8.46895462075061e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37955,-0.0425128440106225,0.0079324083075011,-0.0580603642933247,-0.0269653237279204,8.48772868468811e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,40406,-0.00959482711757445,0.00179043717543385,-0.0131040839814248,-0.00608557025372411,8.48792555071101e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,40327,-0.0231805213138961,0.00433164273954437,-0.0316705410834031,-0.0146905015443892,8.84691279692777e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,37666,-0.0277415888540859,0.00518425868800874,-0.037902735882583,-0.0175804418255888,8.88710633438007e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,40336,-0.053002635589061,0.00990821343508937,-0.0724227339218362,-0.0335825372562858,8.94870263692396e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37666,-0.0373446044321675,0.00698099219119401,-0.0510273491269078,-0.0236618597374272,8.96834425185394e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37709,-0.0159964802721394,0.00299164873025919,-0.0218601117834474,-0.0101328487608314,9.08851435215061e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40497,-0.0168329176797012,0.00314865218432758,-0.0230042759609832,-0.0106615593984191,9.11138944659175e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,37666,-0.0327776950947584,0.00613119101645775,-0.0447948294870156,-0.0207605607025012,9.13862917694126e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRELP,Prolargin,40352,-0.0103220338970431,0.00193147538660155,-0.0141077256547822,-0.00653634213930409,9.21107790833795e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40511,-0.0260397602998468,0.00487350916222542,-0.0355918382578086,-0.016487682341885,9.26048405907826e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,40179,0.0208101481723834,0.0039001993171459,0.0131657575107775,0.0284545388339894,9.65151848426989e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,40223,-0.0157070180917883,0.00294474370087639,-0.021478715745506,-0.00993532043807055,9.74428465920681e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,40336,-0.0274487987954593,0.00514781442397763,-0.0375385150664554,-0.0173590825244631,9.83972943320287e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,40223,-0.0243286077627453,0.00456507282436042,-0.0332761504984917,-0.0153810650269989,9.99520986799598e-08
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,37617,-0.0292314589024726,0.00549064313494082,-0.0399931194469566,-0.0184697983579886,1.03252462165807e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37666,-0.0386107798447756,0.00725607767928059,-0.0528326920961655,-0.0243888675933856,1.04789483674283e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,37955,-0.0302828605259066,0.00569316817161618,-0.0414414701422743,-0.0191242509095389,1.05912292493933e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37567,-0.0302010963955134,0.00567787682881572,-0.0413297349799922,-0.0190724578110346,1.06005558425285e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,38008,0.0293115611852397,0.00551297978074608,0.0185061208149774,0.040117001555502,1.07267835193161e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REN,Renin,40354,0.0315202680163126,0.00593553120686351,0.0198866268508602,0.0431539091817651,1.1083341785863e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40448,-0.0291819457780087,0.00549872056027637,-0.0399594380761503,-0.018404453479867,1.1290415250538e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,37896,-0.0295868671602128,0.00557742239845574,-0.040518615061186,-0.0186551192592395,1.14613009709155e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,37993,-0.0363412565562987,0.00686054239083987,-0.0497879196423448,-0.0228945934702526,1.19472115775871e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40512,-0.0104487870843189,0.00197395054623312,-0.0143177301549358,-0.00657984401370194,1.21683386824823e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,37985,-0.0189055840108978,0.00357282881199903,-0.0259083284824158,-0.0119028395393797,1.23217531564305e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37666,-0.0490491951977026,0.00927470557461153,-0.0672276181239412,-0.030870772271464,1.25296356623577e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37985,-0.0325468818332081,0.00615774060723056,-0.04461605342338,-0.0204777102430362,1.27293017685804e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,40374,-0.0139256550040355,0.00263684925920991,-0.019093879552087,-0.0087574304559841,1.30047720160031e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,40327,-0.011613634544916,0.00219956496283575,-0.0159247818720741,-0.00730248721775796,1.30908246015392e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,40223,-0.0163458821774439,0.00309922092039446,-0.022420355181417,-0.0102714091734707,1.35104247039007e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37858,-0.0189867171525093,0.00360073584729801,-0.0260441594132134,-0.0119292748918052,1.36289315939898e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37905,-0.0179019858116442,0.0034019593796073,-0.0245698261956745,-0.0112341454276139,1.44483189863843e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,40274,-0.0313940732044669,0.00596725057949821,-0.0430898843402834,-0.0196982620686504,1.45093240941607e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37985,-0.0466092826017258,0.00886720364225308,-0.0639890017405419,-0.0292295634629098,1.49162157640385e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,37637,-0.0139261798090403,0.00265267892356632,-0.0191254304992303,-0.00872692911885033,1.54583160549213e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,37955,-0.023851846449807,0.0045438170194485,-0.0327577278079261,-0.014945965091688,1.54994717988253e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,40327,0.0229796271971711,0.00437946663980238,0.0143958725831584,0.0315633818111837,1.56474282081464e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,40354,-0.0345552374806056,0.00659057214714109,-0.0474727588890022,-0.0216377160722091,1.59894584045234e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37709,-0.0241297947987269,0.0046061386109825,-0.0331578264762526,-0.0151017631212012,1.64262908171417e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37895,-0.0409827675849528,0.0078259412632214,-0.0563216124608667,-0.0256439227090388,1.65863117134923e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,40417,-0.0123855316606811,0.00236813262405349,-0.0170270716038259,-0.00774399171753624,1.71572687644177e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37982,-0.0203166794483313,0.00388531997038607,-0.027931906590288,-0.0127014523063747,1.72886839666224e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,40336,-0.0351277707428651,0.00672629321229011,-0.0483113054389537,-0.0219442360467765,1.78793569663393e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37896,-0.0422740693675919,0.00810394585238328,-0.0581578032382631,-0.0263903354969206,1.85064770684992e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,40300,-0.0409978347204989,0.00786352268936568,-0.0564103391916557,-0.0255853302493422,1.87464202368845e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,40466,-0.0130177831812397,0.00249731129624254,-0.0179125133218751,-0.00812305304060436,1.88404544345331e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,40484,-0.0146555553609007,0.00281255887556146,-0.0201681707570012,-0.00914293996480026,1.90404524643534e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,40395,-0.0308769058787642,0.0059289617736467,-0.0424976709551118,-0.0192561408024167,1.93458768591868e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39975,-0.0266526773846622,0.00511948494581333,-0.0366868678784564,-0.0166184868908681,1.95285049829474e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,40300,-0.0102631226166039,0.00197895665072687,-0.0141418776520285,-0.00638436758117921,2.17354153146571e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37937,-0.0414731777350868,0.00800328297013046,-0.0571596123565425,-0.0257867431136311,2.22663189790624e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37895,-0.030084220580454,0.00581178676021827,-0.0414753226304818,-0.0186931185304262,2.29451384118039e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,39975,-0.0242547118769535,0.00468861571221343,-0.0334443986728918,-0.0150650250810151,2.33098309771809e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,40223,-0.0406569525088803,0.00786251432722742,-0.0560674805902461,-0.0252464244275146,2.3570975901033e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,40037,-0.032117561887292,0.00621401595486626,-0.0442970331588298,-0.0199380906157541,2.38809190337127e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37985,-0.0329598603972712,0.00638262625718756,-0.0454698078613588,-0.0204499129331836,2.45162105255325e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39975,-0.0328366059203607,0.00635946694660196,-0.0453011611357006,-0.0203720507050209,2.45472809829057e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,40429,-0.0265342959701681,0.00513954769207481,-0.0366078094466347,-0.0164607824937014,2.4624292768379e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,40417,-0.036756449864224,0.00712055473839799,-0.0507127371514841,-0.022800162576964,2.47229925884274e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,40037,-0.0414052746783695,0.00802378903701347,-0.0571319011909159,-0.0256786481658231,2.495622738139e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37895,-0.0352404963288726,0.0068378239977607,-0.0486426313644835,-0.0218383612932616,2.58935304906236e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,40355,-0.0268913952539601,0.00522174974292849,-0.0371260247500999,-0.0166567657578202,2.6376166955422e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,40223,-0.0252508593765967,0.0049194468224608,-0.0348929751486199,-0.0156087436045736,2.88754806619948e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37993,-0.00901384344922853,0.0017561880450499,-0.0124559720175263,-0.00557171488093072,2.8969571648995e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,40187,-0.0325996980642766,0.00635707924105083,-0.0450595733767362,-0.020139822751817,2.96164375530127e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,40305,-0.0198869990220814,0.00387928094026733,-0.0274903896650053,-0.0122836083791574,2.98705780544218e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,40354,-0.0281363240074207,0.00548902850658976,-0.0388948198803367,-0.0173778281345048,2.99558598334382e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,37985,-0.0222218791528785,0.00433649486502565,-0.0307214090883288,-0.0137223492174282,3.02617596649914e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37666,0.0155519835453017,0.0030352800986487,0.00960283455195022,0.0215011325386531,3.03758243219766e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39975,-0.0224171701455374,0.00438228527712804,-0.0310064492887084,-0.0138278910023664,3.16796541769248e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,40275,-0.0108932803260434,0.00213047573509314,-0.0150690127668259,-0.0067175478852608,3.20656121837545e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40511,-0.0162076828393772,0.00317231093133509,-0.022425412264794,-0.00998995341396047,3.27391066668156e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,40367,-0.0126085492849885,0.00246842583618611,-0.0174466639239133,-0.0077704346460637,3.29468747408831e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40466,-0.00977260868572499,0.00191341485403846,-0.0135229017996404,-0.00602231557180961,3.30340306476629e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40484,-0.0150624881202054,0.00294958208549189,-0.0208436690077695,-0.00928130723264125,3.31675158388898e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,37637,-0.0434112355698433,0.00851302656848254,-0.0600967676440691,-0.0267257034956175,3.4547768670646e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37896,-0.0357209411590699,0.00700842115682931,-0.0494574466264554,-0.0219844356916845,3.5002171516844e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,37819,-0.0123743177623694,0.00242880488121226,-0.0171347753295454,-0.00761386019519334,3.53836221190151e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,37666,-0.0287027539084675,0.00563515320149572,-0.0397476541833991,-0.0176578536335359,3.56322498293603e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,40039,-0.0200552118386258,0.00393852166711542,-0.027774714306172,-0.0123357093710796,3.58311917795006e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37666,-0.0399638979998364,0.00784988699942772,-0.0553496765187147,-0.0245781194809581,3.61048237333293e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40517,-0.0233787495686743,0.00459324835060384,-0.0323815163358578,-0.0143759828014908,3.62473892468854e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,40336,-0.0169763585905035,0.00333705495702729,-0.023516986306277,-0.01043573087473,3.6747619245359e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,40367,-0.0114428283973575,0.00225089884423104,-0.0158545901320504,-0.00703106666266468,3.74409107871362e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,40039,-0.0150749804497588,0.00296784061537312,-0.0208919480558901,-0.00925801284362743,3.82911539438625e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,40325,-0.0133248627060888,0.00262368703030275,-0.0184672892854821,-0.00818243612669538,3.84375714699187e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",40417,-0.0115676784168065,0.00228026374662382,-0.0160369953601892,-0.00709836147342382,3.9607535806958e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,40266,-0.022886380397077,0.00451183699572656,-0.0317295809087011,-0.0140431798854529,3.9702704043183e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37557,-0.0515472239260698,0.0101614198341635,-0.0714636068010303,-0.0316308410511093,3.97288552104592e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37955,-0.0526489665337638,0.0104043942752704,-0.0730415793132937,-0.0322563537542339,4.24182323366476e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLC,Galectin-10,40328,-0.0276676171168257,0.00547327297581986,-0.0383952321494326,-0.0169400020842188,4.35086324151503e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPSE,Heparanase,37843,-0.0388430146375889,0.00768794498594874,-0.0539113868100485,-0.0237746424651294,4.41907789873015e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,40336,-0.0191704440556618,0.00379558868726305,-0.0266097978826974,-0.0117310902286262,4.4503298578823e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,40492,-0.0199844060595393,0.00395924513433133,-0.0277445265228287,-0.0122242855962498,4.52459679510944e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37593,-0.0131445991231862,0.00260442226081675,-0.018249266754387,-0.00803993149198533,4.54728985010993e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGN,Mimecan,40327,-0.0170626582444043,0.00338518308713397,-0.0236976170951869,-0.0104276993936217,4.69684070291574e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37593,-0.0179688374909976,0.0035668534887182,-0.0249598703288852,-0.0109778046531099,4.77344156191053e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,40172,-0.0141222933081485,0.00280381417191539,-0.0196177690851027,-0.00862681753119435,4.78586324966376e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37955,-0.0198636040055474,0.00394647819019196,-0.0275987012583236,-0.0121285067527711,4.88446044458062e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREH,Trehalase,37993,0.0309987512742212,0.00616602098011227,0.0189133501532011,0.0430841523952412,5.0365648068416e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,37341,0.0185505318841382,0.0036905055720067,0.0113171409630051,0.0257839228052714,5.06068926818201e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,37873,-0.0173890505388135,0.00346162077759643,-0.0241738272629025,-0.0106042738147245,5.14214543498551e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39956,-0.0314304445422161,0.00625968408389607,-0.0436994253466524,-0.0191614637377798,5.19490358728647e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37593,-0.0118784906084267,0.0023673320338651,-0.0165184613948023,-0.00723851982205112,5.29856013178113e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,40168,-0.0432005872013925,0.00862487243277095,-0.0601053371696236,-0.0262958372331615,5.53536084495188e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,37993,-0.0251128433767277,0.00501498023947045,-0.0349422046460898,-0.0152834821073656,5.58164034883172e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37955,-0.0215739245715515,0.00431159703959607,-0.0300246547691598,-0.0131231943739432,5.69488121296745e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,40417,-0.0184138010518645,0.00368779965599981,-0.0256418883776241,-0.0111857137261048,6.00234997532003e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,40439,0.0176011106319136,0.00352872517842437,0.0106848092822019,0.0245174119816254,6.16629621934951e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,40336,0.022164832333595,0.00444449664209408,0.0134536189150906,0.0308760457520994,6.19618793823326e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,40300,-0.00911883136426709,0.00182988404461664,-0.0127054040917157,-0.00553225863681847,6.31733407077769e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37593,-0.0376461066959774,0.00755658608339741,-0.0524570154194364,-0.0228351979725185,6.37656115368621e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37567,-0.0223179679398637,0.0044841676425145,-0.0311069365191921,-0.0135289993605353,6.5376871606839e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,40285,-0.018097477425827,0.00363849868971481,-0.025228934857668,-0.010966019993986,6.63114958851649e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,37896,0.0428517288014817,0.00861878211171474,0.0259589158625208,0.0597445417404426,6.71170872927725e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39975,-0.0349198859902327,0.007026336729746,-0.0486915059805349,-0.0211482659999306,6.77162753530337e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,37937,-0.0308491564913014,0.00620847263507323,-0.0430177628560449,-0.0186805501265578,6.81664451109432e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37623,-0.0154720641127251,0.00311826891863248,-0.0215838711932448,-0.00936025703220545,7.0733994264915e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,37937,-0.0287976119152917,0.00580525000220629,-0.040175901919616,-0.0174193219109674,7.11263983600023e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,40466,-0.0539008776681774,0.010878354041852,-0.0752224515902073,-0.0325793037461475,7.31157120040556e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,39956,-0.0291171504629824,0.00588268521333986,-0.0406472134811285,-0.0175870874448363,7.51331102686334e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,40300,-0.0566784330559488,0.0114579602090377,-0.0791360350656626,-0.034220831046235,7.62781591728796e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,40220,-0.0239866921322251,0.00485138899175104,-0.0334954145560572,-0.0144779697083931,7.72060440849025e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37896,-0.0162117352699284,0.00328093742006901,-0.0226423726132636,-0.00978109792659313,7.85818059464967e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37895,-0.0182861306063404,0.00370729986940279,-0.0255524383503698,-0.0110198228623109,8.21686796003218e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,40511,-0.0384010978740939,0.00779970970588499,-0.0536885288976285,-0.0231136668505593,8.5897473022503e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,40336,-0.0125969756609913,0.00255907911007422,-0.0176127707167367,-0.00758118060524578,8.63184695445575e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37557,-0.0269290225770925,0.0054708963934763,-0.0376519795083061,-0.016206065645879,8.66036474192898e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,37985,-0.0292486524921791,0.00594332892886634,-0.0408975771927572,-0.0175997277916011,8.7002105470991e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39834,0.0414693184245394,0.00842950634180886,0.0249474859945941,0.0579911508544848,8.76432149456107e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEP,Leptin,40354,-0.0260986400822666,0.00531135591413754,-0.0365088976739762,-0.015688382490557,9.02429174036196e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39975,-0.0313194066607902,0.00638315772644077,-0.0438303958046141,-0.0188084175169663,9.36228414818563e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40484,0.015073786474707,0.00307529023642384,0.00904621761131629,0.0211013553380977,9.59975311850216e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,40300,-0.0168559251809713,0.00343986300512463,-0.0235980566710156,-0.0101137936909271,9.66981124397525e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39973,-0.01995502396641,0.00407644535969499,-0.0279448568714122,-0.0119651910614078,9.91916167321631e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,40354,-0.0113435337090302,0.00231781823261523,-0.0158864574449561,-0.00680060997310434,9.97462781169339e-07
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPART,Spartin,37666,-0.0313801582955009,0.00641296384853973,-0.0439495674386388,-0.0188107491523631,1.00360144521328e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_A,,37955,-0.0132781203640585,0.00271413752577172,-0.0185978299145711,-0.00795841081354593,1.00861641016338e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39975,-0.0193713164836026,0.00396049858134192,-0.0271338937030327,-0.0116087392641724,1.01262468202858e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39975,-0.0238680463823819,0.00488206226421446,-0.0334368884202422,-0.0142992043445215,1.02400724741739e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",40327,-0.0313997435390103,0.00643015123872527,-0.0440028399669119,-0.0187966471111088,1.05391238493694e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,40409,-0.0236013758760935,0.00483474380108597,-0.033077473726222,-0.014125278025965,1.06235909960522e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37567,-0.0198962433373177,0.00407550224045183,-0.0278842277286033,-0.0119082589460321,1.06299440752351e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40466,-0.0110794935097418,0.00227079612255142,-0.0155302539099426,-0.00662873310954105,1.07583231500652e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37937,-0.0159628476442223,0.00327420476279435,-0.0223802889792992,-0.00954540630914539,1.09861042903727e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,37896,-0.0414166326598438,0.00850413935682646,-0.0580847457992236,-0.0247485195204639,1.12769370829213e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37993,0.0169834838924329,0.00350419986691801,0.0101152521532736,0.0238517156315922,1.26982763806204e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37896,0.0376886397809532,0.00778775639065295,0.0224246372552734,0.052952642306633,1.31629437627629e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,37557,-0.0243156295866752,0.00502556900777952,-0.0341657448419231,-0.0144655143314274,1.32389702873334e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,40300,-0.0360762654040781,0.00746004303646587,-0.0506979497555512,-0.021454581052605,1.33766998029909e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,40424,0.0103181036907734,0.00213466030333102,0.00613416949624462,0.0145020378853022,1.35329527837566e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,40335,-0.0227648243807785,0.00471023469455723,-0.0319968843821107,-0.0135327643794463,1.35710096319528e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39975,-0.017866186824407,0.00369702390197156,-0.0251123536722712,-0.0106200199765427,1.36059129574278e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,40437,-0.0280412480475543,0.00580577693363235,-0.0394205708374737,-0.0166619252576349,1.37875774374011e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,37993,-0.0365162940225993,0.00756086557852661,-0.0513355905565115,-0.0216969974886872,1.38273226080777e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40511,-0.0149852582962244,0.00310403260058764,-0.0210691621933761,-0.00890135439907258,1.39408163128271e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37709,-0.0197821174586755,0.00409864134254198,-0.0278154544900577,-0.0117487804272932,1.40498017441077e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40531,-0.0156642565625114,0.00324965474116012,-0.0220335798551852,-0.00929493326983759,1.44664448780463e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,40336,-0.0257885181446202,0.00535106283567171,-0.0362766013025368,-0.0153004349867037,1.45375225672481e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37917,-0.0333948982762297,0.00694112535873172,-0.0469995039793439,-0.0197902925731156,1.51679768805351e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37567,-0.0324764951312419,0.00675037925658892,-0.0457072384741562,-0.0192457517883276,1.51801102985541e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37982,-0.0210475268723282,0.00437914962724968,-0.0296306601417376,-0.0124643936029189,1.55397720778083e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,40354,-0.0125913896337503,0.00262387122850336,-0.0177341772416169,-0.00744860202588371,1.6108210434256e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37557,-0.0250343000498723,0.00521670257794,-0.0352590371026347,-0.0148095629971099,1.6131974343795e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37709,-0.0423493161609175,0.00882490146008357,-0.0596461230226812,-0.0250525092991537,1.61324698694788e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37955,-0.0470146631027765,0.00980522034262665,-0.0662328949743247,-0.0277964312312282,1.64524832754487e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,37976,-0.00585802690441451,0.00122299203239254,-0.00825509128790389,-0.00346096252092513,1.68622867564635e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OCLN,Occludin,37955,-0.0173046484679246,0.00361358808793107,-0.0243872811202695,-0.0102220158155797,1.69586702270708e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37830,-0.0232991894373734,0.00486660024070289,-0.0328377259091511,-0.0137606529655957,1.70620075514198e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,40354,-0.0269709644892003,0.00564001430009831,-0.038025392517393,-0.0159165364610076,1.75050587211741e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,40177,-0.0276095175811426,0.00578027773180026,-0.0389388619354711,-0.0162801732268141,1.79978414636062e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,40039,-0.0236777062829569,0.00495759657715724,-0.033394595574185,-0.0139608169917287,1.80402533458712e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,40406,-0.0228901511137421,0.0047969589205803,-0.0322921905980795,-0.0134881116294048,1.84199716995424e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37923,-0.0161122983868923,0.00337695022013642,-0.0227311208183597,-0.0094934759554249,1.85000383025707e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,40223,-0.0148645630984913,0.00311718575739007,-0.0209742471829758,-0.00875487901400677,1.87183113312591e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,40387,0.012747160654081,0.00267848490086647,0.00749733024838276,0.0179969910597793,1.9617099848634e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLG,Plasminogen,37700,-0.00884990295754666,0.00185954356039314,-0.0124946083359172,-0.00520519757917612,1.96434555916676e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,37643,0.02264772540018,0.00476108614889919,0.0133159965483376,0.0319794542520224,1.98729580263051e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37937,-0.0392955848935009,0.00826230727952695,-0.0554897071613738,-0.0231014626256281,1.99504579071143e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,40336,-0.0185961739748328,0.003910519348886,-0.0262607918986494,-0.0109315560510162,1.9976983836028e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,40049,0.0294214257131918,0.00618963666730742,0.0172897378452693,0.0415531135811143,2.01872996014955e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,40511,-0.00341896518894786,0.000719592005611577,-0.00482936551994655,-0.00200856485794917,2.03907380032498e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37593,-0.0191569386688368,0.00403178110177024,-0.0270592296283065,-0.0112546477093671,2.04067873425493e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37711,-0.0165969434251357,0.00349948811504146,-0.023455940130617,-0.00973794671965444,2.13108829334086e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,39797,-0.0103791026464798,0.00218993695970032,-0.0146713790874924,-0.00608682620546715,2.16218844649528e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,37666,-0.0212004605095261,0.00447411567455876,-0.0299697272316613,-0.012431193787391,2.17581454978973e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40531,-0.024013327862251,0.00506860204590972,-0.033947787872234,-0.0140788678522679,2.1804517166076e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TF,Serotransferrin,38008,0.00857759548871124,0.00181141538364874,0.0050272213367597,0.0121279696406628,2.20946070185687e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39975,-0.0249301718329901,0.0052665153341674,-0.0352525418879582,-0.014607801778022,2.22395374706291e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,40374,-0.0129361801189019,0.00273812371545293,-0.0183029026011896,-0.00756945763661413,2.32688068661073e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39975,-0.0116434008115184,0.00246799472923555,-0.0164806704808201,-0.00680613114221674,2.40536087889087e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,40354,-0.0496861121585819,0.0105471508457101,-0.0703585278161735,-0.0290136965009902,2.48764213947705e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,40327,-0.0219165275093579,0.00465240635202533,-0.0310352439593276,-0.0127978110593883,2.48843859880329e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,40354,-0.0472305001150376,0.0100319914292712,-0.0668932033164092,-0.027567796913666,2.52283932477655e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39956,-0.0241530736643896,0.0051326957196166,-0.0342131572748381,-0.014092990053941,2.55145859839623e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,40302,-0.0255691314243472,0.00543663398555796,-0.0362249340360408,-0.0149133288126536,2.58378361310438e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37567,-0.0239401480731491,0.00509656102793643,-0.0339294076879045,-0.0139508884583937,2.66279904871143e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,40531,-0.0156872645169542,0.00334029773169375,-0.0222342480710739,-0.00914028096283442,2.67018087172757e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,37937,-0.0143692199498859,0.00305978778203299,-0.0203664040026705,-0.00837203589710121,2.67725627885399e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,39956,-0.0204781088875186,0.00436235454776571,-0.0290283238011394,-0.0119278939738979,2.698383808155e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37895,-0.019132969300448,0.00407725768399322,-0.0271243943610747,-0.0111415442398213,2.72404905221263e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37593,-0.023610584266521,0.00503239857050181,-0.0334740854647046,-0.0137470830683375,2.73654428890039e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,40223,-0.0316495661226599,0.00674934721479077,-0.0448782866636498,-0.01842084558167,2.76467491014576e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,40037,-0.0125267897943378,0.00267262770486076,-0.0177651400958649,-0.00728843949281074,2.79491286731725e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,40037,-0.0205214101867856,0.00438201975569027,-0.0291101689079385,-0.0119326514656327,2.84960480984348e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,37895,-0.0303042151882542,0.00647575560476387,-0.0429966961735914,-0.017611734202917,2.90180639557681e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,39975,-0.0330494588620497,0.00706365010821282,-0.0468942130741468,-0.0192047046499526,2.90983308187315e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,38008,-0.0118717257708477,0.00253787370467739,-0.0168459582320154,-0.00689749330967997,2.92736534600336e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39956,-0.0148784332350546,0.00318529029253256,-0.0211216022084184,-0.00863526426169074,3.02279943127848e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,40511,-0.0198021159091632,0.00424242398280018,-0.0281172669154515,-0.0114869649028748,3.07138666361502e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39975,-0.0259610160902836,0.00556273998792995,-0.0368639864666263,-0.0150580457139409,3.08262028890866e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40448,-0.0227963984493633,0.00488749733950527,-0.0323758932347936,-0.013216903663933,3.12285240146101e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,40417,-0.0357590341327644,0.00767230272660234,-0.0507967474769049,-0.0207213207886238,3.17535840173219e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,40223,-0.0174354856358687,0.00374145225490615,-0.0247687320554847,-0.0101022392162526,3.18663894707734e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39956,-0.0106963979123731,0.00229689053400088,-0.0151983033590149,-0.00619449246573141,3.23664284773431e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40484,-0.0146573670605315,0.00315005807890526,-0.0208314808951858,-0.00848325322587717,3.29682303956133e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,37567,-0.0188598742652956,0.00405461805071704,-0.026806925644701,-0.0109128228858902,3.3282149468912e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,38008,-0.00766584152980307,0.00165401356651896,-0.0109077081201802,-0.00442397493942591,3.60803575674226e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37593,-0.0303414146845036,0.00654947824534165,-0.0431783920453732,-0.017504437323634,3.6448756524202e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40466,-0.025523362571289,0.0055326602830429,-0.0363673767260531,-0.0146793484165249,3.99555483569913e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37709,-0.0141600989072884,0.0030739401554352,-0.0201850216119414,-0.00813517620263541,4.13320292560308e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37937,-0.0152449174410079,0.00330989073235772,-0.0217323032764291,-0.00875753160558682,4.14508125381239e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37993,0.00882550846230939,0.00191671229006231,0.00506875237378727,0.0125822645508315,4.17213591515847e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NADK,NAD kinase,40354,-0.0205016041112283,0.00445450742421025,-0.0292324386626804,-0.0117707695597762,4.2079801430106e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,40484,0.0228733202321966,0.00497113446783735,0.0131298966752354,0.0326167437891578,4.2322628924922e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37993,-0.0236647029676965,0.00514356116921535,-0.0337460828593586,-0.0135833230760344,4.24607794438446e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEXN,Nexilin,37982,-0.026069717838475,0.0056691425318491,-0.0371812372008992,-0.0149581984760507,4.29339849260157e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,40223,-0.0232865114048314,0.00506465010795483,-0.0332132256164229,-0.0133597971932399,4.30184362318912e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39975,-0.0115233985438967,0.00251392978489569,-0.0164507009222922,-0.00659609616550116,4.60120530712481e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,39975,-0.0158895892664766,0.0034665551496311,-0.0226840373597536,-0.0090951411731997,4.60419550908921e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,39955,-0.0150133252224108,0.00327682729687511,-0.0214359067242861,-0.00859074372053563,4.648838183721e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,37623,0.0259593205787631,0.00566925751345214,0.0148475758523969,0.0370710653051293,4.71566554521367e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,40300,-0.021348676479769,0.00467318226167584,-0.0305081137126537,-0.0121892392468844,4.95313138809932e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37593,-0.0340034017017125,0.00744531162631025,-0.0485962124892806,-0.0194105909141444,4.99038496156115e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,40354,-0.0102138860788174,0.002236883361269,-0.0145981774669047,-0.00582959469073016,5.00551867285872e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39956,-0.0101316206229131,0.00222190602781673,-0.0144865564374339,-0.00577668480839233,5.15750135569924e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,37982,-0.00845157097999035,0.00185562316919444,-0.0120885923916115,-0.00481454956836925,5.29505755016211e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,40223,-0.0294975782925559,0.0064793638196854,-0.0421971313791393,-0.0167980252059725,5.33977405791341e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39975,-0.0224536413387202,0.00493438013186477,-0.0321250263971751,-0.0127822562802652,5.39376737713358e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,40511,-0.0239030014027075,0.00525641905693947,-0.0342055827543089,-0.0136004200511061,5.47116497250146e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37916,-0.0145447034669359,0.00320218799221504,-0.0208209919316774,-0.00826841500219446,5.61765446219142e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,37666,-0.00996625811237523,0.00219588211230196,-0.0142701870524871,-0.0056623291722634,5.71252051595108e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40466,-0.0242254878354621,0.00534574770606487,-0.0347031533393492,-0.0137478223315749,5.89256759895676e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37623,0.0138577326373846,0.0030581432191236,0.00786377192790234,0.0198516933468668,5.910390383352e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40466,-0.0246405185462542,0.00544236884691896,-0.0353075614862153,-0.013973475606293,6.01057279615156e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,40438,-0.0115691838653198,0.00256088822735087,-0.0165885247909275,-0.0065498429397121,6.29789809679453e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,40037,-0.0415259586851721,0.00919837853768649,-0.0595547806190376,-0.0234971367513066,6.39352415659294e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",40374,-0.0128713960516736,0.00285609077281245,-0.018469333966386,-0.00727345813696115,6.63288213408346e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,40451,-0.0219936477358185,0.0048804360428728,-0.0315593023798492,-0.0124279930917878,6.63751728746183e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40531,-0.0117111336061668,0.0026016597205458,-0.0168103866584366,-0.00661188055389707,6.79785586967092e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,40353,-0.0215406089051098,0.00478792854206633,-0.0309249488475598,-0.0121562689626598,6.87766304173995e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,40211,-0.0140785982246588,0.00313093152018276,-0.0202152240042171,-0.00794197244510063,6.95360118474156e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,40302,-0.025722627719486,0.0057221058439778,-0.0369379551736825,-0.0145073002652896,6.99616239164555e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,40484,-0.0136269623308564,0.00303228705036993,-0.0195702449495815,-0.00768367971213138,7.04015385584647e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,40406,-0.0238223191960211,0.00530462078238751,-0.0342193759295006,-0.0134252624625416,7.14330380284832e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,40327,-0.00989917766656725,0.00220486606341308,-0.0142207151508569,-0.00557764018227761,7.18272139586539e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,40352,-0.0110679332692845,0.00246763748002079,-0.0159045027301252,-0.00623136380844373,7.33438013054405e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,40354,-0.0214471966737532,0.0047831386797773,-0.0308221484861167,-0.0120722448613897,7.379779296625e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37985,-0.0271952065875365,0.00606747720266391,-0.0390874619047578,-0.0153029512703152,7.45093207242008e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,40336,-0.0373450934984709,0.00834620112505461,-0.0537036477035779,-0.0209865392933638,7.71216344823647e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,40412,-0.042001417874632,0.00938752762119838,-0.0604009720121808,-0.0236018637370831,7.72379463840842e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,40306,-0.0326183558368138,0.00730223978653038,-0.0469307458184133,-0.0183059658552143,7.99109046120355e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,40223,-0.0351838684182613,0.00788597273295858,-0.0506403749748602,-0.0197273618616625,8.19219275421175e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39956,-0.0250315974016675,0.00561442509949267,-0.0360358705966732,-0.0140273242066619,8.31364486824191e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,39975,-0.0159632058406676,0.00358069061183534,-0.0229813594398649,-0.00894505224147038,8.3254916068947e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37666,-0.0307542139708169,0.00690293385316436,-0.044283964323019,-0.0172244636186147,8.44887407844269e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",40301,0.0256472933736748,0.00575742442892291,0.0143627414929859,0.0369318452543637,8.46064574406378e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,40336,-0.0174603596305623,0.00392161847946302,-0.0251467318503098,-0.00977398741081478,8.55203699617997e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37593,-0.0122141183118621,0.00274411799935864,-0.017592589590605,-0.00683564703311916,8.61678507749209e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37593,-0.0195651501437668,0.00440341276366326,-0.0281958391605468,-0.0109344611269868,8.93643086225674e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",40327,-0.0139814587187878,0.0031487288125947,-0.0201529671914734,-0.00780995024610221,9.04187471296525e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,40362,-0.0136667946285807,0.00307823964452278,-0.0197001443318454,-0.00763344492531609,9.06450090993845e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,37993,-0.0150372026104261,0.00338960608504209,-0.0216808305371086,-0.00839357468374357,9.22536891582737e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,37852,-0.0263855722651175,0.00594935535564386,-0.0380463087621795,-0.0147248357680556,9.27923170148296e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39882,-0.0068181420606202,0.00153772687145482,-0.00983208672867164,-0.00380419739256875,9.31784617550497e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,40354,-0.0253051105741987,0.00571228581863151,-0.0365011907787164,-0.0141090303696809,9.48866208505388e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,40211,-0.0178507783472043,0.00402957802896279,-0.0257487512839713,-0.00995280541043719,9.48955844102548e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37993,-0.0147742160096075,0.0033360472700919,-0.0213128686589876,-0.00823556336022735,9.55638169784871e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,40223,-0.0372028041141271,0.00840151494409805,-0.0536697734045592,-0.0207358348236949,9.5702942903203e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPL,Periplakin,37593,-0.0121204814593475,0.002738200175913,-0.017487353804137,-0.00675360911455806,9.65727410654588e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,40327,-0.00992990660271003,0.00224352595342446,-0.014327217471422,-0.00553259573399809,9.66243252185537e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,37536,-0.0366180689502392,0.00827555965775059,-0.0528381658794303,-0.020397972021048,9.72917544322684e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,40369,-0.039174592859519,0.00885908013866756,-0.0565383899313075,-0.0218107957877306,9.84526893580897e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNC,Tenascin,40398,-0.0174007735637357,0.0039357382012954,-0.0251148204382747,-0.00968672668919673,9.87927446681764e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,37536,-0.0143651894126903,0.00324911238365352,-0.0207334496846512,-0.00799692914072939,9.89151797786061e-06
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,37895,-0.0129968489711085,0.00294481407298702,-0.018768684554163,-0.00722501338805394,1.02519243769468e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,37895,-0.0300459240490236,0.00681060774355418,-0.0433947152263897,-0.0166971328716574,1.0339032016548e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANG,Angiogenin,40304,-0.0126397877265482,0.00286692808996222,-0.0182589667828741,-0.00702060867022221,1.04615937672494e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37896,-0.0320154262906267,0.00726424669358582,-0.0462533498100549,-0.0177775027711985,1.05497431840059e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFD,Complement factor D,38008,-0.00696685636084439,0.00158261808632691,-0.0100687878100451,-0.00386492491164365,1.08024008531402e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,40406,-0.0191192767119327,0.00434428241557225,-0.0276340702464543,-0.0106044831774111,1.08442175418305e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,37814,-0.0162932173959508,0.0037020540150062,-0.0235492432653629,-0.00903719152653862,1.08524088921689e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37896,-0.0170451954212895,0.00387424103089812,-0.0246387078418498,-0.0094516830007292,1.09274295134535e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,39975,-0.02518531199686,0.00572706184944256,-0.0364103532217674,-0.0139602707719526,1.10183833907121e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37666,-0.0177093924113878,0.00403540355055409,-0.0256187833704738,-0.00980000145230181,1.15017161190429e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,40294,-0.0103544409429461,0.00236098681214133,-0.0149819750947431,-0.00572690679114907,1.16390492806649e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,40428,-0.0217343745817154,0.00495778497227625,-0.0314516331273768,-0.0120171160360539,1.17324097430389e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37937,0.0148000807517836,0.00337595805920086,0.0081832029557499,0.0214169585478173,1.17420781536173e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,39929,-0.025172000102314,0.00574251801435761,-0.0364273354104549,-0.0139166647941731,1.17588014899686e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39956,-0.0287164585721037,0.00655354751604898,-0.0415614117035597,-0.0158715054406477,1.18465676980229e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",40336,-0.035047590799958,0.00800310825015148,-0.0507336829702549,-0.019361498629661,1.19851665559101e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39975,-0.0246922530094169,0.00564150621608677,-0.035749605192947,-0.0136349008258869,1.21170996927369e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,37955,-0.0110640789026744,0.00252891350151573,-0.0160207493656453,-0.00610740843970362,1.22324974858573e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,37937,-0.0303312537034413,0.00693481188405031,-0.0439234849961799,-0.0167390224107027,1.23036658115273e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,40300,-0.0277014082114896,0.00633505684322362,-0.0401181196242079,-0.0152846967987713,1.23492215731508e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,40300,-0.0195680786631603,0.00448157615777432,-0.0283519679323979,-0.0107841893939226,1.27147548314251e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,40187,-0.00861765240784306,0.00197516407340369,-0.0124889739917143,-0.00474633082397183,1.29104219392075e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37557,-0.0134886576764911,0.00309494884464265,-0.0195547574119907,-0.00742255794099154,1.32086172696289e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37955,-0.0174294653006698,0.00399994677543636,-0.0252693609805251,-0.00958956962081454,1.32573896850828e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37623,-0.0201857678367635,0.00463276963328572,-0.0292659963180035,-0.0111055393555235,1.32751954902601e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,37414,-0.0194037679518274,0.00445628697076487,-0.0281380904145266,-0.0106694454891283,1.34550466436922e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,40374,-0.0120906175718901,0.00277730806594624,-0.0175341413811448,-0.00664709376263552,1.34904010050576e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,37562,-0.015483523889179,0.00356182607966305,-0.0224647030053186,-0.00850234477303944,1.39005291956294e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,37666,0.0186314335024486,0.0042884378593259,0.0102260952981698,0.0270367717067274,1.4058785811986e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37623,-0.0123105202953581,0.00283359152853221,-0.0178643596912812,-0.00675668089943494,1.40642366735584e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37709,-0.0315137656063868,0.00725487497932991,-0.0457333205658735,-0.0172942106469002,1.41076420544801e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,40392,-0.0397059555405011,0.00914375600268957,-0.0576277173057726,-0.0217841937752295,1.41796682711187e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,40417,-0.0314320815648832,0.00723937595315755,-0.045621258433072,-0.0172429046966944,1.42176257699628e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37985,-0.0116452809590771,0.00268440705505208,-0.0169067187869792,-0.00638384313117501,1.447475437261e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37895,-0.0182246872064444,0.00420687505080726,-0.0264701623060266,-0.00997921210686217,1.4875185164231e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,40354,-0.0276638968021879,0.00639226805717032,-0.0401927421942417,-0.015135051410134,1.51586177799155e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,40223,-0.0188923725256743,0.00436610702013169,-0.0274499422851325,-0.0103348027662162,1.52048183226852e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37937,-0.0212799402227351,0.00492362611494979,-0.0309302474080367,-0.0116296330374336,1.55725439212451e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37937,-0.0143779093338483,0.00332865645421244,-0.0209020759841047,-0.00785374268359191,1.57549125757978e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",38008,-0.00586509995105567,0.00135802277478479,-0.00852682458963385,-0.00320337531247749,1.57957801381467e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F2,Prothrombin,38008,-0.00527336509463281,0.00122199488088172,-0.00766847506116099,-0.00287825512810463,1.60462230820635e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37993,0.0165351037665387,0.00383186935665709,0.00902463982749078,0.0240455677055866,1.60623745350712e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,40223,-0.00917683638560803,0.00212727929619613,-0.0133463038061525,-0.00500736896506361,1.61386752457306e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,37993,-0.0186620843290916,0.00432787122326568,-0.0271447119266924,-0.0101794567314909,1.62877439279254e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI3,Elafin,40069,-0.0191307400065417,0.00444373815369662,-0.0278404667877871,-0.0104210132252964,1.67927148147333e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,37896,-0.0124398894834448,0.00289106228647853,-0.0181063715649427,-0.00677340740194689,1.69785135927792e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,40354,-0.0228844406974296,0.00531937566911249,-0.03331041700889,-0.0124584643859691,1.70203440909348e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGRN,Neugrin,37937,-0.00783527157231773,0.00182564259972904,-0.0114135310677866,-0.00425701207684881,1.78476670753307e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,39929,0.0221453840003871,0.00517868631832352,0.011995158816473,0.0322956091843012,1.91202690268662e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37666,-0.0193665081199994,0.00453106767041424,-0.0282474007540113,-0.0104856154859875,1.93204260949968e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37985,-0.0313391864885702,0.00734049297592659,-0.0457265527213863,-0.0169518202557541,1.97373194273803e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39975,-0.0127558603833525,0.00299085423914873,-0.018617934692084,-0.00689378607462099,2.01124952310467e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZN,Kazrin,37896,-0.0366173947340031,0.00859788385694971,-0.0534692470936246,-0.0197655423743817,2.06845902082678e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37955,-0.0231676390097473,0.00544028118240544,-0.033830590127262,-0.0125046878922327,2.0716108942349e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,37993,-0.0108891980897626,0.00255854679177559,-0.0159039498016428,-0.00587444637788245,2.09509023635909e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,39956,-0.0160547292101892,0.00377436557281877,-0.023452485732914,-0.00865697268746438,2.11572466996955e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",40406,-0.0217090206080806,0.00510441792756115,-0.0317136797461005,-0.0117043614700608,2.12139550789701e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37599,-0.0120976137932439,0.00285015868170801,-0.0176839248093916,-0.00651130277709615,2.20544840090558e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37955,-0.0378830841665741,0.00892595135810356,-0.055377948828457,-0.0203882195046911,2.20887988572569e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,40223,-0.0367832392062285,0.00869361417438,-0.0538227229880133,-0.0197437554244437,2.33902130020071e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,40304,-0.0188038337149168,0.00444458351661564,-0.0275152174074834,-0.0100924500223501,2.34242547140659e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37567,-0.0242902245332533,0.005741135582373,-0.0355428502747044,-0.0130375987918023,2.34329805320326e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",40309,-0.038415782976358,0.00910021758886055,-0.0562522094505247,-0.0205793565021913,2.44126991881391e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,37567,-0.0458496940319455,0.010864128995909,-0.0671433868639271,-0.0245560011999638,2.4563830163915e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39975,-0.0192883189764194,0.00457116262056449,-0.0282477977127258,-0.010328840240113,2.46164131108787e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37557,-0.0235142144943151,0.00557240926182809,-0.0344361366474982,-0.0125922923411321,2.46211789826753e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,40327,0.0094313377188845,0.00223726863226228,0.00504629119965042,0.0138163842381186,2.5053906948474e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37896,-0.0358204425087364,0.00849992225214945,-0.0524802901229493,-0.0191605948945234,2.52292339017855e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,40355,-0.0133488212004234,0.00317623515673964,-0.0195742421076331,-0.00712340029321373,2.65168790911628e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXN,Paxillin,39956,-0.0180627151728848,0.00430035540637958,-0.0264914117693887,-0.00963401857638078,2.68069801776387e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,40336,-0.0320520653716387,0.00763357603515839,-0.0470138744005491,-0.0170902563427282,2.69762643893818e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37982,0.00902086869660602,0.00215140549827681,0.00480411391998348,0.0132376234732286,2.77026769069635e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,40327,-0.0137335879322184,0.0032798962949321,-0.0201621846702853,-0.0073049911941515,2.83937664526381e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,40039,-0.0396414252581976,0.00946898050047634,-0.0582006270391312,-0.021082223477264,2.84905082535742e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39971,-0.02713240795226,0.00648129420907726,-0.0398357446020514,-0.0144290713024686,2.85146801104932e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37666,-0.0203782973372769,0.00486989962891261,-0.0299233006099456,-0.0108332940646082,2.87589759959211e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37985,-0.0163035728640754,0.00389621004483405,-0.0239401445519501,-0.00866700117620065,2.87636949883788e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37709,-0.0254523438070348,0.00608744235562126,-0.0373837308240524,-0.0135209567900171,2.91936857261383e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,40223,-0.0335535130636036,0.00802859120667102,-0.0492895518286788,-0.0178174742985284,2.94044552611034e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,40039,-0.027494172571672,0.00659559029962949,-0.0404215295589458,-0.0145668155843982,3.0817339959556e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,40336,-0.0184046811579739,0.00441675129346929,-0.0270615136931737,-0.00974784862277413,3.10243486039407e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,40039,-0.0239005747996369,0.00573933527229907,-0.0351496719333431,-0.0126514776659307,3.13926758873193e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,40327,-0.00792296024642363,0.00190475929582243,-0.0116562884662356,-0.00418963202661166,3.20538267836386e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,40282,-0.030619126336804,0.00738358932822681,-0.0450909614201285,-0.0161472912534794,3.38739940260674e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40466,-0.0196938388216292,0.00475460985875645,-0.0290128741447918,-0.0103748034984666,3.45978812253647e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37896,-0.0264300584520933,0.00638102784482332,-0.0389368730279471,-0.0139232438762396,3.46432346894559e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,40306,-0.0313939671268122,0.00758440412123663,-0.046259399204436,-0.0165285350491884,3.50199266902051e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37557,-0.0232460670560051,0.0056201043124445,-0.0342614715083963,-0.0122306626036138,3.55254264598222e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37623,-0.0142157141737292,0.00344059250568317,-0.0209592754848682,-0.00747215286259021,3.62215924051603e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37955,-0.0119016931876856,0.00288068806532051,-0.0175478417957138,-0.00625554457965745,3.62504538506727e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,40467,-0.0079926377446078,0.00193736309949757,-0.011789869419623,-0.00419540606959256,3.71760512935467e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,37929,-0.0333274876569031,0.00808094012655666,-0.0491661303049542,-0.0174888450088521,3.74242084462765e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,40531,-0.0181645985898091,0.00440474676190123,-0.0267979022431355,-0.00953129493648271,3.74432696699453e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,40406,-0.00909714319181427,0.00220615888069862,-0.0134212145979836,-0.00477307178564497,3.75012681519053e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37937,-0.0224188598148071,0.00544274395648807,-0.0330866379695238,-0.0117510816600905,3.82730137096274e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,40327,0.0122542520638917,0.00297664731823619,0.00642002332014879,0.0180884808076346,3.86116875292967e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37567,-0.0211927875315155,0.00514783317382479,-0.0312825405522121,-0.0111030345108189,3.86460013775232e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,40460,-0.013870992797356,0.0033722007804276,-0.0204805063269941,-0.00726147926771792,3.9193219492288e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37593,-0.0138584209265175,0.00336942659479238,-0.0204624970523106,-0.00725434480072447,3.92943770264616e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,40300,0.0301401095677381,0.00733174320657862,0.015769892882844,0.0445103262526322,3.96094179445907e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37985,-0.0136544238236933,0.00332145394089465,-0.0201644735478468,-0.00714437409953978,3.96311722253021e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,40223,-0.0148071428381099,0.00360367576143221,-0.021870347330517,-0.00774393834570273,3.99556895282732e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,39956,-0.0204629928779483,0.00498101195644115,-0.0302257763125729,-0.0107002094433236,4.00802908402189e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,39975,0.0425186216496305,0.0103552360853789,0.0222223589222879,0.0628148843769731,4.04626593668894e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,40039,-0.0187066662370476,0.00456026141335533,-0.0276447786072241,-0.0097685538668712,4.11490055515297e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,40429,-0.0205197524785222,0.00500309360716653,-0.0303258159485686,-0.0107136890084758,4.12668804092836e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37985,-0.0112318422033107,0.00273858456048191,-0.0165994679418552,-0.00586421646476615,4.13182550358441e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37937,-0.0156601097772113,0.00382280510329964,-0.0231528077796786,-0.00816741177474401,4.21899661277119e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,40223,-0.0184634053863686,0.00450951373825815,-0.0273020523133545,-0.00962475845938259,4.25514306917743e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37557,-0.013882435555077,0.00339078037296078,-0.0205283650860801,-0.00723650602407386,4.26223045158831e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37557,-0.0111700301843328,0.00273072122539646,-0.0165222437861099,-0.00581781658255579,4.33007717524355e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40466,-0.00951876839725399,0.00232747148741984,-0.0140806125125969,-0.0049569242819111,4.33955659408201e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,37805,-0.0102877984784783,0.0025159346836667,-0.015219030458465,-0.00535656649849154,4.35670009792462e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,40231,-0.0235489009289063,0.00576198613121359,-0.0348423937460849,-0.0122554081117276,4.39259727066983e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,40037,-0.0167249980873414,0.0040985190659024,-0.0247580954565101,-0.00869190071817272,4.51157949360078e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,40406,-0.00873072266725615,0.00214010262393429,-0.0129253238101674,-0.00453612152434495,4.53361569880244e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37955,-0.0231099504769712,0.00566568454714898,-0.0342146921893832,-0.0120052087645592,4.55024949274159e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,40484,-0.020602475425532,0.00506004638877912,-0.030520166347539,-0.0106847845035249,4.69158269627425e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37623,-0.0169347681398134,0.00416138241011355,-0.025091077663636,-0.00877845861599084,4.73879090999055e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37985,-0.0112708566952135,0.00277109330175294,-0.0167021995666493,-0.00583951382377772,4.78312969322624e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39754,-0.0104478762710367,0.00256949587505491,-0.0154840881861444,-0.00541166435592911,4.80417274985376e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,37982,-0.0181739059925714,0.0044749515401123,-0.0269448110111915,-0.00940300097395134,4.90853046442786e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37895,-0.0194145882477676,0.00478159663667293,-0.0287865176556465,-0.0100426588398887,4.92930997407792e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39975,-0.0167267912876199,0.00412065281991523,-0.0248032708146538,-0.00865031176058609,4.94702691013102e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37666,-0.0237073974293052,0.00584869294175862,-0.0351708355951521,-0.0122439592634584,5.07564028466494e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,40039,-0.0175072356783058,0.0043215482516761,-0.025977470251591,-0.00903700110502066,5.12136435429576e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",40327,-0.012459189253997,0.00308227181628472,-0.018500442013915,-0.00641793649407893,5.31995676375973e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40492,-0.02132398604992,0.00527749787208151,-0.0316678818791997,-0.0109800902206402,5.35748714320333e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FURIN,Furin,40406,-0.0112979918761811,0.00279790349062907,-0.016781882717814,-0.00581410103454808,5.41561087204795e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37955,-0.0131408509050041,0.0032576734282482,-0.0195258908243705,-0.00675581098563759,5.51806030023923e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,40478,-0.0233597613781106,0.00579358209297515,-0.0347151822803419,-0.0120043404758793,5.5558533973296e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37623,-0.0249763607945708,0.00619690574113923,-0.0371222960472037,-0.0128304255419379,5.59816558640124e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,40354,-0.0227518349070964,0.00564777038302701,-0.0338214648578294,-0.0116822049563635,5.64036070158647e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37709,-0.0225006524750289,0.00558850754665358,-0.0334541272664699,-0.0115471776835879,5.69921448077324e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSN,Gelsolin,37923,-0.00636477714840919,0.00158088448374212,-0.00946331073654374,-0.00326624356027464,5.70234813072737e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,40216,-0.00958649724510822,0.00238208531526688,-0.0142553844630313,-0.00491761002718513,5.73841751905258e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37709,-0.0176188497719544,0.00438070522173638,-0.0262050320065577,-0.00903266753735111,5.80454162682741e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40484,-0.0114481383658686,0.00284661730139467,-0.0170275082766022,-0.00586876845513504,5.80531639441108e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,40037,-0.0110657471054716,0.00275416469179816,-0.016463909901396,-0.00566758430954723,5.90140078395607e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37955,-0.0222364668157131,0.00553537094488756,-0.0330857938676927,-0.0113871397637335,5.92230092792415e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37557,-0.0165700126814892,0.00412666828861869,-0.0246582825271818,-0.00848174283579658,5.96887136025437e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37993,0.00924452361831231,0.00230366797582245,0.00472933438570031,0.0137597128509243,6.02851360722806e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,40406,-0.0105159543946674,0.00262648935679103,-0.0156638735339778,-0.00536803525535693,6.26135523020189e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,40039,-0.0220871012767427,0.00551840617280829,-0.0329031773754469,-0.0112710251780384,6.29820794988429e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,40187,-0.026665373864193,0.00666527737997344,-0.0397293175289409,-0.0136014301994451,6.3460498741368e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37955,-0.0124285263993011,0.00310943137882752,-0.018523011901803,-0.00633404089679913,6.44799520851895e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,40336,-0.0209077942383933,0.00523201061116962,-0.0311625350362858,-0.0106530534405008,6.46769897175054e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37896,-0.0168324755272381,0.00422072975052796,-0.025105105838273,-0.00855984521620334,6.69716247349326e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,40395,-0.0172711474900334,0.00433836105366937,-0.0257743351552254,-0.00876795982484146,6.89212924512291e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,37666,0.0298391908661869,0.00750098129313078,0.0151372675316506,0.0445411142007232,6.98568390213665e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,40336,-0.0202009439343397,0.00508211760472727,-0.0301618944396051,-0.0102399934290742,7.07182242481233e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,40517,-0.0111571129546355,0.00280772659709622,-0.0166602570849441,-0.00565396882432694,7.10685008466383e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,40336,-0.0123406410793326,0.0031121259410407,-0.0184404079237724,-0.00624087423489285,7.3612265505778e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,37895,-0.0105239802647274,0.00265588576139233,-0.0157295163570564,-0.00531844417239847,7.45482973965219e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38480,0.0103280955999153,0.00260863904725243,0.00521516306730058,0.0154410281325301,7.55757381442058e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,40406,-0.013995024579634,0.00353502870286736,-0.020923680837254,-0.00706636832201394,7.56044487130586e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39929,-0.0176563147421202,0.00446203848992653,-0.0264019101823762,-0.00891071930186418,7.62335890910718e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37895,-0.0179735004982979,0.00454426257955613,-0.0268802551542279,-0.00906674584236784,7.68606092456625e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,40484,-0.021573398356455,0.00546101258242109,-0.0322769830180003,-0.0108698136949096,7.83418375511365e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37623,-0.0305069185430707,0.00772336331729464,-0.0456447106449682,-0.0153691264411732,7.85739341626719e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37666,-0.0221399965051582,0.00560635992009649,-0.0331284619485473,-0.011151531061769,7.88572707288864e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40466,-0.00960851950631287,0.00243422061376854,-0.0143795919092992,-0.00483744710332653,7.93860171054716e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37593,-0.0171491056140945,0.00434526698986944,-0.0256658289142386,-0.00863238231395034,7.96756950393027e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,40294,-0.0259829362598421,0.00658534537085478,-0.0388902131867175,-0.0130756593329668,7.99538980353859e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37937,-0.00717811070991731,0.00181964824415098,-0.0107446212684532,-0.00361160015138139,8.02779271239158e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,40327,-0.00778804896387168,0.00197515505379359,-0.0116593528693071,-0.00391674505843625,8.08119162925328e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,40300,-0.0372306603970835,0.00944483704743087,-0.055742541010048,-0.018718779784119,8.11838522307361e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37982,-0.00726740751234322,0.00184412180327394,-0.0108818862467601,-0.0036529287779263,8.16015545525788e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,40393,0.0209710524636533,0.00532300537643975,0.0105379619258313,0.0314041430014752,8.19306771551497e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,40414,-0.0190998478448715,0.00484917945931265,-0.0286042395851243,-0.00959545610461871,8.22454133182371e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37874,-0.0135866154712937,0.00345302650712569,-0.02035454742526,-0.00681868351732734,8.37211435392701e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,40354,0.0129525582497337,0.00329599186847279,0.00649241418752702,0.0194127023119404,8.53795513595791e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39956,-0.0109122798750696,0.00278151560511421,-0.0163640504610935,-0.00546050928904577,8.7778594140042e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39690,-0.0153962342071628,0.00392689598662881,-0.0230929503409553,-0.00769951807337034,8.86736212832182e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,40354,-0.0116459822096329,0.00297350676447859,-0.017474055468011,-0.00581790895125489,9.0188578193076e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",40391,-0.0283472539769793,0.00725729871050174,-0.0425715594495628,-0.0141229485043959,9.42104648184948e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37937,-0.009741970509255,0.00249877149112874,-0.0146395626318673,-0.00484437838664267,9.71772488596553e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37593,-0.01831749405798,0.00469965113347957,-0.0275288102795999,-0.00910617783636001,9.76215686266713e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,40336,-0.0273776180645249,0.00702531143644665,-0.0411472284799603,-0.0136080076490895,9.7792467062772e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,40531,-0.00530365739943324,0.0013610125922516,-0.00797124208024639,-0.0026360727186201,9.78482731556482e-05
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37955,-0.0217088350044657,0.00557850124382275,-0.0326426974423583,-0.0107749725665731,0.000100097676598373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,40223,-0.0199162106362472,0.00511946048508231,-0.0299503531870085,-0.00988206808548584,0.000100533636272448
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37955,-0.0159555893580687,0.00410295342938556,-0.0239973780796644,-0.00791380063647298,0.000101221218220541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37896,-0.0350621311251626,0.00901815836072794,-0.0527377215121894,-0.0173865407381358,0.000101581253662628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,37623,-0.0377112248385278,0.0097025006545262,-0.0567281261213992,-0.0186943235556565,0.000102091929609435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,40328,-0.00707174876965826,0.00182275297654287,-0.0106443446036823,-0.00349915293563423,0.000105004294149645
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",40037,-0.0295815952596853,0.0076361451152158,-0.0445484396855083,-0.0146147508338623,0.000107549289936194
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37937,-0.0221117258311588,0.0057115723179803,-0.0333064075744002,-0.0109170440879175,0.000108726685271663
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,37623,-0.0195440038095523,0.00504873249333124,-0.0294395194964815,-0.00964848812262304,0.000108881107529621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,40223,-0.0110037413117401,0.00284362341318125,-0.0165772432015754,-0.00543023942190488,0.000109443917878562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37937,-0.0283679574383557,0.00733932356220695,-0.0427530316202813,-0.0139828832564301,0.000111518261360925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37895,0.0125921740480624,0.00326297112068085,0.00619675065152791,0.0189875974445968,0.000114331270631817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBN1,Drebrin,37593,-0.0165514247950956,0.00429142063492515,-0.0249626092395489,-0.00814024035064231,0.000115399117108516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,40354,-0.00560284176082382,0.00145496964298319,-0.00845458226107088,-0.00275110126057676,0.000118179141458772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,40187,-0.0175955885063279,0.00457073139692834,-0.0265542220443075,-0.00863695496834839,0.000118768146044076
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,40039,-0.0276003442165994,0.0071719170862063,-0.0416573017055638,-0.0135433867276351,0.000119370162466333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,40336,-0.0215939574875791,0.00561531671346627,-0.032599978245973,-0.0105879367291852,0.000120753836673376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,37593,-0.0376132082307269,0.00979522670629086,-0.056811852575057,-0.0184145638863968,0.00012363545082696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,40398,-0.0106231352928576,0.00276824419002719,-0.0160488939053109,-0.00519737668040429,0.000124772946280314
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37709,-0.024199280928829,0.00631001462272987,-0.0365669095893796,-0.0118316522682785,0.000126115085461239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,37993,-0.0356524045954032,0.00929871883373125,-0.0538778935095164,-0.01742691568129,0.000126585153640121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,37557,-0.0149646164432004,0.00390382034942544,-0.0226161043280743,-0.00731312855832657,0.00012701321879888
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,40391,-0.0282519015379022,0.00738119584765777,-0.0427190453993115,-0.013784757676493,0.000129919242629303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37593,-0.0310011661390097,0.00810215958443203,-0.0468813989244965,-0.0151209333535229,0.00013069435901873
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40465,-0.0093532286906652,0.00244614769585179,-0.0141476781745347,-0.00455877920679569,0.000131985197942641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,40037,-0.0105541401603671,0.00276113679307546,-0.015965968274795,-0.00514231204593922,0.000132678592295964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,40134,-0.0243684921923949,0.0063775460524672,-0.0368684824552306,-0.0118685019295592,0.000133433942293679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,40398,-0.00864715076691787,0.00226360378268358,-0.0130838141809777,-0.00421048735285804,0.000133913404180137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,40204,-0.0214979978160608,0.00563294181049329,-0.0325385637646277,-0.010457431867494,0.000135887907727081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40511,-0.0215324766718237,0.00564546609277283,-0.0325975902136584,-0.0104673631299889,0.000137181354999168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",40327,-0.0144972284194836,0.0038015350067889,-0.0219482370327899,-0.00704621980617737,0.000137519989868887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37774,-0.00257221481641602,0.000674472628022822,-0.00389418116734075,-0.00125024846549129,0.000137536829734965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,37937,-0.0337331764667655,0.00885194289613501,-0.0510829845431901,-0.0163833683903409,0.000139121040892757
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37937,-0.0118782241268993,0.00311807215304272,-0.017989645546863,-0.00576680270693556,0.000139879022058031
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',37557,-0.0136822510531343,0.00359346706736632,-0.0207254465051723,-0.0066390556010963,0.000140998655827222
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39956,-0.0127214335633809,0.00334195690679098,-0.0192716691006913,-0.00617119802607062,0.000141442642610901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37567,-0.0167710676888374,0.00440884214763924,-0.0254123982982103,-0.00812973707946448,0.000143046273616845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,40406,-0.00867087751544989,0.00228185682360055,-0.013143316889707,-0.00419843814119281,0.000145279385332122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37567,-0.0172725986435665,0.00454917857427927,-0.0261889886491539,-0.00835620863797915,0.00014720022731721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,40531,-0.00929078203478115,0.00244885213796973,-0.0140905322252018,-0.00449103184436049,0.000148822683846161
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37955,-0.0246162579841625,0.00649363593542856,-0.0373437844176025,-0.0118887315507226,0.00015079897581637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,39956,-0.0111536791573734,0.00294650496678871,-0.0169288288922793,-0.00537852942246751,0.000154044080150131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37623,-0.00949906890747185,0.0025118131962071,-0.0144222227720378,-0.00457591504290594,0.000156413191630033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39956,-0.0266981737788609,0.00706829956696745,-0.0405520409301171,-0.0128443066276047,0.000159212784209185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37985,0.0186573859591075,0.00494415484389678,0.00896684246506978,0.0283479294531452,0.000161579087143481
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,40198,-0.0124231051304915,0.00329935225388733,-0.0188898355481107,-0.00595637471287232,0.000166943130581088
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37593,-0.0138423952005373,0.00368102703164485,-0.0210572081825612,-0.00662758221851335,0.000170329268405058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37623,-0.00890494455360849,0.00236920432187161,-0.0135485850244768,-0.00426130408274013,0.000171589310539745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,40037,-0.0167634047594978,0.00446467269760042,-0.0255141632467946,-0.00801264627220098,0.000174195881008642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,40336,-0.0283823606517004,0.00755930931962989,-0.043198606918175,-0.0135661143852258,0.000174221279090576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,40327,-0.0165986468547374,0.00442289380091002,-0.025267518704521,-0.00792977500495376,0.000175428165108941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,40209,-0.00717360847275138,0.00191247201913521,-0.0109220536302564,-0.00342516331524637,0.000176788841139304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,40037,-0.0065285558203648,0.00174118162703413,-0.0099412718093517,-0.00311583983137791,0.000177830093749664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,40187,-0.0201308083278879,0.00537034367180401,-0.0306566819246237,-0.00960493473115201,0.000178521866872702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,40332,0.0314230208047209,0.00838867288268553,0.0149812219546573,0.0478648196547845,0.000180393070078721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,40354,-0.0109927097904265,0.00293826536858214,-0.0167517099128475,-0.00523370966800553,0.000183769564559442
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,39306,-0.0150190178597874,0.00401478303196706,-0.0228879926024429,-0.007150043117132,0.000184031027882193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,40466,0.0114096305020486,0.00305232207852856,0.0054270792281326,0.0173921817759645,0.000186122911592464
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",40300,-0.0130514816976282,0.00349437422367129,-0.0199004551760239,-0.00620250821923244,0.000188374291699555
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37593,-0.0168015540591513,0.0045025990740559,-0.0256266482443009,-0.00797645987400177,0.000191127017575702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,40336,0.0242899207942115,0.00651096811643591,0.0115284232859971,0.0370514183024259,0.000191677196528018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37955,-0.0215302140128624,0.00577267533574365,-0.0328446576709199,-0.0102157703548048,0.000192509928128213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37955,-0.0244420369667848,0.00656603836122935,-0.0373114721547943,-0.0115726017787753,0.000198066087474928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37896,-0.0129782937385539,0.0034923037794989,-0.0198232091463717,-0.00613337833073603,0.000203016753860899
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37557,-0.0191400544362486,0.00515097535070737,-0.0292359661236351,-0.00904414274886218,0.000203394507352742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,37743,-0.00872090065414295,0.00234750507874803,-0.0133220106084891,-0.00411979069979681,0.000204063704784438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,37536,-0.0138801349738256,0.00374020403471746,-0.0212109348818719,-0.00654933506577941,0.000207245573861544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,37593,-0.0106868379221879,0.0028925658741034,-0.0163562670354306,-0.00501740880894529,0.000221137673122443
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37637,-0.0262449707395407,0.00710399411376096,-0.0401687992025122,-0.0123211422765692,0.000221300878666553
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37557,-0.0213528008131249,0.00578049791515308,-0.032682576726825,-0.0100230248994249,0.000221705524706574
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39952,-0.00867225853372778,0.00234926489264198,-0.0132768177233061,-0.00406769934414949,0.00022371953013704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,37557,-0.0123081248240625,0.00333805129737927,-0.0188507053669259,-0.00576554428119912,0.000227634185815492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,40309,-0.0123961228181325,0.00336617971296127,-0.0189938350555366,-0.00579841058072844,0.000231680029169752
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,40354,-0.0262845895879368,0.00715256522283277,-0.040303617424689,-0.0122655617511846,0.000238773060344316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,40319,-0.00742559223189236,0.0020259217411252,-0.0113963988444978,-0.00345478561928697,0.000247863350959956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,40245,-0.0155529505746943,0.00424420796473865,-0.0238715981855821,-0.00723430296380658,0.000248621934859715
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37906,-0.0173903166771209,0.00474849474992169,-0.0266973663869674,-0.00808326696727439,0.000250939114477294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37709,-0.0225865254797542,0.00617551726444316,-0.0346905393180628,-0.0104825116414456,0.000255742753076903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,40336,-0.0305127644297426,0.00835667327650318,-0.0468918440516888,-0.0141336848077963,0.000261748746621309
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,40398,-0.0152382206353328,0.00417578958385024,-0.0234227682196793,-0.00705367305098633,0.000263915181795199
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,40336,-0.0316821714539981,0.00868580212954717,-0.0487063436279105,-0.0146579992800856,0.000265567070954883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37557,-0.0116649555255516,0.00319800952858027,-0.017933054201569,-0.00539685684953428,0.000265761386432601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37593,-0.0116526726839718,0.00319998605931552,-0.0179246453602303,-0.00538070000771343,0.000272121062241632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,37982,-0.019648846467462,0.005404803699586,-0.0302422617186505,-0.00905543121627343,0.000278534517753253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,40417,-0.031537910830249,0.00868142595067376,-0.0485535056935696,-0.0145223159669284,0.000281237720849914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37896,-0.0195339114242077,0.00538687368222816,-0.0300921838413749,-0.00897563900704053,0.000288679857985515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37557,-0.0203565983487403,0.00561600578540154,-0.0313639696881273,-0.00934922700935325,0.000290340341566202
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37658,-0.0137027062919865,0.00378108500532992,-0.0211136329024331,-0.00629177968153983,0.000291154899677665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,40406,-0.0251769290483597,0.00695907828970451,-0.0388167224961806,-0.0115371356005389,0.000297973321830914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37593,-0.0276861425147309,0.00766040149363647,-0.0427005294422584,-0.0126717555872034,0.00030241429363912
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,40511,-0.0230049020168599,0.00636550418468372,-0.03548129021884,-0.0105285138148798,0.000302435960223585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40466,-0.0141554844919,0.00391792940107952,-0.0218346261180159,-0.00647634286578418,0.000303599627932346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,40531,-0.0129171084939599,0.00357711079804987,-0.0199282456581376,-0.00590597132978211,0.000305893532565112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37593,-0.0190810374384037,0.00528766591583317,-0.0294448626334367,-0.00871721224337065,0.000309004952369943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,40336,-0.0102127831257392,0.00283089711643982,-0.0157613414739612,-0.00466422477751711,0.000309974633182343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40466,-0.0288240938760326,0.00799163904151393,-0.0444877063973999,-0.0131604813546653,0.000310961760879094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40466,-0.0134951181404015,0.00375732491845154,-0.0208594749805665,-0.00613076130023647,0.000329533727084667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37557,-0.0202353281412458,0.00563667361849362,-0.0312832084334932,-0.00918744784899826,0.000331960510099237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37593,-0.0171176124026478,0.00477064243426682,-0.0264680715738108,-0.00776715323148481,0.000334288805328213
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37955,-0.0163497280760115,0.00456571771803653,-0.0252985348033631,-0.0074009213486599,0.000343514636510189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,39956,-0.0199959853784216,0.00559621762927574,-0.0309645719318021,-0.00902739882504117,0.000353816222282465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39956,-0.0332810613799874,0.00933486053250717,-0.0515773880237015,-0.0149847347362734,0.000364610579420547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39956,-0.0181191281571705,0.00508382365295182,-0.028083422516956,-0.00815483379738489,0.000366238875492134
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,40531,-0.0260621962096601,0.007315385240342,-0.0404003512807305,-0.0117240411385898,0.000368184591399415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,40531,-0.0156381097804796,0.00439498365676083,-0.0242522777477309,-0.00702394181322841,0.000374519354883305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40531,-0.0212428953166812,0.00597183576404654,-0.0329476934142124,-0.00953809721915003,0.000375935364367787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,37593,-0.00771988961367979,0.00217597430565402,-0.0119847992527617,-0.0034549799745979,0.00038983881358119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37567,-0.0177915537302126,0.00502764552332991,-0.0276457389559393,-0.00793736850448602,0.000403425239293504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37937,-0.0136578057039388,0.0038614535229434,-0.0212262546089079,-0.00608935679896974,0.000406120450489953
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39975,-0.0122113691653555,0.00345679190754941,-0.0189866813041523,-0.00543605702655866,0.00041273156945837
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,37593,-0.00834711049517753,0.00236308303713645,-0.012978753247965,-0.00371546774239008,0.000413379373661483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37896,-0.0158436335837473,0.00448584372310364,-0.0246358872810304,-0.00705137988646415,0.000413938905778656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39975,-0.015024752750432,0.00425697705455012,-0.0233684277773503,-0.00668107772351379,0.000417642232536346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37896,-0.0149399388003447,0.00423311144626413,-0.0232368372350224,-0.006643040365667,0.000418045593252661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,40466,-0.0192638108423925,0.00546168850642257,-0.0299687203149807,-0.00855890136980425,0.000421345699764305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37623,-0.0298970049945583,0.00848514482442758,-0.0465278888504363,-0.0132661211386802,0.000427407037931131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARTN,Artemin,40039,-0.0130821116383869,0.00371301610686899,-0.0203596232078501,-0.00580460006892364,0.000427410586212988
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37985,-0.0162499195186551,0.00461927411491892,-0.0253036967838962,-0.00719614225341407,0.000436482524778774
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,40354,-0.0129190704628424,0.00367311612705593,-0.020118378071872,-0.00571976285381273,0.000437347038621865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,40336,-0.0178848450235257,0.00508894057088592,-0.0278591685424621,-0.00791052150458935,0.000441886174597315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,40300,-0.00603562519612446,0.00172013889245346,-0.00940709742533324,-0.00266415296691568,0.000451379489643011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40466,-0.0192058357061266,0.00547618267202794,-0.0299391537433013,-0.00847251766895182,0.00045416139262251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37895,-0.0331356293945967,0.00947410115030279,-0.0517048676491901,-0.0145663911400032,0.000471165007871604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37955,-0.0137583172105185,0.00393557179846195,-0.021472037935504,-0.00604459648553311,0.000474004183292475
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALB1,Calbindin,40300,-0.0123390994436352,0.00353578404246961,-0.0192692361668756,-0.00540896272039473,0.000484736367899178
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37955,-0.0077124148172676,0.00221259339852099,-0.0120490978783687,-0.00337573175616647,0.000492428054849842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],40300,-0.0165885353352944,0.00475970166299566,-0.0259175505947659,-0.00725952007582294,0.000493089964270409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,40325,-0.0083854901512062,0.00240612630473551,-0.0131014977084878,-0.0036694825939246,0.000493358038014599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37666,-0.0228423370026859,0.00656229211619761,-0.0357044295504333,-0.00998024445493864,0.000501443782608227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39975,-0.0140686333662182,0.00404346524503925,-0.0219938252464952,-0.00614344148594131,0.00050400922634755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,40154,-0.010935047125711,0.00314598583834929,-0.0171011793688756,-0.00476891488254635,0.000510569099305469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,38008,-0.00515273130544398,0.00148389627165894,-0.00806116799789551,-0.00224429461299246,0.000517370820125381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37895,-0.0208118746390106,0.00599857966466738,-0.0325690907817587,-0.00905465849626258,0.000523126595264251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,40300,0.014301873998165,0.00412703426525786,0.0062128868382596,0.0223908611580704,0.000530821084944709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37623,-0.017669816958427,0.00509882687939106,-0.0276635176420334,-0.00767611627482049,0.000530997372747471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,39801,0.0115895042330016,0.00334539447134242,0.00503253106917048,0.0181464773968328,0.000533032371528295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37666,-0.0212481702014236,0.00614379440580346,-0.0332900072367984,-0.00920633316604882,0.00054495107141211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTG,Protogenin,40484,0.00723964408307312,0.00209392413288358,0.0031355527826213,0.0113437353835249,0.000546722132125881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,37937,-0.0178065566326103,0.00516397902345987,-0.0279279555185916,-0.00768515774662894,0.000566009078202325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,37895,-0.0281112719861702,0.00815636298960502,-0.0440977434457961,-0.0121248005265444,0.000569540352475779
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,37593,-0.0124831029146833,0.0036220689528493,-0.0195823580622679,-0.00538384776709868,0.000569883128540478
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,40393,-0.0427369277186601,0.0124081073867983,-0.0670568181967847,-0.0184170372405354,0.000574066832001444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,39919,-0.0194915692255127,0.00566004586928141,-0.0305852591293043,-0.00839787932172116,0.000575306213016595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,40336,-0.0197252106311702,0.0057287798059716,-0.0309536190508745,-0.00849680221146583,0.000576402312778246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,37536,-0.0156827619030746,0.00455666353013027,-0.0246138224221299,-0.00675170138401929,0.000579834028345354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,40198,-0.00961646317996425,0.00279427616219143,-0.0150932444578595,-0.00413968190206904,0.000580029653746554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,40300,-0.00435916547841555,0.00126725277950789,-0.00684298092625102,-0.00187535003058008,0.000583525107856316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,40466,-0.017231937256168,0.00501560256205238,-0.0270625182777907,-0.00740135623454535,0.00059259769090847
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,37567,-0.0228415557717105,0.00665508777037375,-0.035885527801643,-0.00979758374177792,0.00060056571895671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,37567,-0.0128817315032644,0.00375862442745675,-0.0202486353810796,-0.00551482762544916,0.000611607528649231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,40336,0.013590735936941,0.00397139571888758,0.00580680032792132,0.0213746715459606,0.000622832101601368
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,40147,-0.01052133891588,0.00307844516030418,-0.0165550914300762,-0.00448758640168384,0.000633026324317905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,40300,-0.01688294375376,0.00494034722613061,-0.026566024316976,-0.00719986319054399,0.000633905472111491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37623,-0.0091946805876515,0.00269215368587057,-0.0144713018119578,-0.00391805936334518,0.000638893880505719
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,40300,-0.00786760299865317,0.00230648756791445,-0.0123883186317655,-0.00334688736554086,0.000648686761922968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,37436,-0.0202192405425835,0.00592956189207883,-0.031841181851058,-0.00859729923410896,0.000651833288378842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37666,-0.0294250535564691,0.0086335838563002,-0.0463468779148175,-0.0125032291981207,0.000655860526227337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,37536,-0.0175569736822597,0.00515165564051854,-0.0276542187376761,-0.00745972862684339,0.00065631952125601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,37929,-0.0237187270536171,0.0069714069743384,-0.0373826847233203,-0.0100547693839138,0.00067018687756287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,40336,-0.019103223776466,0.00561719453563629,-0.0301129250663131,-0.0080935224866189,0.000673426211179512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,37937,-0.0160074263855724,0.00471297047475253,-0.0252448485160873,-0.00677000425505743,0.000684600284383471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39975,-0.0197493377916971,0.00581555112989191,-0.0311478180062852,-0.00835085757710895,0.000685615156211127
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,39985,-0.0253555315687457,0.00747256801457933,-0.0400017648773212,-0.0107092982601702,0.000692667306687031
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37623,-0.0157524511559697,0.00464360212736241,-0.0248539113256,-0.00665099098633939,0.000695146325339884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37937,-0.00931049429635359,0.00274670625320847,-0.0146940385526422,-0.00392695004006499,0.000701711225627936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,37536,-0.0228242662772296,0.00673341575264654,-0.0360217611524168,-0.00962677140204237,0.000701755314082869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F3,Tissue factor,40388,0.00791468763751481,0.00233553838635824,0.00333703240025265,0.012492342874777,0.000703675525801787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37985,-0.0230271664595699,0.00679905465540401,-0.0363533135841617,-0.00970101933497805,0.000709093144307043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37926,-0.0304056663224503,0.00899334912334978,-0.0480326306042158,-0.0127787020406847,0.000724525036013592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,40252,-0.0187301558939141,0.00554774899488222,-0.0296037439238833,-0.00785656786394499,0.000736789851341584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37955,-0.0132385642883456,0.00392463466167709,-0.0209308482252327,-0.00554628035145852,0.000745096814728063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39956,-0.0136525736589882,0.00404844848431778,-0.021587532688251,-0.00571761462972534,0.000747260623832778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,40354,0.0166562788365356,0.00494642577139477,0.00696128432460185,0.0263512733484693,0.000760780060860063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37982,-0.00716255354919129,0.00213077958801846,-0.0113388815417075,-0.0029862255566751,0.000777431706691984
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,37982,-0.0252584296296524,0.00752036810510675,-0.0399983511156616,-0.0105185081436431,0.00078534883556983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,40039,-0.0168077464135553,0.00500634185393579,-0.0266201764472694,-0.0069953163798411,0.000788984890117173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40493,-0.0147175099154565,0.00438645970733495,-0.023314970941833,-0.00612004888908002,0.00079487569389267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,37676,-0.00586539888859878,0.00174827657570521,-0.00929202097698099,-0.00243877680021656,0.000795995456904674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39956,-0.0140102041038408,0.0041763619538489,-0.0221958735333847,-0.00582453467429698,0.000796579518624089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,40300,-0.0103985014991725,0.00310078091138444,-0.016476032085486,-0.00432097091285904,0.000799802960148344
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,37896,0.029706130988045,0.00886403967335837,0.0123326132282625,0.0470796487478274,0.000806522592188764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,39720,-0.00880593059059096,0.00263032841565044,-0.0139613742852658,-0.0036504868959161,0.000816394884637297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,39892,-0.0130947037073649,0.00391207629362861,-0.020762373242877,-0.00542703417185285,0.000818119879534291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,37558,-0.0136870122467291,0.00409076047303423,-0.0217049027738761,-0.00566912171958197,0.000822654505726785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,37895,-0.00987266258892902,0.00295366061497816,-0.0156618373942862,-0.00408348778357182,0.000832486241497302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40531,0.00959083148688257,0.00287539095457256,0.00395506521592036,0.0152265977578448,0.000853425984142235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37896,-0.0125908046470035,0.00377579620520353,-0.0199913652092024,-0.00519024408480458,0.000856503816891852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,37896,-0.0193899266326935,0.00581807310597277,-0.0307933499204001,-0.00798650334498688,0.000862379133276386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,40300,-0.0174188109300282,0.005246575444681,-0.027702098801603,-0.0071355230584535,0.000902095049426625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,39975,-0.026946884133475,0.0081165011354982,-0.0428552263590515,-0.0110385419078986,0.000902208750326848
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37896,-0.0288928129056343,0.00870666452505828,-0.0459578753747486,-0.0118277504365201,0.000907521774481114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,40037,-0.0231953076498478,0.00699824048107294,-0.0369118589927508,-0.00947875630694486,0.000920335315038254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,37557,-0.0304730254935407,0.00921911642255711,-0.0485424936817526,-0.0124035573053288,0.000950898227299928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39956,-0.0182492270493499,0.00552958095397834,-0.0290872057191474,-0.00741124837955232,0.000968025368889979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFM,Afamin,38008,0.00510330794522194,0.0015477709628205,0.00206967685809377,0.00813693903235011,0.000979056884238209
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,40037,0.0352206536926378,0.0106979497785573,0.0142526721266655,0.05618863525861,0.000995994680067437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37623,-0.0260446568265429,0.00792129983621817,-0.0415704045055305,-0.0105189091475553,0.00101192390764397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39975,-0.0129850642115739,0.00395546680826618,-0.0207377791557756,-0.00523234926737219,0.00103003375268842
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,37623,-0.0253035147434504,0.00771293793426597,-0.0404208730946117,-0.0101861563922891,0.00103834222432018
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,37567,-0.0178713163971993,0.00545748142387397,-0.0285679799879922,-0.00717465280640628,0.00106068918681776
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,39929,-0.024319988008197,0.00743036815478184,-0.0388835095915694,-0.00975646642482457,0.00106625814416313
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37603,-0.0218183374906597,0.00666584366790601,-0.0348833910797555,-0.00875328390156396,0.00106628721220029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,40401,-0.010961952562535,0.00335035745400834,-0.0175286531723914,-0.00439525195267867,0.00107063585493028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,40279,-0.00948588442751321,0.0029022509840195,-0.0151742963561914,-0.00379747249883498,0.00108365982204644
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37557,-0.0172543503816201,0.00527917354791983,-0.0276015305355429,-0.0069071702276972,0.00108443274446983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37896,-0.00705084209121392,0.00215976265723912,-0.0112839768994026,-0.00281770728302524,0.00109878295274713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37955,-0.00728233601881268,0.00223228747092673,-0.0116576194618291,-0.00290705257579628,0.00110796181287997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,40466,-0.00960345310033166,0.00294590514803111,-0.0153774271904726,-0.00382947901019069,0.00111671208994192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,37536,-0.0312244798853841,0.00958196073810551,-0.0500051229320709,-0.0124438368386973,0.00112220102756803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37896,0.00814774234453386,0.0025013762879756,0.00324504482010168,0.013050439868966,0.00112754889521709
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,40354,0.0265904937849243,0.0081659665391778,0.0105851993681358,0.0425957882017128,0.00113127462080766
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37709,-0.020068837707403,0.0061708166230075,-0.0321636382884977,-0.00797403712630828,0.00114794639600254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,37567,-0.0185402792618931,0.00570460378148881,-0.0297213026736111,-0.007359255850175,0.0011567332847474
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39956,-0.0100673480248126,0.00309894813483788,-0.0161412863690948,-0.00399340968053033,0.0011620746169086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,37709,-0.0142041028016545,0.0043751534072128,-0.0227794034797916,-0.00562880212351737,0.00117107921695295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37955,-0.0114906600977973,0.00354039303992755,-0.0184298304560553,-0.00455148973953928,0.00117493508985547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,40531,-0.00744898792720865,0.00229587105774645,-0.0119488952003917,-0.00294908065402561,0.00117891208216986
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,40319,-0.0277077883292754,0.00854514717968102,-0.0444562768014502,-0.0109592998571006,0.00118723446529515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,40386,-0.0106791274846977,0.00329524227299592,-0.0171378023397697,-0.0042204526296257,0.00119451373910562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,40354,-0.0157245664380366,0.00485353025096137,-0.0252374857299209,-0.00621164714615233,0.00119850753168624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,40406,0.00998817824875196,0.00308410838357946,0.00394332581693622,0.0160330306805677,0.00120365638816501
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37895,-0.00944213745931666,0.00291615296256834,-0.0151577972659506,-0.00372647765268272,0.00120715831741492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,40283,-0.00806730796519927,0.00249182061163663,-0.0129512763640071,-0.00318333956639149,0.00120823577446956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,40448,-0.00839384041494747,0.0025933296010193,-0.0134767664329453,-0.00331091439694965,0.00121164861419439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37985,-0.00675010378537518,0.0020863135109602,-0.0108392782668572,-0.00266092930389318,0.00121755063309548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37567,-0.0116335621212626,0.00359578928171275,-0.0186813091134196,-0.00458581512910563,0.00121803744829383
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,37666,-0.0136147366558068,0.00421149276422248,-0.0218692624736829,-0.00536021083793075,0.0012290215843833
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,40304,-0.0179790168377341,0.00556401728052635,-0.0288844907075658,-0.00707354296790246,0.00123479463996283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40466,-0.0129753728849854,0.00401654954761015,-0.0208478099983013,-0.00510293577166949,0.0012383311452732
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,40412,-0.0179391099192539,0.00555325568717428,-0.0288234910661155,-0.00705472877239231,0.00123877429643978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37666,0.00871769412160252,0.00270016000939128,0.00342538050319561,0.0140100077400094,0.00124708330603114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,37937,-0.010023040816719,0.0031047485932374,-0.0161083480594643,-0.00393773357397368,0.00124828800782167
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,40300,-0.0212509121621384,0.00658291964561458,-0.034153434667543,-0.00834838965673383,0.00124829866577942
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37623,-0.020668709817621,0.00640386832260752,-0.0332202917299318,-0.00811712790531028,0.00125167193365588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,40354,-0.00852353319290242,0.00264139916132325,-0.013700675549096,-0.00334639083670884,0.00125392174294731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37593,-0.0288245211860777,0.00895092295853537,-0.046368330184807,-0.0112807121873484,0.00128374725880536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,40039,-0.0161108922293354,0.00502111555933046,-0.0259522787256231,-0.00626950573304772,0.00133639675513683
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40511,-0.00974575114622628,0.00303786489376977,-0.015699966338015,-0.00379153595443752,0.00133880745611828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,37536,-0.0154290972688322,0.00480999286304852,-0.0248566832804073,-0.00600151125725706,0.00134115044296878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,40327,-0.0063145726514555,0.00196996380552836,-0.0101757017102911,-0.00245344359261991,0.00135129703880785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,40511,0.00724747004295912,0.00226516336720936,0.00280774984322877,0.0116871902426895,0.00137916777660598
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,40327,-0.0150157106893264,0.00469372491322469,-0.0242154115192468,-0.00581600985940596,0.00138126578189516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,40406,-0.0182886105363225,0.00571698612792639,-0.0294939033470583,-0.00708331772558682,0.0013817704175172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,40037,-0.00813763461082698,0.00254389702248531,-0.0131236727748982,-0.00315159644675576,0.00138236056959333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37993,-0.0219068441568579,0.00685158472892354,-0.0353359502255481,-0.0084777380881678,0.00139020260765402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37623,-0.0185526783318223,0.00580429671176976,-0.029929099886891,-0.00717625677675354,0.00139497153311343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,40300,0.0145421128582564,0.00455978142271585,0.00560494126973337,0.0234792844467795,0.0014293839045219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37557,-0.00948364403393775,0.00297363722362527,-0.0153119729922433,-0.00365531507563223,0.00142982820091595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,37895,-0.0311011603482981,0.00976591325704402,-0.0502423503321044,-0.0119599703644919,0.00145252411560469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37896,-0.0219499414480265,0.00689971497321445,-0.0354733827955269,-0.00842650010052622,0.00146957857556733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37593,-0.00540213419635587,0.00170071839906439,-0.00873554225852208,-0.00206872613418965,0.00149468310839498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,40485,0.0119545846092348,0.00376812096718954,0.0045690675135433,0.0193401017049263,0.00151387061776101
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,37895,0.0106222037335329,0.00335014549049343,0.00405591857216576,0.0171884888949,0.00152429553195133
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,40300,0.0095351866077636,0.00300827916073894,0.00363895945271527,0.0154314137628119,0.0015291386044404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,37477,0.0133380777901619,0.00420849574237324,0.00508942613511037,0.0215867294452135,0.00153148526450024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,37536,-0.019251072690802,0.00608372198899786,-0.0311751677892378,-0.00732697759236619,0.00155781499495065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH1,Somatotropin,40325,-0.0460586009223237,0.0145633584145522,-0.0746027834148461,-0.0175144184298013,0.00156642169089747
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39956,-0.0223285063397413,0.00706080323712059,-0.0361676806844977,-0.00848933199498498,0.00156820137007815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,39975,-0.0121432107291161,0.00384125986887555,-0.0196720800721122,-0.00461434138612001,0.00157391720898334
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37830,-0.0086301250758152,0.00273105113500223,-0.0139829853004196,-0.00327726485121083,0.00158119949423895
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,37937,-0.0186418211353739,0.00590409631525469,-0.030213849913273,-0.00706979235747466,0.00159512536840999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37896,-0.0144047626369995,0.0045624847394826,-0.0233472327263854,-0.00546229254761357,0.0015963376291249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37985,0.0207950639123004,0.00658945000015872,0.00787974191198932,0.0337103859126115,0.00160402895200299
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40531,-0.0107539249390117,0.00340974892818445,-0.0174370328382533,-0.0040708170397702,0.00161414096406746
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37666,-0.0176362790556927,0.00559260850942838,-0.0285977917341723,-0.00667476637721308,0.00161687546700352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,40255,-0.00780136603784938,0.0024752018537307,-0.0126527616711616,-0.0029499704045372,0.00162564900778097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,40336,-0.0209479306985834,0.00665575801234901,-0.0339932164027874,-0.00790264499437931,0.00165068090014647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,40223,-0.023261387173817,0.00740492301249992,-0.0377750362783168,-0.00874773806931716,0.00168487137591508
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,40039,0.0114294221841466,0.00363865330497858,0.00429766170638855,0.0185611826619046,0.00168621714492722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40484,-0.0160080098290539,0.00509749389844945,-0.0259990978700148,-0.00601692178809296,0.00169041937002613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37955,-0.0161751905096975,0.00515213526712956,-0.0262733756332714,-0.00607700538612352,0.0016959419205108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,40039,-0.0100725577352526,0.00321134849434946,-0.0163668007841775,-0.0037783146863276,0.00171265835264075
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39975,-0.0150799208268033,0.00480953585323744,-0.0245066110991487,-0.00565323055445797,0.00171927651186553
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,39975,-0.00809760383171646,0.0025836139145943,-0.0131614871043213,-0.00303372055911163,0.00172635026002807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,37477,-0.013493266768409,0.00431076110073096,-0.0219423585258416,-0.00504417501097629,0.00175111743546438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39975,-0.0104798089009378,0.00335707261428883,-0.0170596712249439,-0.00389994657693171,0.00180133717267953
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,39956,-0.0128054501530997,0.00410374489637748,-0.0208487901499995,-0.00476211015619979,0.00180918414356517
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37557,-0.0303729194731385,0.00973445842711428,-0.0494524579902825,-0.0112933809559945,0.0018115455696712
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,40354,0.0147835443023653,0.00474115807151577,0.00549087448219438,0.0240762141225362,0.00182327658437646
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,37776,-0.00619435404335881,0.00198743918422052,-0.010089734844431,-0.0022989732422866,0.00183244474599061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,40352,-0.00690046322547863,0.00221496847675133,-0.0112418014399112,-0.00255912501104602,0.0018403635908843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,40511,-0.00974844221585777,0.00312917310399136,-0.0158816214996808,-0.00361526293203469,0.00184055771047648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,40037,-0.0152380962263425,0.00489466617424261,-0.024831641927858,-0.00564455052482699,0.00185402814893938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,40336,-0.0242392462627077,0.00780421191824658,-0.039535501622471,-0.00894299090294437,0.00190023006762965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40531,-0.00761833048337452,0.00245405460806436,-0.0124282775151807,-0.00280838345156839,0.00191006078123393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37896,-0.00703221641376663,0.00226586315711139,-0.011473308201705,-0.00259112462582831,0.0019161157565135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,40484,-0.0105600511071467,0.0034027896604505,-0.0172295188416297,-0.00389058337266376,0.00191675291671621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39975,0.00876860315003583,0.00282706883423826,0.00322754823492884,0.0143096580651428,0.00192784584416253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,40325,0.00502886048521045,0.0016241812019624,0.00184546532936415,0.00821225564105674,0.00196330772295884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",40300,-0.0198373695812403,0.00641178673295426,-0.0324044715778307,-0.00727026758464995,0.00197893746705367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,37593,-0.00761684912101635,0.00246183046737122,-0.0124420368370639,-0.00279166140496875,0.00197906678088147
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37985,-0.00870928915056425,0.00282069507797544,-0.0142378515033961,-0.00318072679773239,0.00202161233971325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40484,-0.00649491730826574,0.00210535668870126,-0.0106214164181202,-0.00236841819841127,0.00203933755317675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,40406,-0.00885034555752477,0.00287114766859104,-0.0144777949879632,-0.00322289612708633,0.00205611844676123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,40039,-0.0175111531458525,0.00568159999148203,-0.0286470891291573,-0.00637521716254777,0.00205917268979302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,37895,-0.0135147359637541,0.00438554175651775,-0.0221103978065289,-0.00491907412097931,0.00206268002657092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,37623,-0.00765727506278232,0.00248577033502685,-0.012529384919435,-0.0027851652061297,0.0020711848219951
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37672,0.0169082594380411,0.00549091875341904,0.0061460586813398,0.0276704601947424,0.0020790370487408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39920,-0.0169076196774262,0.00549400040823047,-0.0276758604775579,-0.0061393788772945,0.00209131053540359
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,40314,-0.00628690824339981,0.00204349030149326,-0.0102921492343266,-0.00228166725247302,0.00209764988572714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37709,-0.00888575693221781,0.00289199927806171,-0.0145540755172188,-0.00321743834721685,0.00212682361775707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",40300,-0.0112172572004873,0.00365099579895629,-0.0183732089664417,-0.00406130543453299,0.0021271726652976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37557,-0.0131157893279874,0.00426892199855877,-0.0214828764451625,-0.00474870221081217,0.00212788318886396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,37536,-0.0157941831516705,0.00514451910567401,-0.0258774405987916,-0.00571092570454948,0.00214426240011732
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,37985,-0.0163433813225466,0.00532404544466973,-0.0267785103940992,-0.0059082522509939,0.0021467668234974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,37985,-0.0142809958962163,0.004660181696879,-0.0234149520220992,-0.0051470397703335,0.00218483699147309
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37557,-0.0188513041622069,0.00615826948251531,-0.0309215123479369,-0.00678109597647689,0.00220944715164229
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37895,-0.0112858837995121,0.00369007014080922,-0.0185184212754982,-0.00405334632352605,0.00222924997436967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39920,-0.0121118365533982,0.00396536801154597,-0.0198839578560283,-0.00433971525076807,0.00225891582616046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,37955,-0.00949538096287008,0.00311097996525344,-0.0155929016947668,-0.00339786023097334,0.00227600454512613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,37716,-0.00638565914263043,0.00209266796203774,-0.0104872883482244,-0.00228402993703646,0.00228193634784659
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,40417,-0.0106442923475798,0.00349055118271496,-0.0174857726657011,-0.00380281202945848,0.00229629525847283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37955,-0.0288476559197333,0.00945975309265678,-0.0473887719813406,-0.010306539858126,0.00229655405270552
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,37937,-0.0343681694875924,0.0112927662061304,-0.0565019912516081,-0.0122343477235767,0.00234387763846964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,39866,-0.017695587704271,0.00581666137225613,-0.029096243993893,-0.006294931414649,0.00235231923672332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,40039,-0.0369208609486417,0.012166638295862,-0.0607674720085312,-0.0130742498887521,0.00241253119943397
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,40398,-0.00767701746901815,0.00253230348784669,-0.0126403323051977,-0.00271370263283862,0.00243624325743935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37666,-0.0213715520985091,0.00705083207377352,-0.0351911829631052,-0.00755192123391305,0.00244162043824447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,37557,-0.0128596449029552,0.00425483926327995,-0.0211991298589839,-0.0045201599469265,0.00251298692546749
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37623,-0.0194015134315611,0.00642357676564983,-0.0319917238922347,-0.00681130297088738,0.00252958566346033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40466,-0.0239447863060773,0.00793730759608909,-0.0395019091944119,-0.00838766341774266,0.00255910712767736
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NBN,Nibrin,40039,-0.0127702503638333,0.00424076713637241,-0.0210821539511232,-0.00445834677654336,0.002605427794898
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,40350,-0.0461924283740227,0.0153507254622957,-0.0762798502801222,-0.0161050064679232,0.00262401853571684
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,40037,-0.0230213735007111,0.00766746390688237,-0.0380496027582005,-0.00799314424322163,0.00268217966324975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37709,-0.017355350647891,0.00578951802382581,-0.0287028059745896,-0.00600789532119239,0.00272512036036964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,40511,-0.00749926428239756,0.00250178163062954,-0.0124027562784315,-0.00259577228636366,0.00272558020701302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARC,SPARC,40406,-0.0176299179026645,0.00588636810212376,-0.0291671993828271,-0.00609263642250195,0.00274828468462402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,40039,-0.00964683221918459,0.00322535425887513,-0.0159685265665799,-0.00332513787178933,0.00278557347268072
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39956,-0.0121409774602399,0.00406219266568088,-0.0201028750849744,-0.00417907983550534,0.00280537848246318
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37850,-0.0119393964200058,0.00399483695540924,-0.0197692768526079,-0.00410951598740368,0.00280668920813933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,39956,-0.0177936113142442,0.00596651856040777,-0.0294879876926434,-0.00609923493584498,0.00286589191431327
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,37477,-0.0165057994083038,0.00554865607030776,-0.027381165306107,-0.00563043351050055,0.00293776431110153
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRNN,Cornulin,39852,-0.0164534816503559,0.00553327585970332,-0.0272987023353744,-0.0056082609653374,0.00294830751486797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37623,-0.0142959041831323,0.0048117239026475,-0.0237268830323214,-0.0048649253339432,0.00297312862884191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,40223,-0.00726526545816137,0.00244985605537517,-0.0120669833266967,-0.00246354758962604,0.00302556628581502
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39956,-0.0129893779155465,0.00438299093035358,-0.0215800401390395,-0.00439871569205345,0.00304537505137415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,40352,-0.00941500998529242,0.00318169583968141,-0.015651133831068,-0.00317888613951685,0.00308976675152367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,40223,-0.0118761773201665,0.00401561427450135,-0.0197467812981892,-0.00400557334214386,0.00310605090119303
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37896,0.0126712858882835,0.00429185745803827,0.00425924527052846,0.0210833265060385,0.00315857823124471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,40039,-0.0113763542271787,0.00385763154964607,-0.018937312064485,-0.00381539638987239,0.00319224073382892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,40484,-0.0109863359401306,0.00373033310231762,-0.0182977888206731,-0.00367488305958806,0.00323277123208915
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,40430,0.0108300991676125,0.00367988195716753,0.00361753053156409,0.0180426678036608,0.00325456711008086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37623,-0.0122526943034811,0.00417558417411504,-0.0204368392847466,-0.00406854932221559,0.00334806023576933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,40255,-0.0137876686509991,0.00471000254381077,-0.0230192736368682,-0.00455606366512994,0.00342388019147893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37666,0.00764153162522249,0.00261119813805546,0.00252358327463378,0.0127594799758112,0.00343442399058566
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37630,0.0118309509205048,0.00404382653997529,0.00390505090215324,0.0197568509388564,0.00344288354165539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,37557,-0.0163163682540154,0.00557766964345564,-0.0272486007551885,-0.00538413575284233,0.0034471217394096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,40448,0.0283819281615961,0.009728051485909,0.00931494724921448,0.0474489090739778,0.0035330119883334
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37709,-0.0112761630930275,0.00386497065927769,-0.0188515055852117,-0.00370082060084318,0.00353409417444553
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37593,-0.00854791370346643,0.00293007870812931,-0.0142908679713999,-0.00280495943553297,0.00353675716065135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,37895,-0.00820987618225523,0.00281867346838702,-0.0137344761802938,-0.00268527618421667,0.00358938492870394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,40250,-0.0108396534738372,0.0037224972248867,-0.0181357480346151,-0.0035435589130593,0.00359704954167105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37557,-0.0215970798513258,0.00742007165435695,-0.0361404202938654,-0.00705373940878614,0.00361308726399577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37937,-0.0115483095124561,0.00396812394257752,-0.0193258324399081,-0.00377078658500419,0.00361708015373573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37623,0.0143994761543467,0.00495389392941943,0.00468984405268461,0.0241091082560088,0.0036587398035416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,40039,-0.00875338894802735,0.00301174501893425,-0.0146564091851385,-0.00285036871091621,0.00366107887639523
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39975,-0.0110419997995713,0.00381566880357937,-0.0185207106545869,-0.00356328894455573,0.00381071111040944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,39956,-0.0161595983063235,0.00558468104420292,-0.0271055731529613,-0.0052136234596858,0.00381434596383026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40484,-0.0313461835148637,0.0108358593827773,-0.0525844679051072,-0.0101078991246201,0.00382314712013547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,40336,-0.02488708156089,0.00860977747150458,-0.041762245405039,-0.00801191771674106,0.00385076581537667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,40406,-0.0197648347451849,0.00685994348657177,-0.0332103239788655,-0.0063193455115042,0.00396698521988036
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39956,-0.00950055927416243,0.00329896405285156,-0.0159665288177515,-0.00303458973057338,0.00398394777229991
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,40347,-0.0181948491565394,0.00632033389621599,-0.0305827035931228,-0.00580699471995609,0.00399749508655066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTTG1,Securin,37709,-0.00991356678387987,0.00344569943431103,-0.0166671376751295,-0.00315999589263024,0.00402009234486114
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39975,-0.0125782791061114,0.00437635852245385,-0.0211559418101209,-0.00400061640210182,0.00405675879776084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,37593,-0.0141266609697313,0.00491761889229868,-0.0237651939986367,-0.00448812794082589,0.00407679922353033
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37593,-0.0189542862022283,0.00660960018044964,-0.0319091025559096,-0.00599946984854699,0.00414137916661981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37666,-0.00987267535827385,0.00344298816242571,-0.0166209321566282,-0.00312441855991945,0.00414418665183884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37937,0.0204738638702007,0.00714758863623129,0.00646459014318737,0.034483137597214,0.00418387660815169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,37536,-0.00823369930680199,0.00287854622398366,-0.01387564990581,-0.00259174870779402,0.00423820604772451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37982,-0.00574301055914328,0.00200800764101239,-0.00967870553552756,-0.00180731558275899,0.00424216903491006
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37937,-0.0108643520055102,0.0038028151644629,-0.0183178697278575,-0.00341083428316293,0.00428423145437726
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,37477,-0.0337123037073816,0.0118121692261077,-0.0568641553905527,-0.0105604520242105,0.00432363461494812
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37593,-0.0115597510736504,0.00405159271075606,-0.0195008727867322,-0.00361862936056847,0.00433575018524621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",40223,-0.0138674222258789,0.00487403444753868,-0.0234205297430547,-0.00431431470870313,0.0044445892144146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37682,-0.0152145998352738,0.00535009610910082,-0.0257007882091114,-0.00472841146143623,0.0044647455556094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40531,-0.00540637091967091,0.00190367594214595,-0.00913757576627698,-0.00167516607306485,0.00451752757186179
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,40327,0.00600171225955292,0.00211903125852305,0.00184841099284774,0.0101550135262581,0.00462740138532985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37895,-0.00681678162110192,0.00240865997649822,-0.0115377551750384,-0.00209580806716542,0.00466004550575509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,39956,-0.0124036609999848,0.0043830684530183,-0.0209944751679007,-0.00381284683206895,0.00466218783976175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39934,-0.0135931229641929,0.00480343124676572,-0.0230078482078537,-0.00417839772053206,0.00466257293340011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39956,-0.00713481511813789,0.00252209914026375,-0.0120781294330548,-0.00219150080322095,0.00467654135439024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39881,-0.0128988892067764,0.00456080029945553,-0.0218380577937092,-0.00395972061984352,0.00468697886357208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,40531,-0.00549257430990815,0.00194278686473603,-0.00930043656479078,-0.00168471205502553,0.00470204722250579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,40039,-0.00825468916187365,0.00292013698963669,-0.0139781576615616,-0.00253122066218573,0.00470732355485396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,37985,-0.0125751475196844,0.00445114437276797,-0.0212993904903096,-0.00385090454905914,0.00473277494719394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,39986,-0.0116655891121403,0.00413134164797512,-0.0197630187421715,-0.00356815948210902,0.00475360900166351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,38008,-0.00410588682033305,0.0014550079935864,-0.0069577024877624,-0.0012540711529037,0.00478095448626156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,40446,-0.0069987241977617,0.00248149075493111,-0.0118624460774267,-0.00213500231809673,0.00480272117347627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39956,-0.011613474913411,0.00412265984564488,-0.019693888210875,-0.00353306161594705,0.00485379239462348
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,40327,-0.0172446094353782,0.00613202471571446,-0.0292633778781785,-0.00522584099257786,0.00492610376265976
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37593,-0.00882120730241294,0.00313812638380008,-0.0149719350146611,-0.00267047959016478,0.00494641130851682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37955,-0.0136266282266968,0.00484784126258577,-0.0231283971013649,-0.00412485935202866,0.00494796386395173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,40008,-0.0169475756681935,0.00603118774592423,-0.028768703650205,-0.00512644768618204,0.00496049398430664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39975,-0.0153213801816624,0.0054545017946999,-0.0260122036992742,-0.00463055666405055,0.0049766682027793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,37761,-0.00769822776523336,0.0027476043939619,-0.0130835323773987,-0.00231292315306805,0.00508923455374047
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,37773,-0.0253932395578414,0.00906971211716414,-0.0431698753074831,-0.0076166038081997,0.00512103230734319
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,37666,-0.0088762511127792,0.00317768772939101,-0.0151045190623856,-0.00264798316317282,0.0052247531360191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,40223,-0.01679208643851,0.00601440784729611,-0.0285803258192104,-0.00500384705780965,0.00524501706861068
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,37477,-0.0131440230105238,0.00470770785058137,-0.0223711303976633,-0.00391691562338427,0.00524561521774045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37593,-0.0103609578787416,0.0037117685904432,-0.0176360243160103,-0.00308589144147296,0.00525594999542333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,39975,-0.0224721756674558,0.00806380602795665,-0.0382772354822508,-0.00666711585266076,0.00532967593658417
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,37593,-0.00802738618035394,0.00288112560383143,-0.0136743923638635,-0.00238037999684433,0.00534067459923395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,39956,0.0116027268760901,0.00417357343763252,0.00342252293833034,0.0197829308138498,0.00544166786486161
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37567,-0.019422419399033,0.00698838761291906,-0.0331196591203543,-0.00572517967771161,0.00545634973618944
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,40354,-0.0120217483753133,0.00432891522041897,-0.0205064222073345,-0.00353707454329215,0.0054913709061119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,37916,-0.00733434941885728,0.00264283848295158,-0.0125143128454424,-0.00215438599227218,0.0055247455527159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,40327,0.00447684130152498,0.00161531890560055,0.0013108162465479,0.00764286635650206,0.00558652268211714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37593,-0.0103001741400315,0.00372265669954055,-0.017596581271131,-0.00300376700893206,0.00566733136582751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,37623,-0.011365948137642,0.00410967664233629,-0.0194209143566211,-0.00331098191866286,0.00568876944432975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,37567,-0.00992024354777941,0.00358974954742515,-0.0169561526607327,-0.00288433443482611,0.00572662755720972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37557,-0.0140958984547749,0.00510707547319151,-0.0241057663822303,-0.00408603052731958,0.00578688334100006
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,40039,-0.00681624214595877,0.00247099270911034,-0.011659387855815,-0.0019730964361025,0.0058134366582284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,37895,-0.0102350962703319,0.00371375079940446,-0.0175140478371646,-0.00295614470349911,0.00585918775821783
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37666,-0.00835150272418942,0.00303045428437104,-0.0142911931215567,-0.00241181232682218,0.00586185653059171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,40198,-0.00715134013116157,0.00260249507543977,-0.0122522304790235,-0.00205044978329962,0.00600505046076535
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,40367,-0.00410893356006492,0.0014956664334696,-0.00704043976966534,-0.0011774273504645,0.00601693378663193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37557,-0.0126993655615068,0.00462540997636267,-0.0217651691151776,-0.00363356200783592,0.00604890824872644
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,40380,-0.0273053641812125,0.00995402813555745,-0.0468152593269051,-0.00779546903551989,0.00609214442624074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37895,-0.0245528935231802,0.0089599252547397,-0.04211434702247,-0.00699144002389034,0.00614639319324682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37955,-0.0130838828145756,0.00477681483788025,-0.0224464398968209,-0.00372132573233027,0.0061699873076522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40531,-0.00514507548561453,0.00187852365081704,-0.00882698184121592,-0.00146316913001313,0.00617143116796492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37985,-0.0147889073849167,0.00540898037541364,-0.0253905089207274,-0.00418730584910597,0.00626248653988055
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,37567,-0.0175639381798276,0.00642426261094503,-0.0301554928972799,-0.00497238346237533,0.00626538754279625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37937,-0.0540593214805936,0.0197984766621096,-0.0928643357383284,-0.0152543072228589,0.00633245411015581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,38008,-0.00671351514113001,0.0024609144836098,-0.0115369075290052,-0.00189012275325481,0.00637906431152132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37896,-0.00597601938924223,0.00219192184707448,-0.0102721862095082,-0.00167985256897626,0.00641155459009679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,37937,-0.0216831232387576,0.00795490707969295,-0.0372747411149558,-0.00609150536255938,0.00642375245696141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,37386,-0.00789560509918403,0.00290683560863633,-0.0135930028921112,-0.00219820730625682,0.00661197774598122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,40037,-0.0101288824888975,0.00373295197429657,-0.0174454683585188,-0.00281229661927626,0.00666757368241062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,39975,-0.00921890439858709,0.00339985515697199,-0.0158826205062522,-0.002555188290922,0.00670415266684192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,38008,0.0169005112522478,0.00623323205230498,0.00468337642973006,0.0291176460747656,0.00670930608310971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,37572,-0.0155277676084628,0.00572947255911074,-0.0267575338243199,-0.00429800139260579,0.00673388658712122
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,40354,-0.00581446173853397,0.0021463662197171,-0.0100213395291795,-0.00160758394788846,0.00675627999863503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37567,-0.023446215297042,0.00866644627362262,-0.0404324499933423,-0.00645998060074168,0.006831005875353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMD,Dystrophin,37623,-0.0116408750418453,0.00431170697177789,-0.02009182070653,-0.00318992937716065,0.00694635518035665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,40336,-0.0185054033317971,0.00685642181588324,-0.0319439900909283,-0.00506681657266594,0.00696241544689679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,40336,-0.00783863569978727,0.00290723134569093,-0.0135368091373415,-0.00214046226223304,0.00701979628680814
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,39975,-0.0132141840673092,0.00491579677635993,-0.0228491457489747,-0.00357922238564375,0.00719351833570575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,37536,-0.0122716063729099,0.00456747833773315,-0.0212238639148669,-0.00331934883095296,0.00722452136458425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,40391,-0.0192803485335003,0.00717738744224011,-0.033348027920291,-0.00521266914670973,0.00723311271982935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,40466,-0.00582217945664482,0.00216956652727577,-0.0100745298501053,-0.0015698290631843,0.00729160128295528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37567,-0.00723417244869857,0.00269565709951749,-0.0125176603637528,-0.00195068453364429,0.00729169496439445
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37557,-0.0198286482450017,0.00738993096599384,-0.0343129129383496,-0.00534438355165375,0.00730133422338994
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37567,-0.00868312247178194,0.00324151309218542,-0.0150364881324654,-0.00232975681109853,0.00739951960668908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39975,-0.0122870177623873,0.00458903296866662,-0.0212815223809738,-0.00329251314380069,0.00742575642461521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,37593,-0.0230533475303196,0.00861352622753433,-0.0399358589362869,-0.00617083612435236,0.00745073632855528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAYN,Layilin,40187,-0.00764067781362777,0.00285790684797145,-0.0132421752356518,-0.00203918039160373,0.00751367441855675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37896,-0.0112270428887236,0.00420069099205416,-0.0194603972331498,-0.00299368854429749,0.00753419923997044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,37709,-0.00657500339369401,0.00246187151318952,-0.0114002715595455,-0.00174973522784255,0.00757780232167727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,40484,0.00860037784232641,0.00322127772189145,0.00228667350741917,0.0149140821772337,0.00759581554498346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37895,-0.0210600525828555,0.00789177636030221,-0.0365279342490478,-0.00559217091666315,0.00762578425079346
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,40328,-0.0183125688126955,0.00687802737065785,-0.0317935024591849,-0.00483163516620616,0.00776467497354233
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,40039,-0.0154208561386475,0.00579865131780983,-0.0267862127215548,-0.00405549955574022,0.00783630877049172
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37709,-0.0168040908158397,0.00632736913576501,-0.0292057343219391,-0.00440244730974031,0.00792202235440081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,40354,-0.00624516217640322,0.00235179314787588,-0.0108546767462399,-0.0016356476065665,0.00792723245867771
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37895,-0.00827565824008028,0.00311834618949488,-0.0143876167714902,-0.00216369970867032,0.00796701636500999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39975,-0.014147790334208,0.00533296704282373,-0.0246004057381425,-0.00369517493027348,0.00798864018103045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39975,-0.0204518790483724,0.00771023032528708,-0.0355639304859351,-0.00533982761080974,0.00799642463734541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,37593,0.0102188662508022,0.0038572888599742,0.00265858008525276,0.0177791524163516,0.0080770616555164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,40187,-0.0245520617486656,0.00927444532147226,-0.0427299745787512,-0.00637414891857993,0.00812227705612297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,37982,0.0104565218025711,0.00395220265955918,0.00271020458983511,0.0182028390153071,0.00816054072948543
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37955,-0.0095774015612926,0.0036217700365703,-0.0166760708329704,-0.00247873228961482,0.00819310070405345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39975,-0.0162725098971079,0.00615604555621619,-0.0283383591872916,-0.00420666060692418,0.00821754785360492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,37567,-0.0152149262743657,0.00575882703948507,-0.0265022272717564,-0.00392762527697497,0.0082511429979748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,39975,-0.0165457605990223,0.00626787832608952,-0.0288308021181577,-0.0042607190798868,0.00830451161216547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,37937,-0.0207184171448411,0.00787758023412134,-0.036158474403719,-0.0052783598859633,0.0085469684826666
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,37955,-0.014421823263057,0.00548507638542819,-0.0251725729784963,-0.00367107354761775,0.00856618397768602
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40531,-0.0147381807597822,0.00560993693034547,-0.0257336571432594,-0.00374270437630512,0.00861834861561089
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,37593,-0.0136122382153992,0.00518324485235965,-0.0237713981260241,-0.00345307830477425,0.00864441531093234
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,40466,0.00674898986196191,0.00257160444767619,0.00170864514451658,0.0117893345794072,0.00868771057702377
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37623,-0.0159597569543686,0.00608402122136602,-0.027884438548246,-0.00403507536049117,0.00872020693599621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,40223,-0.00755346007423879,0.00288831188957385,-0.0132145513778035,-0.00189236877067405,0.00892649023356519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37557,-0.0147547761073722,0.0056464440724479,-0.0258218064893701,-0.00368774572537437,0.00898250511269492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37666,0.00863282811457197,0.00331045425213559,0.00214433778038622,0.0151213184487577,0.0091242694263564
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37557,-0.00555875480340099,0.00213838227130134,-0.00974998405515161,-0.00136752555165037,0.00934605133310602
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,40417,-0.00919773334708315,0.00353884196969437,-0.0161338636076841,-0.00226160308648218,0.00935599561368426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,38008,0.00422533574995677,0.00162744170494461,0.00103555000826534,0.00741512149164819,0.00943339376441706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37557,-0.00807801846230422,0.00312918777389144,-0.0142112264991315,-0.001944810425477,0.00984777394236502
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,40437,-0.0156942387423078,0.00608274105907169,-0.0276164112180883,-0.00377206626652726,0.00988526412478326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,39891,-0.00657290142952953,0.00254767693239998,-0.0115663482170335,-0.00157945464202556,0.0098903650337446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,37477,-0.0127880929701738,0.00495851186942639,-0.0225067762342496,-0.0030694097060981,0.00991901914253816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37709,-0.0142448157745274,0.00552582796301152,-0.02507543858203,-0.00341419296702483,0.00995209575969212
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,40039,-0.0109674820402585,0.00425538483766139,-0.0193080363220749,-0.0026269277584422,0.0099661190152066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,37895,-0.0135666256677467,0.00526980026549578,-0.0238954341881184,-0.00323781714737499,0.0100517270403028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,37536,-0.0122474077162799,0.0047624544915008,-0.0215818185196214,-0.00291299691293828,0.0101321984437575
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,40328,-0.0130777667297082,0.00508894622844871,-0.0230521013374677,-0.00310343212194871,0.0101836509658748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,40039,-0.00832260060270018,0.00323866391516924,-0.0146703818764319,-0.00197481932896846,0.0101860013570523
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39975,-0.00802006081375185,0.00312761660551885,-0.0141501893605688,-0.00188993226693489,0.0103485596463653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HLA_DRA,,40283,-0.00768663236793749,0.00300015131859318,-0.0135669289523801,-0.00180633578349486,0.0104138587425573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39975,-0.0106118810513767,0.00414903076323687,-0.018743981347321,-0.00247978075543246,0.0105468022725792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,37536,-0.01241449294859,0.00485613708608798,-0.0219325216373224,-0.00289646425985754,0.0105856832385509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,40300,-0.00735170960189233,0.00287620713958909,-0.012989075595487,-0.00171434360829771,0.0105962420085071
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,37593,-0.00887584688009685,0.00347519600112751,-0.0156872310423068,-0.00206446271788692,0.0106587792161995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,37536,-0.0230137458041158,0.00901482270020571,-0.040682798296519,-0.00534469331171263,0.0106949293583528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,40037,-0.0103879516393263,0.00406987683566795,-0.0183649102372355,-0.00241099304141713,0.0107078271211661
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37937,-0.0114798094665765,0.00449806326025738,-0.0202960134566809,-0.00266360547647201,0.010716439601296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37955,-0.0196143335916175,0.00769549833159112,-0.0346975103215362,-0.00453115686169894,0.0108202020827238
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37709,-0.0152275301556549,0.00597734926281741,-0.026943134710777,-0.00351192560053274,0.0108597641705999
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,37929,-0.00545862450830499,0.0021441917151087,-0.00966124026991804,-0.00125600874669195,0.010914655803677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,39975,-0.0128708365437271,0.00508054753856301,-0.0228287097193105,-0.00291296336814356,0.011307366049665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37937,0.00561655699745456,0.0022177165333591,0.00126983259207073,0.00996328140283839,0.0113337162372978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",37477,-0.0122339260019261,0.0048345936280389,-0.0217097295128824,-0.00275812249096991,0.0114017742943155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37955,-0.0129303640054616,0.00511589613726418,-0.0229575204344994,-0.0029032075764238,0.0114995014708512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,40198,-0.00958441962315,0.0037924221204962,-0.0170175669793226,-0.00215127226697744,0.0115054886109253
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37557,-0.00587458606857565,0.00232783642251339,-0.0104371454567019,-0.00131202668044941,0.0116268995416287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,37347,-0.00813042737734853,0.00322173569561063,-0.0144450293407454,-0.0018158254139517,0.0116273489925758
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,40511,0.00819418800252271,0.00325013055358596,0.00182393211749422,0.0145644438875512,0.0117055555394837
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,40039,-0.00998397364841547,0.00396483422238256,-0.0177550487242853,-0.00221289857254565,0.0118078622871123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,40300,-0.0115230266493283,0.00457826918048994,-0.0204964342430886,-0.00254961905556803,0.0118491694768386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39975,-0.0127210352618162,0.00505993558242097,-0.0226385090033613,-0.00280356152027109,0.0119446865526115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,37477,0.00632834336922138,0.00251762816768609,0.00139379216055663,0.0112628945778861,0.0119621070119043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,37536,-0.0103241843717598,0.00412767907463341,-0.0184144353580413,-0.00223393338547835,0.0123891647553554
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37896,-0.00902376900405394,0.00361037977307628,-0.0161001133592834,-0.00194742464882444,0.0124523463963224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,37666,-0.00599008927067241,0.00239783041935207,-0.0106898368926025,-0.00129034164874236,0.012497136884594
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,40336,-0.0162681392495972,0.00651245296004494,-0.0290325470512853,-0.00350373144790917,0.012499477916778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37895,-0.00850426247754912,0.00340619673709883,-0.0151804080822628,-0.00182811687283541,0.0125472544215755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39975,-0.026233229738113,0.0105404490455443,-0.0468925098673798,-0.00557394960884617,0.0128273536298518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39975,0.0106441758157984,0.00428316936816063,0.00224916385420357,0.0190391877773933,0.0129613466564408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37567,-0.0150840140010532,0.00607861548680053,-0.0269981003551823,-0.0031699276469242,0.0130959275717004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,37993,-0.0103058500334274,0.00415690471191582,-0.0184533832687824,-0.00215831679807237,0.0131793627238963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40531,-0.0071775827130725,0.00289724451620044,-0.0128561819648254,-0.00149898346131964,0.0132451973121337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,39920,-0.009190420779762,0.00371000055980085,-0.0164620218769717,-0.00191881968255234,0.0132522967784955
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37955,-0.00568724621916408,0.0022996306661884,-0.0101945223248933,-0.00117997011343482,0.0134063977088195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,37623,-0.0139825853949078,0.00565441644994628,-0.0250652416368025,-0.00289992915301309,0.0134161569683291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,37895,0.0165885444415181,0.00672074651970427,0.00341588126289769,0.0297612076201384,0.0135895477703738
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37895,-0.00756991101310352,0.00306984898803312,-0.0135868150296484,-0.00155300699655861,0.0136797075078306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37964,-0.00990129807053098,0.00401939336910926,-0.0177793090739851,-0.00202328706707683,0.0137757197970441
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,37567,-0.00996192910665663,0.00404482976310414,-0.0178897954423407,-0.00203406277097252,0.013795368480432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,40300,-0.0054198628354492,0.00220143750638815,-0.00973468034796997,-0.00110504532292842,0.0138283687659777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,40354,-0.0177687490006045,0.00723089557147643,-0.0319413043206983,-0.0035961936805107,0.0140077190037273
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,40327,0.00986286092741188,0.00401886189464144,0.00198589161391467,0.0177398302409091,0.0141327504504636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,37536,-0.006926582829323,0.00282278241658561,-0.0124592363658308,-0.0013939292928152,0.0141479511297037
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37593,-0.0119495691671527,0.00487222029695359,-0.0214991209491817,-0.00240001738512367,0.0141960117173335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37559,-0.00580701532780399,0.00236943004055558,-0.0104510982072929,-0.00116293244831505,0.0142666132528163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,37593,-0.0181196674926802,0.00739430072709202,-0.0326124969177806,-0.00362683806757988,0.0142790951617437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,40327,-0.00892745113295807,0.00364950347283696,-0.0160804779397185,-0.00177442432619762,0.0144474719823945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",37536,-0.01173196036212,0.00482652092007838,-0.0211919413654736,-0.00227197935876638,0.0150818600772961
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",40300,-0.0196657592574041,0.00809071139665796,-0.0355235535948537,-0.00380796491995445,0.0150824162209792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37993,0.00621272709300066,0.00256267865039055,0.00118987693823518,0.0112355772477661,0.0153505167142921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,37603,-0.00835822704442567,0.00345136710189728,-0.0151229065641443,-0.00159354752470699,0.0154609002689589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,40417,-0.00529308121639914,0.00218852139207607,-0.00958258314486824,-0.00100357928793005,0.0155929737184794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,37557,-0.00867475086326703,0.00358879227523303,-0.0157087837227238,-0.00164071800381029,0.0156549142437518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,40283,-0.0176591241662938,0.00731042679668885,-0.031987560687804,-0.00333068764478367,0.0157202196284658
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37709,-0.00828965299914371,0.00343424318855117,-0.015020769648704,-0.00155853634958342,0.0157996211320977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37567,-0.0157868035611751,0.00655484410782699,-0.028634298012516,-0.00293930910983416,0.016035536928863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,40336,-0.0111922962087356,0.00464892784791364,-0.0203041947906463,-0.00208039762682484,0.0160734685401465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,40484,-0.00587740892433632,0.00244251369605208,-0.0106647357685984,-0.00109008208007424,0.0161264798801647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37593,-0.00781540293351909,0.00325140660300301,-0.014188159875405,-0.00144264599163319,0.0162438900692373
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39975,-0.0125813910062499,0.005234590980011,-0.0228411893270715,-0.00232159268542838,0.0162501814087364
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37985,0.012636168386459,0.00525856092684454,0.00232938896984373,0.0229429478030743,0.0162758606267321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39920,-0.00874033339461788,0.00364258969240945,-0.0158798091917404,-0.00160085759749535,0.0164299792280151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37567,-0.0203190756502488,0.00848691035203854,-0.0369534199402444,-0.00368473136025326,0.0166721457833175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37557,-0.013266582364044,0.00554224735029602,-0.0241293871706242,-0.0024037775574638,0.0166924997318191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39956,-0.0129761794233889,0.00544505890102362,-0.0236484948693952,-0.00230386397738261,0.0171789910580977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37985,-0.00572748740968699,0.00240709321469344,-0.0104453901104861,-0.00100958470888785,0.0173536517208142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,40336,-0.0140318880142707,0.00591539496733797,-0.0256260621502531,-0.00243771387828826,0.0176993134492987
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,40336,-0.0113754427352924,0.00480074713929974,-0.0207849071283199,-0.00196597834226497,0.0178233120707282
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLGN,Calmegin,37567,-0.00877727357128754,0.00370804986198084,-0.01604505130077,-0.0015094958418051,0.0179431931897399
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,40300,-0.0120554542722041,0.00510696909311425,-0.0220651136947081,-0.00204579484970018,0.0182579883895328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37985,-0.00929369935497864,0.0039458777803956,-0.017027619804554,-0.00155977890540326,0.0185222847644824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,40039,-0.00825171537566162,0.00350397044095447,-0.0151194974399324,-0.00138393331139087,0.0185369532183638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,37477,-0.00827898628797806,0.0035174833357053,-0.0151732536259605,-0.00138471894999567,0.0186040044041914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,37536,-0.00946962574775731,0.00402559258241401,-0.0173597872092888,-0.00157946428622586,0.0186696567334451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37985,-0.014412397529357,0.00613991689059347,-0.0264466346349202,-0.00237816042379384,0.0189229410167664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,37557,-0.00745720138320911,0.00318279662976772,-0.0136954827775539,-0.00121891998886438,0.0191457255419597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,37900,-0.0186957185501904,0.00798080490233467,-0.0343380961587664,-0.00305334094161447,0.0191651427799485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",40406,0.00675897867105915,0.0028912977808561,0.00109203502058119,0.0124259223215371,0.0194152574956574
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,40375,0.0092171021244776,0.00394651978652693,0.00148192334288481,0.0169522809060704,0.0195295986372917
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRN1,Neuritin,37955,0.00710168808110037,0.00304354533841919,0.00113633921779876,0.013067036944402,0.0196438410236297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37666,-0.00436104983889619,0.0018695277739166,-0.00802532427577274,-0.000696775402019653,0.019678761452593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,40511,-0.0065503312957072,0.00282975231207107,-0.0120966458273665,-0.0010040167640479,0.0206360267483528
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,40300,-0.036144212057541,0.015623305541466,-0.0667658909188142,-0.0055225331962677,0.0207089707409967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,39898,-0.0220046848145179,0.0095120620222495,-0.0406483263781269,-0.00336104325090884,0.0207167232886211
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NENF,Neudesin,37895,-0.0207034874057176,0.00900575348689256,-0.038354764240027,-0.00305221057140821,0.0215248675836512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,40327,-0.010063443838837,0.00438826681360047,-0.018664446793494,-0.00146244088418011,0.0218459548015386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,40354,-0.00665247621848808,0.00290247412312017,-0.0123413254998036,-0.000963626937172557,0.0219185366314821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,37623,0.00998199285983239,0.00436663475765439,0.00142338873482979,0.018540596984835,0.0222718626700828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37709,0.00838569499820602,0.00366999980310312,0.00119249538412391,0.0155788946122881,0.0223326168604415
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37895,-0.0124699545414143,0.00545772764907874,-0.0231671007336087,-0.00177280834922001,0.0223385760393993
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,40039,-0.00556561714314647,0.0024373397069517,-0.0103428029687718,-0.000788431317521139,0.0224154864607324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,37896,0.0155741336590118,0.00682866642934059,0.0021899474575042,0.0289583198605193,0.0225818320513886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,40223,0.00684281170062451,0.00300167402029142,0.00095953062085332,0.0127260927803957,0.0226408476146928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,37896,-0.0113983276226174,0.0050031115764123,-0.0212044263123856,-0.00159222893284933,0.0227274398587507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39975,-0.0109653176532747,0.0048157871908095,-0.0204042605472613,-0.00152637475928806,0.0228026206892267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,37536,-0.00869788368728735,0.00382560885819975,-0.0161960770493589,-0.00119969032521583,0.0230065020684341
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,40039,-0.00891140126624983,0.00392070185507781,-0.0165959769022023,-0.00122682563029731,0.0230451723495164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37937,-0.0120447734596107,0.00531396329498161,-0.0224601415177747,-0.00162940540144678,0.0234287824204007
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,40429,-0.00894939964831258,0.00396009639001406,-0.0167111885727401,-0.00118761072388502,0.0238412131465053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37593,-0.0126091741660429,0.00558092374726664,-0.0235477847106855,-0.00167056362140025,0.0238788898013335
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,40037,-0.0111346603206565,0.00493179614846371,-0.0208009807716453,-0.00146833986966758,0.023976322504118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,39975,-0.0158665878183938,0.00703857580550529,-0.0296621963971842,-0.00207097923960348,0.0241954156905487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37709,-0.0144673564213066,0.00642025687069445,-0.0270510598878677,-0.00188365295474545,0.0242507058573389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37623,-0.0115775439730448,0.00514122755312536,-0.0216543499771705,-0.00150073796891904,0.0243448283564226
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,40336,-0.0152789289859818,0.00678596601268643,-0.0285794223708472,-0.00197843560111639,0.0243644501166269
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,40470,-0.0040804082213769,0.00181256041398089,-0.00763302663277945,-0.00052778980997435,0.0243873417705046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,37896,-0.0127001072774876,0.00564262847000021,-0.023759659078688,-0.00164055547628721,0.0244179019054871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,37536,-0.00877348378954939,0.0038997918919241,-0.0164170758977206,-0.00112989168137815,0.0244825601442063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37623,-0.00990017476313641,0.00440292293972777,-0.0185299037250028,-0.00127044580126998,0.024557857983485
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,37557,0.00879626949862317,0.00391318919102443,0.00112641868421529,0.016466120313031,0.0246021971259925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,40350,-0.00841137206936968,0.0037582858526869,-0.015777612340636,-0.00104513179810336,0.0252291483222788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,37993,-0.00812708096042303,0.00363187640751618,-0.0152455587191547,-0.00100860320169132,0.0252562626504189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,40327,-0.00649673215687233,0.00290473267709307,-0.0121900082039747,-0.000803456109769909,0.0253261672314527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,40497,-0.010069750545627,0.00450331184924711,-0.0188962417701513,-0.00124325932110262,0.0253604416978268
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,40288,-0.00581046137169779,0.00260243641196846,-0.010911236739156,-0.000709686004239604,0.025582615641981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,40336,-0.0196569205439136,0.00880451172046496,-0.0369137635160249,-0.00240007757180223,0.0255894574677112
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,37593,-0.00777127958284414,0.00348136718372541,-0.014594759262946,-0.000947799902742328,0.0256152731820345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,39975,-0.0174127733423842,0.00780478496768216,-0.0327101518790413,-0.00211539480572721,0.0256928261507799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,37557,-0.0134775076652439,0.00604281365676157,-0.0253214224324966,-0.00163359289799125,0.0257419782376548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40531,-0.00578295139768621,0.00259320741879633,-0.010865637938527,-0.000700264856845409,0.0257586613580803
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCN,Decorin,40037,-0.00422603606275627,0.00190068708011131,-0.00795138273977443,-0.000500689385738111,0.0262014057608409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39975,-0.0165226914376809,0.00744399350352354,-0.031112918704587,-0.00193246417077478,0.0264602958449471
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,40336,0.0090693912946074,0.00408639067902772,0.00106006556371307,0.0170787170255017,0.0264726657682577
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,37536,-0.0141950256592479,0.00640928715688193,-0.0267572284867364,-0.00163282283175928,0.0267937818686664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37567,-0.00660339972628611,0.00301096395852186,-0.0125048890849889,-0.000701910367583272,0.0283163632083232
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37937,-0.0138433766622683,0.00632330911749591,-0.0262370625325603,-0.00144969079197632,0.0285949254558121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37955,-0.0125361712559265,0.00573830285392852,-0.0237832448496264,-0.00128909766222657,0.0289318075453467
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,37593,-0.00496004576354701,0.0022705804179086,-0.00941038338264786,-0.000509708144446149,0.0289443376916596
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37557,0.00607853154054517,0.00279397513949114,0.000602340267142541,0.0115547228139478,0.0296040849954591
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37709,-0.00778028419905448,0.00358310315848089,-0.014803166389677,-0.000757402008431932,0.0299200160963293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,37709,-0.0132669807052473,0.00611106299585267,-0.0252446641771186,-0.00128929723337611,0.0299505505684081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37557,-0.0182373210363998,0.00842724109390264,-0.034754713580449,-0.00171992849235062,0.0304753304618828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37557,-0.00703564484758558,0.00325500625325209,-0.0134154571039597,-0.000655832591211477,0.0306759987823878
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,40369,-0.0102417496831881,0.00474099040627695,-0.0195340908794909,-0.000949408486885267,0.0307677878837721
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40466,-0.0129653205042289,0.00600189220449418,-0.0247290292250375,-0.00120161178342035,0.030771552837759
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37782,-0.0110536541291225,0.00511703730484702,-0.0210830472466227,-0.00102426101162234,0.0307775248604287
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,40037,-0.0109862470822768,0.00509517175728122,-0.020972783726548,-0.000999710438005567,0.0310827248901302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,40406,-0.0142198357658649,0.00660948884717733,-0.0271744339063325,-0.00126523762539738,0.0314574408637816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,40531,-0.00793185709711734,0.0036987006482522,-0.0151813103676917,-0.000682403826543027,0.0320079278822691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,40223,-0.0059803097963529,0.002790210095244,-0.0114491215830311,-0.000511498009674664,0.0321027582498261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,40354,-0.011389786584588,0.00532854487428751,-0.0218337345381916,-0.000945838630984517,0.0325722170523674
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,37536,-0.0113584479672792,0.005315412290948,-0.0217766560575373,-0.000940239877021113,0.0326254825134322
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37557,-0.00868661712716927,0.00406842768978336,-0.0166607353991447,-0.000712498855193894,0.0327689813285607
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37895,-0.00905096162310829,0.0042414915456692,-0.0173642850526199,-0.000737638193596657,0.0328681863401317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,40511,-0.0108097152860419,0.00506799757343725,-0.0207429905299789,-0.000876440042104855,0.0329450822463621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BGN,Biglycan,39951,0.0215505311554177,0.0101091175187456,0.00173666081867633,0.0413644014921592,0.0330396689205115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,37955,0.00452364514639335,0.00212668951675943,0.000355333693544862,0.00869195659924184,0.0334312611672242
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37709,-0.00940692986074757,0.00442247895124312,-0.0180749886051841,-0.000738871116311065,0.0334325358992744
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,37593,-0.00527325388578194,0.00247940242366812,-0.0101328826361715,-0.000413625135392421,0.0334532426391998
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,37536,-0.0211397124792291,0.00995824689316601,-0.0406578763898345,-0.00162154856862369,0.033786426209374
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORT1,Sortilin,40325,-0.00641215269434043,0.00302114387529429,-0.0123335946899172,-0.000490710698763611,0.0338174649403707
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37593,-0.00891337273256411,0.00419964721093022,-0.0171446812659873,-0.000682064199140884,0.0338219828090239
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39848,-0.0156522622269141,0.00738116689438802,-0.0301193493399146,-0.00118517511391358,0.0339741637919892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,37638,-0.0249004782863682,0.011746014263334,-0.0479226662425028,-0.00187829033023363,0.0340323690480426
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,37557,-0.00642518448253814,0.00303170093546608,-0.0123673183160517,-0.000483050649024611,0.0340810680899658
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,37526,-0.0155000350518065,0.00731651304260065,-0.0298404006153038,-0.00115966948830927,0.0341515293347887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37593,-0.00723181922926273,0.00341365934863059,-0.0139225915525787,-0.000541046905946771,0.0341519072181764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,39956,-0.00987930362284153,0.00467548669962463,-0.0190432575541058,-0.000715349691577266,0.0346167011217936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37709,-0.011695473376695,0.00554118766942325,-0.0225562012087646,-0.000834745544625454,0.0348216171317343
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,37895,-0.00721285849973013,0.00342157109130079,-0.0139191378386797,-0.000506579160780575,0.0350447309096974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,40258,-0.0148777587034713,0.00706220230683223,-0.0287196752248625,-0.00103584218208016,0.0351615568665
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,37937,-0.00641597867726183,0.00304756619646044,-0.0123892084223243,-0.000442748932199365,0.0352854302429138
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAST,Gastrin,37937,0.0226977927353982,0.0107948629642974,0.00153986132537523,0.0438557241454211,0.035515072782192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,37593,-0.00779641224047881,0.00371936968568304,-0.0150863768244176,-0.000506447656540051,0.0360866397915829
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSC1,Hamartin,37593,-0.0132684999357806,0.00634159832009394,-0.0256980326431647,-0.000838967228396456,0.0364311951607727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37593,-0.00980632975513961,0.0046879296590088,-0.0189946718867969,-0.000617987623482351,0.0364732935947271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37709,-0.00657168018128229,0.00314235128371632,-0.0127306886973663,-0.000412671665198303,0.0365178579061256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",40336,-0.0165223180545211,0.00791111342787839,-0.0320281003731627,-0.00101653573587947,0.0367691205560382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37895,-0.00762968887946389,0.00366131603644263,-0.0148058683108914,-0.000453509448036332,0.0371912745051713
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,37477,-0.0163839013669219,0.00786400473757288,-0.0317973506525647,-0.000970452081279043,0.0372338367710795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37593,-0.0120799356933522,0.00579945677020646,-0.0234468709629569,-0.000713000423747568,0.0372757405845548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37895,-0.00993402759316344,0.00476929951174915,-0.0192818546361918,-0.000586200550135103,0.0372781681112468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,40300,-0.00780798671763906,0.00375024513058446,-0.0151584671735846,-0.000457506261693529,0.0373590502514141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37896,0.0298746793658209,0.0144044102228112,0.00164203532911086,0.058107323402531,0.0380987357297846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39975,-0.0147605789650869,0.00711949828811854,-0.0287147956097993,-0.000806362320374591,0.0381644417505395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37955,-0.0154943738817369,0.00748328732558874,-0.0301616170398908,-0.000827130723582958,0.0384216624984627
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,40223,-0.00730127232095965,0.00353207322222642,-0.0142241358365234,-0.000378408805395862,0.0387377087115916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39956,-0.00663646529330183,0.00321209385723887,-0.01293216925349,-0.000340761333113648,0.0388368392427775
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,38008,-0.00445344540413051,0.00215993196672769,-0.00868691205891679,-0.000219978749344233,0.0392414913497141
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,40352,-0.00580844214870833,0.00281969395299148,-0.0113350422965716,-0.000281842000845041,0.0394190979793345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,40037,0.00837785805395467,0.00407034033115252,0.000399991004895725,0.0163557251030136,0.0395808418577293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37617,0.00488736299117494,0.00237610657262953,0.000230194108821052,0.00954453187352882,0.0397175543991196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37593,-0.00556888304416033,0.00271174515528669,-0.0108839035485222,-0.000253862539798416,0.0400326242581978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,39975,-0.0288612641582,0.0140623919269162,-0.0564235523349558,-0.00129897598144427,0.0401502221809218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40511,-0.00595770277770992,0.0029044267478328,-0.0116503792034622,-0.000265026351957635,0.0402588805488065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,40024,-0.00656479065999524,0.00320074908530518,-0.0128382588671934,-0.000291322452797089,0.0402819911955166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,40395,-0.0058184978956818,0.00283998732350944,-0.0113848730497603,-0.000252122741603306,0.0405003585517313
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POSTN,Periostin,37993,-0.00643261713356949,0.00314072602523817,-0.0125884401430363,-0.000276794124102669,0.0405664459221257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37557,0.0060644223421288,0.00296123956329838,0.000260392798063971,0.0118684518861936,0.0405863812922198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37993,-0.0234174363450883,0.0114347406281733,-0.045829527976308,-0.00100534471386852,0.0405870654174885
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37623,0.00614731374839127,0.00300305631843606,0.000261323364256593,0.0120333041325259,0.040676006659081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,40336,-0.0144672395583003,0.00708726652411663,-0.0283582819455689,-0.000576197171031733,0.0412374741831691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40531,-0.00497744224837054,0.00244170633622628,-0.00976318666737405,-0.000191697829367034,0.04151530292676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,37623,-0.00857577656206638,0.00421002824069064,-0.01682743191382,-0.000324121210312729,0.0416712079726804
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39975,-0.0166985700264276,0.00821670562393214,-0.0328033130493346,-0.000593827003520651,0.0421432493938024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,40300,-0.00445513044181061,0.0021936253371696,-0.00875463610266301,-0.000155624780958203,0.04227732296215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37985,0.00652492442939499,0.00322000641512288,0.000213711855754133,0.0128361370030358,0.0427464555900963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,40531,-0.00511811530320233,0.00252701418828658,-0.010071063112244,-0.000165167494160625,0.042846823172702
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,37567,-0.0103114184889863,0.00509274816206356,-0.0202932048866308,-0.000329632091341679,0.0429157521347798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37895,-0.00846685769654904,0.00418761088603877,-0.016674575033185,-0.000259140359913056,0.0432082489350296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,40336,0.00572043480710514,0.00283287803153637,0.000167993865293851,0.0112728757489164,0.0434726571821489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,37477,0.00751267830374349,0.0037259206325447,0.000209873863955878,0.0148154827435311,0.0437861701897767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,40019,-0.00709875978958177,0.00352611272562389,-0.0140099407318046,-0.000187578847358949,0.0441110822595685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37709,-0.00910872708157034,0.00452847381547078,-0.0179845357598931,-0.000232918403247608,0.0442998142098879
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,37536,-0.00478017901029438,0.00237734735888304,-0.00943977983370513,-0.000120578186883627,0.0443755562493387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37539,-0.00674001408143908,0.00336261752555217,-0.0133307444315213,-0.000149283731356823,0.0450483189267058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,39929,-0.00598615637618263,0.00298970818231799,-0.0118459844135259,-0.000126328338839365,0.0452747924180283
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,40300,-0.00908714003261219,0.00454006925860046,-0.0179856757794691,-0.000188604285755289,0.0453510111423818
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,37536,-0.012564031307323,0.00627897014724862,-0.0248708127959303,-0.000257249818715709,0.0454162350753444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,37557,0.00614680922832645,0.0030784481891251,0.000113050777641265,0.0121805676790116,0.0458758967790697
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,37477,0.00726033966515482,0.00363907150994583,0.000127759505660988,0.0143929198246486,0.0460519298642145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37557,-0.0116807407330346,0.00585564589900137,-0.0231578066950773,-0.00020367477099195,0.0460872675793312
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37567,-0.0119520020604823,0.00599469988513568,-0.0237016138353483,-0.000202390285616397,0.0461987946116741
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39956,-0.0236299279393169,0.0118532875663829,-0.0468623715694274,-0.000397484309206456,0.0462205306335745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,40039,-0.00988730899063273,0.00496108306305119,-0.0196110317942131,-0.000163586187052393,0.0462817111809246
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,37982,0.00423321636457345,0.00212447368765275,6.92479367740591e-05,0.00839718479237285,0.0463258320225971
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37973,-0.00401723390429102,0.00201942400790069,-0.00797530495977638,-5.91628488056575e-05,0.0466885571382995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37593,-0.0145075144914788,0.0072974058973573,-0.0288104300502991,-0.000204598932658435,0.0468282885303277
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,37536,-0.00459704577266248,0.00231737310399022,-0.00913909705648331,-5.49944888416443e-05,0.0473066574093173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,40286,-0.0116400588926129,0.00587022514251082,-0.0231457001719341,-0.000134417613291709,0.0473960524187135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37557,-0.00751143756512835,0.00379946251187511,-0.0149583840884036,-6.44910418531311e-05,0.0480655264621815
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,39956,-0.0119021434779054,0.00602831738189525,-0.0237176455464201,-8.66414093906812e-05,0.048357132501078
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,37623,-0.00676826319616462,0.00342893232777059,-0.013488970558595,-4.75558337342643e-05,0.0484175059876883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,40039,-0.013080040414633,0.00662793708878736,-0.0260707971086563,-8.92837206098e-05,0.0484595814320967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,40371,-0.0151052821515715,0.00765866248080793,-0.030116260613955,-9.43036891879381e-05,0.0485911285440682
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",37477,-0.0149082795962317,0.00756318903669726,-0.0297321301081583,-8.44290843050322e-05,0.0487263523874427
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,40037,-0.00588697686704089,0.00299021905963832,-0.011747806223932,-2.61475101497842e-05,0.0490001482692482
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37593,-0.0142301774664917,0.00726765070357921,-0.0284747728455069,1.44179125235802e-05,0.0502492458053789
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,37895,-0.004509478700056,0.00230325375819687,-0.00902385606612188,4.89866600987456e-06,0.0502655543543888
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,37623,-0.0119333439620629,0.00609826929303757,-0.0238859517764166,1.92638522907105e-05,0.050387249839163
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39975,-0.00739131728565888,0.00378079644359716,-0.0148016783151093,1.9043743791562e-05,0.0506053544678097
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,37557,-0.0102366930754457,0.00523665675790417,-0.0205005403209378,2.71541700465148e-05,0.050626187030035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37666,-0.00868155891879182,0.00445635624420905,-0.0174160171574416,5.28993198579217e-05,0.0514206164972667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37593,-0.0151497314590166,0.0077923459310365,-0.0304227294838482,0.000123266565814914,0.0518949319361073
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37937,-0.00578949540792466,0.00297879041054155,-0.0116279246125861,4.89337967367765e-05,0.0519677897214636
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37623,0.00418464730445759,0.00216334664185726,-5.55121135826283e-05,0.00842480672249781,0.0530927661103967
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,40039,-0.0106658793915178,0.00554509083410521,-0.021534257426364,0.000202498643328409,0.0544378057677503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,37536,-0.015540095638611,0.00810219837586846,-0.0314204044553132,0.000340213178091136,0.0551315143439398
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,37981,0.00579780551668911,0.00302959937347861,-0.000140209255328966,0.0117358202887072,0.055676995241105
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,37477,-0.0099743438612832,0.00521991943296119,-0.0202053859498871,0.00025669822732073,0.0560492180751489
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37557,0.0076203066941312,0.00398932756533705,-0.000198775333929421,0.0154393887221918,0.0561327179752824
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37666,-0.00610918722757981,0.00320049146191243,-0.0123821504929282,0.000163776037768545,0.0563059441834407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37557,-0.00782524534416508,0.00410127673051547,-0.0158637477359754,0.000213257047645242,0.0564127529166392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37896,-0.0125566093394663,0.00658118517683824,-0.0254557322860692,0.000342513607136666,0.0564182317871974
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39956,-0.0068495270585809,0.00359066368845889,-0.0138872278879603,0.00018817377079852,0.0564622206665587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37567,-0.00495689703324619,0.00261201714056126,-0.0100764506287463,0.000162656562253888,0.0577539129691565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37895,-0.00609739536586568,0.00321316006195593,-0.0123951890872993,0.000200398355567941,0.0577659801656077
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37666,-0.00334803656062413,0.0017670038981165,-0.00681136420093248,0.00011529107968421,0.0581468954562746
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37955,-0.00623470631056189,0.00329390424289571,-0.0126907586266375,0.000221346005513697,0.058405660913679
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37785,0.00406753081215029,0.0021526874988695,-0.000151736685633924,0.0082867983099345,0.0588448110440086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,37567,-0.0042725244819149,0.00226813012092703,-0.00871805951893187,0.000173010555102081,0.0596248197244425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,40037,-0.00516969921475077,0.00274485795543296,-0.0105496208073994,0.000210222377897831,0.0596631194398723
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,37536,-0.0149213719327444,0.00792965039555722,-0.0304634867080366,0.000620742842547704,0.0598963902895309
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37623,-0.00891071043518657,0.00473880270877539,-0.0181987637443863,0.000377342874013194,0.0600794881273108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39975,-0.00929842738633414,0.00495049359351531,-0.0190013948296242,0.000404540056955862,0.060361204593437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,37593,-0.00689740773588115,0.00367970511007532,-0.0141096297516288,0.000314814279866482,0.0608911741079175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37557,-0.00936344270777029,0.00499823295074735,-0.0191599792912351,0.000433093875694519,0.061042226103532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,37623,-0.0105674010153582,0.0056441101496888,-0.0216298569087482,0.000495054878031861,0.061188877968367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37709,-0.00833115094868676,0.0044552603407079,-0.0170634612164742,0.000401159319100725,0.0615116344000484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,40223,-0.00943376018939486,0.00504945736498616,-0.0193306966247677,0.000463176245978017,0.0617426843837796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,37567,-0.00364126792064685,0.00195184934419217,-0.00746689263526349,0.000184356793969801,0.0621269921956888
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,40262,0.00534644865859712,0.00287547197143826,-0.000289476405421862,0.0109823737226161,0.0629990709078384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,37593,-0.008651460503532,0.00465967337428513,-0.0177844203171309,0.000481499310066854,0.0633809472340416
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,40039,-0.00740554295806607,0.00400154024601905,-0.0152485618402634,0.000437475924131253,0.0642355014909946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37982,-0.022197116879526,0.0119972166159144,-0.0457116614467181,0.00131742768766614,0.064308117084171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,37557,0.00729318888321023,0.0039557248113436,-0.00046003174702323,0.0150464095134437,0.0652487330444478
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37562,-0.00909419044637193,0.0049391484912528,-0.0187749214892274,0.000586540596483566,0.0656080060143894
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37895,-0.00810332450741352,0.00440290309561072,-0.0167330145748105,0.000526365559983496,0.0657241762571218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,37536,-0.00767479476103623,0.0041721341201404,-0.0158521776365114,0.000502588114438958,0.0658588940595301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37593,-0.00643038465678382,0.00350001586960795,-0.0132904157612154,0.000429646447647761,0.0661963865915054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37896,-0.010540951036807,0.00573837257387299,-0.0217881612815981,0.00070625920798407,0.0662432613525996
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40531,-0.003763441926819,0.00204937638331721,-0.00778021963812073,0.000253335784482728,0.0663193401992492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTR,Transthyretin,37866,-0.00388595235438384,0.00211971452783936,-0.00804059282894898,0.000268688120181308,0.0667885519589398
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,40398,-0.00631107802574961,0.0034440229574765,-0.0130613630224035,0.000439206970904325,0.0668996636375198
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,37593,-0.0088704798332655,0.00484337987309804,-0.0183635043845377,0.000622544718006657,0.0670538200614369
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,37709,0.0053634203657696,0.00293015847296876,-0.000379690241249167,0.0111065309727884,0.0672096129653151
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37895,-0.00875225032997131,0.00478525326907648,-0.0181313467373612,0.000626846077418581,0.0674210577649916
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37895,-0.0078553472532981,0.0043013669310722,-0.0162860264381996,0.000575331931603413,0.0678356248939977
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,40273,-0.00905310842013908,0.00496128692068951,-0.0187772307846905,0.000671013944412352,0.0680576092246128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,37536,-0.00514635382337312,0.00282307395826718,-0.0106795787815768,0.000386871134830546,0.0683321015853791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37896,-0.0074097138213835,0.00406929289907908,-0.0153855279035785,0.000566100260811502,0.0686465793513277
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37623,-0.00672322351018897,0.00369637480963606,-0.0139681181370756,0.000521671116697711,0.068954035479316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,40336,0.00904238162948478,0.00498918943237282,-0.000736429657965951,0.0188211929169355,0.0699440680317835
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,40037,-0.00822326401280299,0.00454383105714157,-0.0171291728848005,0.000682644859194486,0.0703515749089125
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,37937,-0.00576550214079352,0.00321248295743166,-0.0120619687373596,0.000530964455772527,0.0727209717726796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37985,-0.0109252589821969,0.00609125356612636,-0.0228641159718046,0.00101359800741074,0.0728997063011909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,39872,-0.0127105583402831,0.00708736731017677,-0.0266017982682296,0.00118068158766338,0.0729269119282948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,37709,-0.00343517048637239,0.00191636410780427,-0.00719124413766876,0.000320903164923982,0.0730683669515667
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37709,-0.00755671623769048,0.00421670093130028,-0.015821450063039,0.000708017587658062,0.0731410171781731
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37593,-0.0101601071055688,0.00567823124057705,-0.0212894403370998,0.000969226125962234,0.0735881763761379
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,37557,-0.00746425961616203,0.00418038145745974,-0.0156578072727831,0.000729288040459067,0.0741960605744908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,40327,-0.00479729281672501,0.00270307357383021,-0.0100953170214322,0.000500731387982206,0.0759575403340869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,37536,-0.0134770042220184,0.00759691644651082,-0.0283669604571796,0.00141295201314276,0.0760847811932603
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",40354,-0.0106929050037237,0.00602810260707624,-0.0225079861135931,0.00112217610614577,0.0761083273360871
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,37623,-0.00943437861903955,0.00533846577673987,-0.0198977715414497,0.0010290143033706,0.0772103069862905
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,37557,-0.00963161249506102,0.0054553524012887,-0.0203241032015869,0.00106087821146483,0.0774972720617666
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAT,Catalase,37781,-0.00799046113778513,0.00452806187490444,-0.0168654624125978,0.000884540137027576,0.0776448832817883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNST,Consortin,40354,-0.0158254856130827,0.00896971572732816,-0.0334061284386459,0.00175515721248049,0.0776966247192354
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,37895,-0.00300431730650114,0.00170503360716469,-0.00634618317654394,0.000337548563541657,0.0780872568246301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37896,-0.00621114956543956,0.00352941375433451,-0.0131288005239352,0.000706501393056079,0.0784602703875831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,37593,-0.00492676498610897,0.00280021956196216,-0.0104151953275548,0.000561665355336857,0.078529301809537
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,40223,0.0170773235649127,0.0097205192752851,-0.00197489421464606,0.0361295413444715,0.0789657781181072
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,37477,-0.00790802659901763,0.0045023704918342,-0.0167326727630127,0.000916619564977407,0.0790412404246261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,37477,0.0038563178502722,0.00220188391549244,-0.000459374624092971,0.00817201032463738,0.0799053877167255
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37559,-0.00555917658553765,0.00317597650424124,-0.0117840905338505,0.000665737362775178,0.0800755726974619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39975,-0.00851549760751412,0.00487098255655804,-0.0180626234183679,0.00103162820333964,0.0804475386742214
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,37477,-0.0129622644347817,0.00741654249152587,-0.0274986877181724,0.00157415884860901,0.0805308360041965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,37536,-0.0114423130089525,0.00654830679530699,-0.0242769943277541,0.00139236830984924,0.0805966859133227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37567,-0.0126403396744848,0.00724288001717097,-0.0268363845081399,0.00155570515917033,0.0809719081411487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,40330,0.00257240064801054,0.00147400867974861,-0.000316656364296726,0.00546145766031781,0.0809740453287595
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,39956,-0.0119585635633682,0.00687592033240803,-0.0254353674148879,0.00151824028815157,0.0820203850230145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,40336,-0.0104893279231082,0.00603161805579687,-0.0223112993124701,0.00133264346625369,0.0820441011791972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,37536,-0.0125640343663299,0.0072553931627217,-0.0267846049652645,0.00165653623260461,0.0833537521898826
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,40300,-0.00771730750056831,0.00445828142329892,-0.0164555390902342,0.00102092408909758,0.0834703333138065
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37709,-0.00925770305847856,0.00537752272781565,-0.0197976476049972,0.00128224148804011,0.0851734249029491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37648,-0.00778468034109687,0.00452749602186601,-0.0166585725439542,0.00108921186176051,0.0855608454364439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39956,-0.0069847478483673,0.00406443526770327,-0.0149510409730657,0.000981545276331112,0.0857247082859809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,37536,-0.0139691299349913,0.00818087318576758,-0.0300036413790958,0.00206538150911315,0.0877463220084548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,37709,-0.0050460398350177,0.00295874733696687,-0.0108451846154728,0.000753104945437365,0.088131172858034
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,40263,-0.0102805362186749,0.00602942458142613,-0.0220982083982701,0.00153713596092036,0.088202707433305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,39958,-0.00841097494508192,0.00494688536196264,-0.0181068702545287,0.00128492036436487,0.0891027063687638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,37593,-0.00895201317113339,0.00527603330041966,-0.0192930384399559,0.00138901209768913,0.0897710712072231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,37536,-0.00641430734962908,0.00378152042153521,-0.0138260873758381,0.000997472676579928,0.0898671726197637
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37895,-0.00569020100681756,0.00335472326982316,-0.012265458615671,0.000885056602035828,0.0898757126557599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,39956,-0.0103772686605902,0.00612174325162541,-0.022375885433776,0.00162134811259561,0.0900671862077802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,37593,-0.00666946235602997,0.00394268952157409,-0.0143971338183152,0.00105820910625525,0.0907455527449355
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37593,-0.00908145330177747,0.005373817956473,-0.0196141364964645,0.00145122989290961,0.0910623204379123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37623,0.00511073989117102,0.00303215935010405,-0.000832292435032915,0.011053772217375,0.0919135880380167
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,37955,0.00611473972272344,0.00363968742671426,-0.00101904763363651,0.0132485270790834,0.0929769814701896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,40417,-0.0038919683461974,0.0023177202292508,-0.00843469999552897,0.000650763303134176,0.0931282238836166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,39956,0.00496754001410208,0.00296628818906642,-0.000846384836468097,0.0107814648646723,0.0940200801158173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39975,-0.00734105260044542,0.00438568539688132,-0.0159369959783328,0.00125489077744196,0.0941769531969573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,40223,0.0182951813442346,0.0109439394548474,-0.00315493998726623,0.0397453026757354,0.0945997674605328
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,37955,-0.00617493139642201,0.00369383060216252,-0.0134148393766605,0.00106497658381654,0.0946090799699243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,40417,-0.00380378462919868,0.00227924075624575,-0.00827109651144036,0.000663527253042993,0.0951603094477477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37709,-0.00952980908832347,0.00571487651057549,-0.0207309670490514,0.0016713488724045,0.0954298652536624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37557,-0.00280007373669175,0.00168338676879019,-0.00609951180352052,0.000499364330137019,0.0962648383776937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,37593,-0.00805243553153573,0.00484217497867588,-0.0175430984897405,0.001438227426669,0.0963404770065649
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,37982,0.00333382062830813,0.00201328661675767,-0.00061222114053691,0.00727986239715317,0.0977633178989711
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,37896,-0.0080186788510941,0.00485009318946633,-0.0175248615024481,0.00148750380025991,0.0982923416203301
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,37536,-0.010305236641211,0.00623313170385636,-0.0225221747807694,0.00191170149834751,0.098293813835185
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,37477,-0.00871629123426691,0.00530079635270541,-0.0191058520855695,0.0016732696170357,0.100130912490276
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,40495,-0.00833240024660494,0.00507750255800359,-0.018284305260292,0.0016195047670821,0.100808083165054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37955,-0.00576067855731421,0.00351329988094302,-0.0126467463239625,0.00112538920933411,0.101095546252332
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37709,-0.00501031382587499,0.00305899704751616,-0.0110059480390067,0.000985320387256686,0.10146747783787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,40037,-0.00514464823555268,0.00314964535582448,-0.0113179531329687,0.0010286566618633,0.102403928127884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,37567,-0.0070915446731397,0.00434342304117908,-0.0156046538338507,0.0014215644875713,0.102554278686675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,37895,-0.00525867797707533,0.00323143381135654,-0.0115922882473342,0.00107493229318349,0.103685946783356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37895,-0.00482002503925768,0.00296368975877211,-0.010628856966451,0.000988806887935647,0.103896636685444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37593,0.00296541377318965,0.00182597038459625,-0.000613488180618993,0.0065443157269983,0.104395366499859
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37895,-0.00836930374153012,0.00516535905702558,-0.0184934074933003,0.00175480001024002,0.105196605490671
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,37179,-0.00658328057306731,0.00406810615373973,-0.0145567686343972,0.00139020748826256,0.105629921641872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37593,-0.00289578120486522,0.00179108971370638,-0.00640631704372972,0.000614754633999281,0.105951809245009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,37709,-0.00465177833712092,0.0028776877276618,-0.010292046283338,0.000988489609096208,0.10601033797133
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,37593,-0.00647144932005148,0.00401066959832788,-0.0143323617327741,0.00138946309267117,0.106647273357729
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,37895,-0.0053433840635125,0.0033128219077687,-0.0118365150027392,0.00114974687571415,0.106780944806419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,37536,-0.00445144884464513,0.00276946763747946,-0.00987960541410487,0.000976707724814607,0.108006092303168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37593,-0.00484523616035339,0.00301892717785509,-0.0107623334289494,0.00107186110824258,0.108528183232624
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAG,S-arrestin,37536,0.00712474914790039,0.00445008435761139,-0.00159741619301793,0.0158469144888187,0.10939289434695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,37536,-0.00666320758335466,0.00418004471427588,-0.0148560952233354,0.00152968005662606,0.110948599168304
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,40336,-0.00480350988088911,0.00301918051728149,-0.0107211036947608,0.00111408393298261,0.111629947254168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,39998,-0.00828667881758783,0.00520973441289125,-0.0184977582668547,0.00192440063167902,0.111716704732559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,39826,0.00783631058400692,0.00492757446233006,-0.00182173536215999,0.0174943565301738,0.111788266655839
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,40039,-0.00815509295466243,0.00515026263311059,-0.0182496077155592,0.00193942180623432,0.113343220643922
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39975,-0.00708750100989909,0.00447773535055929,-0.0158638622969953,0.00168886027719712,0.113480224263963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,40039,-0.00707630798959754,0.00449395699966906,-0.0158844637089489,0.00173184772975382,0.115362761376082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,40377,-0.0050807560551081,0.00323497175678325,-0.0114213006984033,0.00125978858818707,0.11630196560816
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37955,-0.00403352561513996,0.00257278198412329,-0.00907617830402161,0.00100912707374169,0.116958685976382
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PALLD,Palladin,37593,-0.00541320978941199,0.0034541108201426,-0.0121832669968915,0.00135684741806751,0.117096945867362
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40531,-0.00381130978399079,0.00243665578541787,-0.00858715512340982,0.000964535555428241,0.117800615380045
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",37536,-0.00423610133838579,0.00271196886540856,-0.00955156031458656,0.00107935763781498,0.118311655353453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37709,-0.00436551132694622,0.00279766197843681,-0.00984892880468237,0.00111790615078994,0.118685914049267
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37982,-0.0061405819993294,0.00393868347360742,-0.0138604016076,0.00157923760894115,0.119009285315028
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37955,0.00565671949189166,0.00362978065853061,-0.00145765059882833,0.0127710895826116,0.119157368381219
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,37534,-0.00531992733943829,0.00341842511432137,-0.0120200405635082,0.00138018588463159,0.119672619659694
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSPN,Persephin,40336,-0.0128308202354175,0.00826937956142511,-0.0290388041758108,0.00337716370497567,0.120776412141797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37895,-0.0061394398937041,0.00395925952430127,-0.0138995885613346,0.00162070877392639,0.121008268613453
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,39956,0.00567355910985846,0.00366192494636501,-0.00150381378501695,0.0128509320047339,0.121320924202171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,39873,-0.00906414716111566,0.00585081120279367,-0.0205317371185913,0.00240344279635995,0.121351276812315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,40336,-0.00852134423857824,0.00550460256809433,-0.0193103652720431,0.00226767679488664,0.121632620265403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,37709,-0.00508978442682254,0.00329307118506196,-0.011544203949544,0.00136463509589889,0.12222407249439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,40300,-0.00882999225547255,0.00571481178862797,-0.0200310233611834,0.00237103885023828,0.122340496778002
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,40354,-0.00896750502552502,0.00581406993273787,-0.0203630820936912,0.0024280720426412,0.123001183606252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,40222,-0.00676813955804244,0.00439196667305929,-0.0153763942372387,0.00184011512115376,0.123330260769829
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37709,-0.00947795388056253,0.00615068277207218,-0.021533292113824,0.00257738435269894,0.123350477869042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],40039,-0.00736312023268358,0.00478357710333049,-0.0167389313552113,0.00201269088984417,0.123763616379168
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39956,-0.00451045497625914,0.00293562647058094,-0.0102642828585978,0.0012433729060795,0.124447482399995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,37536,-0.00784431860629899,0.00511857695697069,-0.0178767294419615,0.00218809222936355,0.125418485660583
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39956,-0.0071353464018559,0.00466101463879613,-0.0162709350938963,0.00200024229018451,0.125825166639119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,40300,0.00412023155901963,0.00269312182968485,-0.00115828722716267,0.00939875034520194,0.126059192622381
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,37929,-0.00400041917076206,0.00262010136363804,-0.00913581784349262,0.0011349795019685,0.126829622991672
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,37637,-0.00459050316541526,0.00300836473126205,-0.0104868980386889,0.00130589170785836,0.127055492458893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,40065,-0.00699197780682869,0.00458644185022176,-0.0159814038332633,0.00199744821960597,0.127406984477311
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37756,-0.00568125316410502,0.0037271708129133,-0.0129865079574151,0.00162400162920505,0.127462467461206
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39975,-0.00654068206538661,0.00429289343494013,-0.0149547531978693,0.00187338906709605,0.127627308962549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39956,-0.00857684149010571,0.00562979693132884,-0.0196112434755102,0.00245756049529882,0.12766090098121
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,40336,-0.00749078504119092,0.00491911261536516,-0.0171322457673066,0.00215067568492479,0.127830674252619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,40354,0.00388329476637195,0.00255313449889804,-0.0011208488514682,0.00888743838421211,0.128281961622829
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37557,-0.00907181550405441,0.00597159584593574,-0.0207761433620885,0.00263251235397965,0.128746099585476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39975,-0.00418744910244586,0.00275715120765092,-0.00959146546944165,0.00121656726454994,0.128843453640877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,40319,-0.0104928993809649,0.00691300867462204,-0.0240423963832241,0.00305659762129426,0.129072535219695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,37593,-0.00335746260536401,0.00221395609335922,-0.00769681654834808,0.000981891337620059,0.129417230650212
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,40328,0.00934712256335681,0.00618546644907056,-0.00277639167682149,0.0214706368035351,0.130771996642854
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,37709,-0.00527338014077572,0.00349240731463124,-0.0121184984774529,0.0015717381959015,0.131078575061014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,37557,0.0053149012567566,0.00352297485233486,-0.00159012945381973,0.0122199319673329,0.131414878547158
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37557,-0.0122047349604588,0.00810189327432231,-0.0280844457781305,0.00367497585721293,0.131987263862208
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40478,-0.00417571952891184,0.00277206666270146,-0.0096089701878067,0.00125753112998302,0.131995493184092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,40341,-0.00346370825384286,0.00230102838942173,-0.00797372389710945,0.00104630738942373,0.13227016892621
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,40336,0.00664049330151882,0.00441413465364356,-0.00201121061962256,0.0152921972226602,0.132505916327952
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,38008,0.00407682680358201,0.00271622896018001,-0.00124698195837081,0.00940063556553484,0.133401027174549
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,37976,0.00450665021971032,0.00301164621836242,-0.00139617636828001,0.0104094768077007,0.134570811808302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPGN,Epigen,37895,0.0061506288907901,0.00411598135705643,-0.00191669456904051,0.0142179523506207,0.135113210033602
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37557,-0.00470419530012404,0.00315432513901262,-0.0108866725725888,0.00147828197234069,0.135894321023676
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,40531,-0.00697419079763175,0.0046834013075454,-0.0161536573604207,0.00220527576515723,0.136472897891465
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,39956,-0.0048464256330366,0.00325650421957896,-0.0112291739034114,0.00153632263733816,0.136710719363806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37955,-0.00599025235427486,0.00403227890164258,-0.0138935190014943,0.00191301429294459,0.137414941623918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,39987,-0.00589890800414036,0.00397469933279259,-0.0136893186964138,0.00189150268813312,0.137798896005788
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,40484,-0.00388077503091271,0.00261983992794802,-0.00901566128969084,0.00125411122786542,0.138545676441872
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,37557,-0.00486021073957288,0.00328169986496751,-0.0112923424749092,0.00157192099576344,0.138629539688961
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD248,Endosialin,37993,0.00490410434155947,0.00332364575087595,-0.0016102413301574,0.0114184500132763,0.140096162510435
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37895,0.00587173265558948,0.00398042123640507,-0.00192989296776446,0.0136733582789434,0.140194676354437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37593,-0.00595118123518769,0.00403752076566015,-0.0138647219358816,0.00196235946550621,0.140513839177255
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37870,-0.00330728061012863,0.00224788245787262,-0.00771313022755897,0.0010985690073017,0.141236923540857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37557,-0.0063796230139929,0.004338211084676,-0.0148825167399579,0.00212327071197207,0.141432701912865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37567,0.00481585437224576,0.00327717071296404,-0.00160740022516376,0.0112391089696553,0.14171690712452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37985,-0.0127573533264288,0.00872109316703913,-0.0298506959338255,0.00433598928096792,0.143540997353142
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,37477,-0.00869940808025421,0.00595526879637773,-0.0203717349211546,0.00297291876064615,0.144096696166383
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37937,-0.00454388695708098,0.00311551686014118,-0.0106503000029577,0.00156252608879574,0.144734409276696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",40187,-0.00897045300299706,0.00616055217947495,-0.021045135274768,0.00310422926877385,0.145381655397014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCLN,Nicalin,40039,-0.00648547280019394,0.00445588313678294,-0.0152190037482885,0.00224805814790063,0.145555071565926
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,40037,0.00366893188054016,0.00252823148464301,-0.00128640182936014,0.00862426559044045,0.146748449705787
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,37557,0.00387265915485832,0.00267123036465506,-0.0013629523598656,0.00910827066958224,0.14714769369694
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,40327,0.00381775169384322,0.00263497534656004,-0.00134679998541446,0.00898230337310091,0.147392055948906
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,40039,-0.00363650770051569,0.00251505242038492,-0.00856601044447013,0.00129299504343875,0.148226093264292
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,40223,-0.00838002392804179,0.00579818130424222,-0.0197444592843565,0.00298441142827295,0.148397744519316
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,40223,-0.00340290358499899,0.00235765119056476,-0.00802389991850592,0.00121809274850794,0.14894322763195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,40391,-0.00917920910148437,0.00637404384961235,-0.0216723350467246,0.00331391684375584,0.149861032863845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37567,0.00726314785550907,0.00505153229411443,-0.00263785544095522,0.0171641511519734,0.150511593904295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37557,-0.00479755892533323,0.00333838298434584,-0.0113407895746511,0.00174567172398462,0.150716115586831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37557,0.00508131328493653,0.00353656395210215,-0.00185035206118368,0.0120129786310568,0.150800455080777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,40354,-0.00763168860985399,0.00531896224078624,-0.018056854601795,0.00279347738208704,0.151361535200062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40484,-0.00644405904238727,0.00449171141437257,-0.0152478134145575,0.00235969532978297,0.151404761297935
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,37937,0.00860950670766613,0.00601450734384564,-0.00317892768627134,0.0203979411016036,0.152322549140297
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,37477,-0.00876706480975959,0.00612492102153152,-0.0207719100119614,0.00323778039244218,0.152346482550117
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,40023,-0.00509191446840403,0.00355863537274209,-0.0120668397989785,0.00188301086217047,0.152489971049625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,37709,-0.00510861648300168,0.00357248046658888,-0.0121106781975159,0.00189344523151253,0.152743042477921
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,37226,-0.00827633068416257,0.00581013399297108,-0.0196641933103859,0.00311153194206075,0.154336429652772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,39956,-0.00715413570057142,0.00503221262006643,-0.0170172724359016,0.00270900103475878,0.155142765835294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,37623,-0.00347432540775723,0.00244721665415701,-0.00827087004990498,0.00132221923439052,0.15571728620242
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37567,-0.00534257059757789,0.00376530350367547,-0.0127225654647818,0.00203742426962603,0.155953372189772
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37593,-0.00331449543755748,0.00233611610900896,-0.00789328301121503,0.00126429213610008,0.15597931361786
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39956,-0.00863612652749089,0.0060877024867328,-0.0205680234014872,0.00329577034650539,0.156030410633992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37844,-0.00341229938410932,0.00240869064704834,-0.00813333305232407,0.00130873428410543,0.156605169185704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",37455,-0.00297961993413283,0.00210815442721003,-0.00711160261146449,0.00115236274319883,0.157568430579457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39956,-0.00649743702179632,0.00459846889350771,-0.0155104360530714,0.00251556200947879,0.15768855662446
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37895,0.00636074724469973,0.00450331111691621,-0.00246574254445605,0.0151872370338555,0.157837682040817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39975,-0.00887779882692022,0.00629004816431059,-0.021206293228969,0.00345069557512853,0.158145581202812
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,40307,-0.00716673243343646,0.00508341873336784,-0.0171302331508374,0.00279676828396451,0.158610883968653
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37557,-0.00399603244707225,0.00283742549729033,-0.0095573864217613,0.0015653215276168,0.15905699493079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39975,-0.00411037729412762,0.00291884350472901,-0.00983131056339648,0.00161055597514124,0.159085608335505
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37557,-0.0056616712250659,0.00403421429374367,-0.0135687312408035,0.0022453887906717,0.16051723176438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37955,-0.00667073038153523,0.00475352399272361,-0.0159876374072735,0.00264617664420304,0.160543485046215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,37895,-0.00684059063915729,0.00487469715733367,-0.0163949970675313,0.0027138157892167,0.160554890555462
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,40306,-0.0102216536465478,0.00728942220873483,-0.0245089211756681,0.00406561388257248,0.160857672373233
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,37623,0.00489966591161139,0.00351665720477382,-0.0019929822097453,0.0117923140329681,0.163560559577845
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,37709,-0.0034138724699594,0.0024586611433768,-0.00823284831097792,0.00140510337105913,0.165005515913869
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,37638,-0.00959357798524566,0.00691184532908035,-0.0231407948302432,0.00395363885975183,0.165163286099865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,37477,-0.00709677975965295,0.00511701235611467,-0.0171261239776377,0.0029325644583318,0.165496270023535
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37896,-0.00551585758876867,0.0039829779936404,-0.0133224944563038,0.0022907792787665,0.166118975773726
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C7,Complement component C7,37673,0.00361242229544534,0.00261917728007471,-0.0015211651735011,0.00874600976439178,0.167850191605256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37709,0.00356195672768095,0.00258422329882302,-0.00150312093801217,0.00862703439337406,0.16811940342024
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37567,-0.00832727898940656,0.00605760357842328,-0.0202001820031162,0.00354562402430307,0.169253520404902
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37593,-0.00335728834260327,0.00244574141152684,-0.00815094150919589,0.00143636482398934,0.169866625071675
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,37666,-0.00801391148886235,0.00583904378438365,-0.0194584373062543,0.00343061432852961,0.169940515992604
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,37650,-0.00422228537256211,0.00307704017625148,-0.010253284118015,0.00180871337289079,0.170027455143727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERVV_1,,37557,-0.00552910682235986,0.00402968816749324,-0.0134272956306466,0.00236908198592689,0.170057981838995
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,37557,-0.0061028823863441,0.00445285294850274,-0.0148304741654095,0.00262470939272127,0.170537017216933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,40039,-0.00427795608168933,0.00313046164208413,-0.0104136609001742,0.00185774873679557,0.171783733135456
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,40391,-0.00648068886399532,0.00474365487229839,-0.0157782524137002,0.00281687468570951,0.171901585159925
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,40037,0.00396434950617726,0.0029179730723739,-0.00175487771567558,0.0096835767280301,0.174293984667459
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",37536,0.0062332355899066,0.00458990297061958,-0.00276297423250778,0.015229445412321,0.174476914529858
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,37557,-0.00390640633096113,0.00288062522806837,-0.00955243177797514,0.00173961911605288,0.175091771087907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,40398,0.00383849892526918,0.0028315160320697,-0.00171127249758742,0.00938827034812579,0.175234901123901
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",37536,0.00518565465516408,0.00382658336063768,-0.00231444873168577,0.0126857580420139,0.175388153446937
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,40406,-0.00991272676791844,0.00731572366748335,-0.0242515451561858,0.00442609162034893,0.175440173993856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,40410,0.00384945211841589,0.00284497097823011,-0.00172669099891512,0.0094255952357469,0.176051623820479
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,40298,-0.00544190384166781,0.0040239951175792,-0.013328934272123,0.00244512658878742,0.176278380563863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,37623,-0.00946668304968297,0.0070002766009466,-0.0231872251875383,0.00425385908817237,0.176293035121195
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,37536,-0.00479544122324234,0.00354616553144065,-0.011745925664866,0.00215504321838133,0.176306201113807
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39956,-0.00577269926608066,0.00427573504453521,-0.0141531399533697,0.00260774142120835,0.177001413294593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,37557,0.00614038499184257,0.00455390273406115,-0.00278526436691728,0.0150660343506024,0.177559946096775
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",40037,-0.00985885616045014,0.00731548922976541,-0.0241972150507903,0.00447950272989007,0.177784540056668
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,40360,-0.00553647765873585,0.00411084978179767,-0.0135937432310593,0.00252078791358758,0.178065002847515
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37985,-0.00557712003357773,0.00414507381865653,-0.0137014647181445,0.00254722465098907,0.178492342540207
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,40300,-0.00213819876482572,0.00159417624144019,-0.00526278419804849,0.000986386668397038,0.179856506464015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37860,-0.00347203419748696,0.00259996566964976,-0.00856796691000048,0.00162389851502656,0.181763096454094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,37477,-0.00463318186804172,0.0034720388791564,-0.0114383780711883,0.00217201433510481,0.182087336373451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",37536,0.00684001104095131,0.00512698231523189,-0.0032088742969032,0.0168888963788058,0.18218766279135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37709,-0.00401200060089527,0.0030097625247983,-0.00991113514949994,0.0018871339477094,0.182556111285963
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,37557,-0.00942774511575756,0.00707935714522654,-0.0233032851204016,0.00444779488888645,0.182974279468559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,40198,0.00503452516853529,0.00378098084751156,-0.00237619729258737,0.012445247629658,0.183030847848648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,40223,0.00251062157584237,0.00188603283289276,-0.00118600277662744,0.00620724592831217,0.183153848656483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,37623,-0.00598275145901938,0.00451027020161665,-0.014822881054188,0.00285737813614926,0.184706085367782
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37985,-0.00334332629897071,0.00253495374094981,-0.00831183563123234,0.00162518303329093,0.187228053617451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,40484,0.00493763627138252,0.00374511199615111,-0.00240278324107365,0.0122780557838387,0.187381413533385
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,40325,-0.00800887154363672,0.00608051335848733,-0.0199266777262719,0.00390893463899844,0.187811586713494
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37593,-0.00342607662791686,0.00261045660105722,-0.00854257156598902,0.0016904183101553,0.189393481890518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37567,-0.00543996893289585,0.00414912427003996,-0.0135722525021742,0.00269231463638247,0.189842693719044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,40451,-0.00471246190994659,0.00359591780678919,-0.0117604608112534,0.00233553699136022,0.190044463679571
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37896,-0.00426355604753107,0.00327121409497967,-0.0106751356736912,0.00214802357862909,0.19247561968452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37709,-0.0068528832738134,0.00526229375558089,-0.0171669790347519,0.00346121248712515,0.192849585551547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,37536,-0.00800362513590868,0.00615364918995911,-0.0200647775482285,0.00405752727641118,0.193407795776863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,39956,-0.00744882103546879,0.00572946554520829,-0.018678573504077,0.00378093143313946,0.193589441099768
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,37895,0.00703113238259665,0.00542639219403182,-0.00360459631770571,0.017666861082899,0.195091199482827
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,40484,-0.00490721667897385,0.00378785137736097,-0.0123314053786014,0.00251697202065366,0.195161428549317
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,37477,-0.00829529779905101,0.00645024994971592,-0.0209377877004942,0.0043471921023922,0.198450970028331
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSPN,Claspin,39920,-0.00365401561079527,0.00284153170875307,-0.00922341775995128,0.00191538653836074,0.198486159693447
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37955,0.0031418808457018,0.0024465896445195,-0.00165343485755642,0.00793719654896002,0.199098246647187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,40336,0.00454532644159565,0.00355134862690203,-0.00241531686713233,0.0115059697503236,0.200603424039351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,37536,-0.00528974824306734,0.00415254303085075,-0.0134287325835348,0.00284923609740014,0.202736536558367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37557,0.00554650181376492,0.00435469915920757,-0.00298870853828191,0.0140817121658118,0.202798737227584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,37567,-0.00417901151666432,0.00328359002434666,-0.0106148479643838,0.00225682493105512,0.203148539152706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,40531,-0.00605263183694446,0.00475633210355607,-0.0153750427599144,0.00326977908602543,0.203199051854156
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,40484,-0.00215732647205203,0.00169691121180883,-0.00548327244719733,0.00116861950309327,0.203631323001053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37623,0.00280981668681457,0.00221402551584178,-0.00152967332423531,0.00714930669786446,0.204428324794223
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37567,-0.00386617100465503,0.00305288931773205,-0.00984983406740986,0.0021174920580998,0.205393343508503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,40037,-0.00661262678950194,0.0052230855074343,-0.0168498743840732,0.00362462080506928,0.205518260426941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYOC,Myocilin,40327,-0.00482359513496472,0.00381390283003818,-0.0122988446818395,0.00265165441191011,0.205983143112323
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,37982,-0.00272177345671206,0.00215434222177834,-0.00694428421139761,0.00150073729797349,0.206470985829547
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,40327,-0.00952160614182833,0.00753806626826738,-0.0242962160276324,0.00525300374397573,0.206558703668687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,40300,-0.00469403105751625,0.00374507304242874,-0.0120343742206766,0.00264631210564409,0.210082886427592
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39975,-0.00322627708156387,0.00257767928191477,-0.00827852847411682,0.00182597431098908,0.210726921092212
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37895,-0.00447754787968429,0.00361508813993906,-0.0115631206339648,0.00260802487459627,0.215525574232808
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,40131,-0.00305091672019221,0.00246382706593927,-0.00788001776943317,0.00177818432904875,0.215629451778197
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,37477,0.00472262363864506,0.00381451569993268,-0.00275382713322299,0.0121990744105131,0.215713764055339
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37785,-0.00574486660813441,0.00465285937149554,-0.0148644709762657,0.00337473775999685,0.216965443859981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,40037,-0.00278678826788138,0.00225900709121719,-0.00721444216666707,0.00164086563090431,0.217357869787026
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,40281,0.0184413081229728,0.0149768929164509,-0.010913401993271,0.0477960182392167,0.218222488203806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37937,-0.00407027635932794,0.00330990477286836,-0.0105576897141499,0.00241713699549405,0.218821135763014
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,40223,-0.00326666487282408,0.00266131729037771,-0.00848284676196439,0.00194951701631622,0.219667453900908
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37993,-0.00300479550092457,0.00245180259519252,-0.00781032858750191,0.00180073758565277,0.220391093640094
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37557,-0.00551941665679036,0.00450806644011843,-0.0143552268794225,0.00331639356584176,0.220845116342103
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,37536,0.00390846133866212,0.00319983336993129,-0.00236321206640322,0.0101801347437274,0.221934752539722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCT,Secretin,37567,0.00468196102534629,0.00383595319858386,-0.00283650724387808,0.0122004292945706,0.222279542164496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,40328,-0.00984345237728954,0.00807351732791481,-0.0256675463400026,0.00598064158542349,0.222776063716954
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,40327,-0.0043926303598571,0.00360581938280752,-0.0114600363501598,0.00267477563044563,0.223163851662567
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,37567,-0.00472872948055476,0.00389682287516028,-0.0123665023158689,0.00290904335475939,0.224966949143452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40484,-0.00596645172997879,0.00491732734699595,-0.0156044133300909,0.00367150987013327,0.225012931307844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,37593,-0.00433620514412272,0.00357899096589063,-0.0113510274372683,0.0026786171490229,0.225698054228776
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37557,-0.00468291011232488,0.0038665353143148,-0.0122613193283819,0.00289549910373214,0.225864135090881
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,40037,-0.00731973550558522,0.00604774347146987,-0.0191733127096662,0.00453384169849572,0.226172539271243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,37985,-0.00292752978552208,0.00242063189163893,-0.00767196829313437,0.00181690872209022,0.226527547700451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,40327,-0.00447744815575046,0.00370353429108805,-0.011736375366283,0.00278147905478211,0.226693797574723
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",40037,-0.0043932710636936,0.00364117652889924,-0.0115299770603361,0.00274343493294892,0.227622798616972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,37965,0.00457354657648522,0.00380306632613603,-0.0028804634227414,0.0120275565757118,0.229154355549479
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39956,0.0069243814025503,0.00577417806595841,-0.00439300760672818,0.0182417704118288,0.230469385122102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,40039,-0.00638318633977299,0.00532695392874215,-0.0168240160401076,0.00405764336056162,0.230825957897321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37557,-0.00404012446202868,0.00339694383014684,-0.0106981343691165,0.00261788544505912,0.234327068591289
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40511,-0.0032582038527049,0.00274206056189908,-0.00863264255402709,0.0021162348486173,0.234759628153459
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,40193,-0.00334601456134835,0.00281795830603491,-0.00886921284117678,0.00217718371848007,0.235091873233884
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,37477,0.00730865805631181,0.00615813539810822,-0.0047612873239803,0.0193786034366039,0.235316442652527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,37933,-0.00229399132172379,0.00193674435580122,-0.00609001025909419,0.0015020276156466,0.236252903606762
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37593,-0.00347469029586715,0.00293512256470773,-0.00922753052269429,0.00227814993095999,0.236501217674058
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,40300,0.00927514184200283,0.00783579045888083,-0.00608300745740359,0.0246332911414093,0.236553804063972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37937,0.00552743896510818,0.00468813684291287,-0.00366130924700105,0.0147161871772174,0.238408307544799
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37955,-0.00360837182192416,0.00306442481733258,-0.00961464446389601,0.00239790082004769,0.239015241030439
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,37985,-0.00891169623288679,0.00757192361550331,-0.0237526665192733,0.0059292740534997,0.239240341901536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,37593,-0.00310456292054764,0.00265417144724822,-0.00830673895715416,0.00209761311605888,0.242146181707049
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,37536,-0.00552171595228449,0.00472579869764321,-0.0147842813996652,0.0037408494950962,0.242658830392171
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,37567,-0.0056526087149343,0.00484116326307445,-0.0151412887105602,0.00383607128069161,0.242983834499356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39818,0.00843496846666484,0.00722562478616445,-0.00572725611421749,0.0225971930475472,0.243079605752057
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,37593,-0.00607053090628499,0.00520440742143643,-0.0162711694523004,0.00413010763973042,0.243465377768118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,37557,-0.00394284688233259,0.00338317337684349,-0.0105738667009458,0.00268817293628066,0.243866773071444
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39975,-0.00393654741201999,0.00338241852838956,-0.0105660877276635,0.00269299290362356,0.244512326922975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",40352,-0.00899797854187934,0.00773851433724241,-0.0241654666428745,0.00616950955911578,0.244947298549757
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,40300,0.00343888583733051,0.00296421755279025,-0.00237098056613837,0.0092487522407994,0.246012241917664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,37477,-0.00546215908764409,0.00471275166183911,-0.0146991523448487,0.00377483416956057,0.24647052133091
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,40039,-0.0042890799080131,0.00370113422139352,-0.0115433029819444,0.00296514316591819,0.246532826342027
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37982,0.00248687877564757,0.00214661729163216,-0.00172049111595146,0.0066942486672466,0.246676197223584
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,37536,-0.00883656110441159,0.00763652524418967,-0.0238041505830233,0.00613102837420017,0.247234564254613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,40511,0.00470631316568071,0.00406728688790817,-0.0032655691346193,0.0126781954659807,0.247243142494189
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37567,-0.00765675482279016,0.00663318290976969,-0.0206577933259388,0.00534428368035843,0.248393793908261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37623,0.00400905426199758,0.00347806072674239,-0.0028079447624175,0.0108260532864127,0.249067014503614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,37536,-0.00553123023718291,0.00480228421841206,-0.0149437073052705,0.00388124683090473,0.24942779899295
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37895,-0.00317992851525866,0.00276152937002409,-0.00859252608050587,0.00223266904998855,0.249542988257578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,40039,-0.00473626425934208,0.00411525728080184,-0.0128021685297137,0.00332964001102952,0.249789567478136
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,40198,-0.00506061375339173,0.00440053943423229,-0.013685671044487,0.00356444353770356,0.250161954022385
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,40039,-0.00534897233408933,0.00467739821447163,-0.0145166728344537,0.00381872816627507,0.252816018310777
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37993,-0.00366026519275545,0.00321485972151344,-0.00996139024692179,0.0026408598614109,0.254912767526792
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,38008,0.00213918320251581,0.00187954846417709,-0.00154473178727128,0.00582309819230291,0.25508349391526
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,38008,-0.00394700709027647,0.00347054995510853,-0.0107492850022892,0.00285527082173624,0.255438941627458
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,37477,-0.00569438609402575,0.00502490732040769,-0.0155432044420248,0.00415443225397332,0.257137671056175
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,37955,0.00600155768566904,0.00530012629503848,-0.00438668985260638,0.0163898052239445,0.257510621252384
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,40300,0.00199504081913178,0.0017630977358878,-0.0014606307432083,0.00545071238147186,0.257838985485025
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",40305,-0.00593331997712963,0.00524589371205816,-0.0162152716527636,0.00434863169850437,0.258055016605904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37567,0.00279206406399241,0.0024788226641214,-0.00206642835768553,0.00765055648567035,0.260030815513544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,37567,-0.00816546373474516,0.00726309113690329,-0.0224011223630756,0.00607019489358528,0.260931441324725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,40354,-0.00396018362805401,0.00353352325608285,-0.0108858892099764,0.00296552195386838,0.262412731191458
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,37477,-0.00537977849698456,0.00480836442856982,-0.0148041727769814,0.00404461578301228,0.263230098142356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,40256,-0.00723277171222923,0.00646491641580059,-0.0199040078871984,0.00543846446273994,0.263254143877108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37914,-0.00354519994165546,0.00317161071334652,-0.00976155693981463,0.00267115705650371,0.263675940022943
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37982,-0.00325014437578258,0.00290789332404234,-0.00894961529090556,0.0024493265393404,0.263716162669454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37895,0.007226655560833,0.00647239191763026,-0.00545923259772232,0.0199125437193883,0.264212925198853
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,40406,0.00263092797442219,0.00235636252875565,-0.00198754258193888,0.00724939853078327,0.264216050887982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,37477,-0.00348962415979231,0.00312882996593365,-0.00962213089302227,0.00264288257343765,0.264736972430941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37985,-0.00261297092590395,0.0023451030029232,-0.00720937281163341,0.00198343095982552,0.265202729220689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,40039,-0.00461824469410947,0.00416257759417053,-0.0127768967786837,0.00354040739046477,0.267245659655261
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,37567,-0.00322579818725246,0.00291194054340276,-0.00893320165232186,0.00248160527781695,0.267975865942857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37567,-0.00297272640817875,0.0026847557177848,-0.00823484761503695,0.00228939479867945,0.268201229999051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,40369,0.00611068709717281,0.00554407654137273,-0.00475570292391774,0.0169770771182634,0.270390932225226
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,37709,-0.00781899341499844,0.00710804041326137,-0.0217507526249907,0.00611276579499385,0.271342965354498
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,37593,-0.00497416253678088,0.00452963644615303,-0.0138522499712408,0.00390392489767907,0.272164679218553
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,37477,0.00236345632303671,0.00215838542140076,-0.00186697910290877,0.0065938917489822,0.273531954652846
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",40336,-0.00410038686518787,0.00375629396224363,-0.0114627230311854,0.00326194930080963,0.275023596277431
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,40336,0.00500454786621667,0.00458702935166965,-0.00398602966305583,0.0139951253954892,0.27527995018333
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37557,-0.00477621082084052,0.00440058439296932,-0.0134013562310604,0.00384893458937935,0.277782956185123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,37593,-0.00442010923946545,0.0040846391448488,-0.0124260019633691,0.00358578348443821,0.27921476701493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37915,-0.00745329253784789,0.00689357672719423,-0.0209647029231486,0.00605811784745279,0.279630273950054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,37172,0.0110731820437332,0.0102501532005199,-0.00901711822928583,0.0311634823167523,0.280031630642918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,37623,0.00159432529047657,0.00148377674533281,-0.00131387713037574,0.00450252771132888,0.282616161708043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40466,0.0114717313201911,0.0106907364584498,-0.00948211213837051,0.0324255747787528,0.283263317853914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,37955,-0.00339790117728705,0.00317478768501399,-0.00962048503991448,0.00282468268534038,0.284513924887161
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,40039,-0.00742897459826915,0.00694817302411575,-0.021047393725536,0.00618944452899772,0.284996894003387
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37567,0.0037311289992759,0.00349138773625634,-0.00311199096378653,0.0105742489623383,0.285239655377427
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37567,-0.00328848727290209,0.00307997652512117,-0.00932524126213959,0.00274826671633541,0.285676047605051
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,39975,-0.00953958254557697,0.00895101024008465,-0.0270835626161429,0.00800439752498895,0.28655105317067
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,40039,0.00544244205380613,0.00511865230715372,-0.00459011646821515,0.0154750005758274,0.287681966155858
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37567,-0.00435664977565772,0.00409757888756775,-0.0123879043952905,0.00367460484397508,0.28769934187039
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELE,E-selectin,40531,0.00441631787720002,0.00415518095032614,-0.00372783678543921,0.0125604725398393,0.287867710755965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MME,Neprilysin,40300,0.00719758634132777,0.00677362966117854,-0.00607872779458215,0.0204739004772377,0.287984436633857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37814,-0.00239191710440537,0.00225106148564157,-0.00680399761626284,0.0020201634074521,0.287994850354696
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37557,-0.00553415377347852,0.00522009905147823,-0.0157655479143759,0.00469724036741882,0.289090171763892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,39948,0.00780096569189377,0.00739916059033361,-0.00670138906516009,0.0223033204489476,0.291760128947886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37623,-0.00286642928082821,0.00271906631997645,-0.00819579926798206,0.00246294070632563,0.29181245434781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37567,-0.00363197413903462,0.00345440754505494,-0.0104026129273423,0.00313866464927306,0.293092952595015
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37982,0.00516016156384552,0.00491788206662134,-0.00447888728673231,0.0147992104144233,0.294074908014159
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,37557,-0.00647601857558677,0.00618983034154845,-0.0186080860450217,0.00565604889384818,0.295471737108493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39956,-0.00356442755335715,0.00341108801402643,-0.0102501600608489,0.00312130495413465,0.296060862117086
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39975,0.0105320868822265,0.0100919725456163,-0.00924817930718145,0.0303123530716345,0.296681959550946
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37557,-0.00527867370343705,0.00506841416786677,-0.0152127654724559,0.00465541806558182,0.297670056003063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,37536,-0.0078948651015706,0.00758813078842292,-0.0227676014468795,0.00697787124373832,0.298162688228542
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,37536,-0.00428120224273884,0.00412258836378568,-0.0123614754357588,0.00379907095028109,0.299068464498132
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39956,-0.00430154902569631,0.00414463867659445,-0.0124250408318214,0.00382194278042882,0.299352061245484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,40327,-0.00246733126108846,0.00238204419838063,-0.0071361378899145,0.00220147536773758,0.300309299594615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,40327,0.0036542693007102,0.00353817416044936,-0.00328055205377055,0.0105890906551909,0.30170754510042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,40039,-0.00279733540510463,0.00271033600378949,-0.00810959397253202,0.00251492316232276,0.302041699530581
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37593,-0.00382039783116155,0.00372472966950882,-0.0111208679833988,0.00348007232107573,0.30505915914092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,40037,-0.00434780615743848,0.00426073616791112,-0.0126988490465443,0.00400323673166732,0.307537835898293
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37709,-0.00577573103901759,0.00566870085357925,-0.0168863847120329,0.00533492263399773,0.308278104671023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37993,-0.00275436231274078,0.00271084007314015,-0.00806760885609546,0.00255888423061391,0.309621402327956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,40027,-0.00366741269899357,0.00361809364456574,-0.0107588762423424,0.00342405084435528,0.310774497459722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,40484,0.00227031200650868,0.00223998775583023,-0.00212006399491857,0.00666068800793593,0.310818700554589
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37895,-0.00239365800943104,0.00236417424619613,-0.00702743953197544,0.00224012351311337,0.31133109869138
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37937,-0.00523138318207298,0.00516954420606845,-0.0153636898259671,0.00490092346182119,0.31157429742469
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,40327,0.00362521955566122,0.00358368271224255,-0.00339879856033418,0.0106492376716566,0.311749285126398
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,37536,-0.00596313043878207,0.00591932082565333,-0.0175649992570626,0.00563873837949846,0.313760682211455
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,40300,-0.00381110609377294,0.00378608162287069,-0.0112318260745995,0.0036096138870536,0.314137789671327
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39956,-0.0053931073670647,0.00536651579089782,-0.0159114783172244,0.00512526358309503,0.314934158698036
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,37477,-0.0040008551327959,0.00398795608858664,-0.0118172490664257,0.00381553880083391,0.315766367747235
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTD,Biotinidase,38008,-0.00171856190504008,0.00171623722919612,-0.00508238687426447,0.00164526306418431,0.31667331749543
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,39956,-0.00517428217191406,0.00516833239258994,-0.0153042136613903,0.00495564931756222,0.316769340293043
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,37557,-0.00332936646693842,0.00334772161510579,-0.00989090083254577,0.00323216789866894,0.31998953585357
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,37536,0.00713855671979682,0.00718083946749429,-0.00693588863649199,0.0212130020760856,0.320186861112734
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37709,0.0037727019354521,0.00379765022542109,-0.00367069250637325,0.0112160963772774,0.320518287982536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37955,-0.00278616495678014,0.00281110026640739,-0.00829592147893863,0.00272359156537834,0.321640013244703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37557,-0.00267893489356722,0.00270738163537445,-0.00798540289890114,0.0026275331117667,0.322440312786561
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,40327,-0.00245976259251292,0.00248842211884405,-0.00733706994544726,0.00241754476042141,0.322931294148408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37557,-0.00551701164251473,0.00558470779858134,-0.0164630389277342,0.00542901564270471,0.323230492985656
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,37623,-0.00463225668570885,0.00470407743495067,-0.0138522484582122,0.00458773508679446,0.324773703075708
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37666,-0.00232423835751408,0.00239042544615924,-0.00700947223198619,0.00236099551695803,0.330913359088263
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37567,-0.00292736155910973,0.00301388943276504,-0.00883458484732921,0.00297986172910975,0.331421652342302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40531,-0.00218142429844944,0.00225003074863022,-0.00659148456576467,0.00222863596886579,0.332306044063652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37557,-0.00382002161718645,0.00395044714473986,-0.0115628980208766,0.00392285478650368,0.333569568482123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37567,0.00563103591618093,0.00586043148877184,-0.00585540980181189,0.0171174816341737,0.336641848285092
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37895,-0.0034081299631575,0.0035518763777869,-0.0103698076636198,0.00355354773730483,0.337309351369521
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39956,-0.00479469358637089,0.00500206348588274,-0.0145987380187011,0.00500935084595928,0.337803901295434
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,40039,0.00553765846324864,0.0058524680994026,-0.00593317901158046,0.0170084959380777,0.344056622966882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,40037,-0.00384064684172047,0.00406976308400661,-0.0118173824863734,0.00413608880293248,0.345336168602874
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37557,-0.00356803915069497,0.00378463552376934,-0.0109859247772829,0.00384984647589293,0.345816166162641
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39956,-0.00465642308279185,0.00494016208166721,-0.0143391407628596,0.00502629459727589,0.345918217652187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37985,-0.00255619433805142,0.00271425256679743,-0.00787612936897438,0.00276374069287154,0.346328595844534
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,37955,0.00643989581725089,0.00685733972217668,-0.0070004900382154,0.0198802816727172,0.347683618868507
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,40403,-0.00189221237361754,0.00201602705266438,-0.00584362539683972,0.00205920064960464,0.347958164835072
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37593,-0.00287298625880971,0.00307111567339571,-0.00889237297866531,0.00314640046104588,0.34955499422524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,40354,-0.00516936106667498,0.00553085981685251,-0.0160098463077059,0.00567112417435594,0.349988212917619
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,37477,-0.00321657488656267,0.00346566034803804,-0.0100092691687172,0.00357611939559189,0.353358603050167
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37985,0.00203754612203042,0.00219955822522606,-0.00227358799941267,0.0063486802434735,0.354284096329012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,40327,-0.00509789217461762,0.00551749567308148,-0.0159121836938573,0.00571639934462208,0.355526198927284
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,37955,0.00277319684676103,0.0030097985714237,-0.00312600835322943,0.00867240204675149,0.356863562060796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",37477,-0.00379841909180559,0.00413439523733953,-0.0119018337569911,0.0043049955733799,0.358250517105556
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,37536,-0.00315181566462518,0.00344037474665138,-0.00989495016806189,0.00359131883881153,0.359617863052342
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,37536,-0.00462987116893406,0.00505582072848026,-0.0145392797967554,0.00527953745888726,0.359814564479748
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,40354,-0.00288102894427073,0.0031588330117277,-0.00907234164725703,0.00331028375871557,0.361753674498539
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,40179,-0.00502028616128795,0.00551173809136889,-0.015823292820371,0.00578272049779508,0.362396067816084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,37477,-0.00341570311239955,0.00375562069516734,-0.0107767196749275,0.00394531345012843,0.363107850572308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39525,-0.00216659543771038,0.0023844149748595,-0.006840048788435,0.00250685791301424,0.363550147663617
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,37937,-0.00404090004559561,0.00445759062248511,-0.0127777776656664,0.00469597757447521,0.364676288619324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37623,-0.00367651292751634,0.00405591473820472,-0.0116261058143976,0.00427307995936492,0.364710516001249
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,37477,0.00514911878042161,0.00569578659798663,-0.00601462295163218,0.0163128605124754,0.366000233128856
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37557,0.00288805631208285,0.0031949010524744,-0.00337394975076698,0.00915006237493267,0.366034297578812
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37567,-0.00405515597824629,0.00449815186227282,-0.012871533628301,0.00476122167180844,0.367330573347146
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,40336,-0.00687359788666153,0.00763856234305097,-0.0218451800790414,0.00809798430571836,0.368211106124379
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37878,-0.00314949549641836,0.0035024132662036,-0.0100142254981774,0.00371523450534069,0.368543187013228
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37982,-0.00467101074216727,0.00521634853844155,-0.0148950538775127,0.00555303239317817,0.370559291741648
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,40187,-0.00377225904845819,0.00422695832140667,-0.0120570973584153,0.00451257926149888,0.372176824673436
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37593,-0.00250207865225877,0.00280389460686946,-0.0079977120817229,0.00299355477720537,0.372217249305692
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37557,-0.00283378092281142,0.00318370996396037,-0.00907385245217376,0.00340629060655091,0.37343516261262
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37937,-0.0021506189059495,0.00241836663932416,-0.00689061751902485,0.00258937970712585,0.373865409948919
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,37709,-0.00425060868922665,0.0047923483081168,-0.0136436113731356,0.00514239399468229,0.375117937999588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,39975,-0.0045692090258083,0.0051570412780695,-0.0146770099308245,0.00553859187920791,0.375623890619079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37623,0.0193001877880056,0.0218086631228448,-0.0234447919327701,0.0620451675087813,0.376184634685137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,40336,0.00179392861911359,0.00203742238003801,-0.00219941924576092,0.00578727648398809,0.378607616985117
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",37477,-0.00409307537365374,0.00468516451549772,-0.0132759978240293,0.00508984707672179,0.382338784873177
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,37477,-0.00587044593315762,0.00676603019841363,-0.0191318651220483,0.00739097325573308,0.385610057088601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,40154,-0.00426403645676379,0.00492555069780839,-0.0139181158244682,0.00539004291094065,0.386669350031308
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,37477,-0.00641946664566924,0.00742386713849692,-0.0209702462371232,0.00813131294578473,0.387215790402823
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37557,-0.00346340093872797,0.00403032714402101,-0.0113628421410092,0.00443604026355322,0.390171470493257
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37895,-0.00321497366013764,0.00376303108310089,-0.0105905145830154,0.0041605672627401,0.392922185922454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,37546,0.00487833310037229,0.00572797184654005,-0.00634849171884621,0.0161051579195908,0.394413692771532
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,37477,0.00181131019847891,0.00213220313304521,-0.00236780794228969,0.00599042833924752,0.395617794951742
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,37536,-0.00211677286314347,0.00249951040209969,-0.00701581325125886,0.00278226752497192,0.3970802898021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37709,-0.00313832688267297,0.0037267480746117,-0.0104427531089119,0.00416609934356596,0.399742316968193
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,37536,-0.00444596612639095,0.00528667969324556,-0.0148078583251522,0.00591592607237034,0.400377237448
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37567,0.002355734861591,0.00280859035333694,-0.0031491022309494,0.0078605719541314,0.40161896510095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37557,-0.00589720967714824,0.00703603468601231,-0.0196878376617324,0.0078934183074359,0.401965165997562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,37536,0.00450958658181588,0.00538241587984679,-0.00603994854268381,0.0150591217063156,0.40213762134585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37623,0.00222031500170485,0.00265625889788497,-0.0029859524381497,0.00742658244155939,0.403237299828613
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,37557,-0.00557600448821375,0.00667814862563229,-0.018665175794453,0.00751316681802554,0.403753974763082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,37623,0.00201499491743968,0.00241449006786336,-0.00271740561557251,0.00674739545045188,0.403990405294192
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRTN,Neurturin,40039,-0.00343656762356764,0.0041296002395663,-0.0115305840931176,0.0046574488459823,0.405320524494054
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,40432,0.00560250590769636,0.0067456503184829,-0.00761896871653012,0.0188239805319228,0.40624817083407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,37895,-0.00332994685068616,0.00401185357106647,-0.0111931798499765,0.00453328614860412,0.406538248409392
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,37666,0.00287038466888063,0.00347141934895037,-0.0039335972550621,0.00967436659282336,0.408330226785204
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37666,-0.00194128382998479,0.00234808237937731,-0.00654352529356432,0.00266095763359474,0.40839208021389
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,37477,0.00288888350990974,0.00349500960927504,-0.00396133532426934,0.00973910234408882,0.408493791553224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,40464,0.00423240105430098,0.00512915279633379,-0.00582073842651326,0.0142855405351152,0.409289805994794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39956,-0.00210285542603975,0.00255960186747933,-0.00711967508629924,0.00291396423421973,0.411342461146615
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,37567,-0.00239949762899412,0.00292320931023236,-0.00812898787704955,0.0033299926190613,0.411750284506118
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37557,0.00279074314938373,0.00343271195834054,-0.00393737228896372,0.00951885858773118,0.416241457741173
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,37495,-0.00233095925838197,0.00286756691469306,-0.00795139041118037,0.00328947189441642,0.41630740509345
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,37536,-0.00296618908182339,0.00366324691725895,-0.0101461530396509,0.00421377487600416,0.418118232958227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,37452,-0.00555234967038066,0.00685800183970853,-0.0189940332762094,0.00788933393544806,0.418175589064137
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,40406,0.00302069676035797,0.00373295394415736,-0.00429589297019046,0.0103372864909064,0.41841365699511
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40531,-0.00471710222615004,0.00583840309625506,-0.01616037229481,0.00672616784250988,0.41913482466476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,37875,0.00342327782789869,0.0042606899419808,-0.00492767445838368,0.0117742301141811,0.4217253196565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39956,-0.00217526030810744,0.00271453790537919,-0.00749575460265066,0.00314523398643578,0.422948718974831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37593,0.00523714292598567,0.00654799448712166,-0.00759692626877277,0.0180712121207441,0.42383610175512
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37709,0.00562867435520498,0.00705095844897335,-0.00819120420478279,0.0194485529151928,0.424719421109438
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,37567,0.00287091328203914,0.00359794938373276,-0.00418106751007707,0.00992289407415535,0.424925313203647
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIM,Vimentin,40037,-0.00785900610410351,0.00986780329048111,-0.0271999005534465,0.0114818883452395,0.425794777068108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,37567,-0.00439112797533011,0.0055290671658629,-0.0152280996204214,0.00644584366976118,0.427099396623394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37709,-0.00422524226946538,0.0053206258864091,-0.0146536690068272,0.00620318446789646,0.427136853485616
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,37536,-0.00226488584634389,0.00285361583882536,-0.00785797289044159,0.00332820119775382,0.427390420554806
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37709,-0.00468328547367728,0.00590870463969447,-0.0162643465674784,0.00689777562012388,0.428020537637337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39975,-0.00375575668415975,0.00473866039399603,-0.013043531056392,0.00553201768807246,0.428036002246255
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37593,-0.00191186275406589,0.00241429262362445,-0.00664387629636981,0.00282015078823803,0.428437042720638
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,37567,-0.00206368132011074,0.00261121950793496,-0.00718167155566326,0.00305430891544179,0.429359152646695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,40354,-0.00778280665506226,0.0098567975308447,-0.0271021298155179,0.0115365165053933,0.429780333314158
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,40037,0.00181398217563739,0.00230770922695897,-0.00270912790920219,0.00633709226047696,0.431848283143404
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37557,0.00264110785686244,0.00336009880036224,-0.00394468579184755,0.00922690150557243,0.431869459131524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37982,-0.00392836876643714,0.00501306300161589,-0.0137539722496043,0.00589723471673001,0.433273047796975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,37937,-0.00151017097707844,0.00192811245761003,-0.0052892713939941,0.00226892943983723,0.433501109272964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,40300,-0.00213806475474417,0.00273520408540695,-0.0074990647621418,0.00322293525265345,0.434412095343011
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,37477,-0.00320972181007134,0.00411553533622058,-0.0112761710690637,0.00485672744892099,0.435461649685795
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,37536,-0.00460733550908595,0.00591293407779496,-0.0161966863015641,0.00698201528339218,0.435878266370663
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,37477,-0.00373897202593261,0.00480489404997169,-0.0131565643638771,0.00567862031201191,0.436489360497546
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37623,0.00366865919457729,0.00472463661510936,-0.00559162857103706,0.0129289469601916,0.437470405219722
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37593,-0.0059575169265336,0.00770666935643616,-0.0210625888651485,0.00914755501208128,0.439516202574704
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37709,-0.00342737692434171,0.0044433009599128,-0.0121362468057708,0.00528149295708738,0.440508352973992
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39752,0.00418411473225803,0.00542612024467702,-0.00645108094730893,0.014819310411825,0.44065591897448
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37567,-0.00321400008211499,0.00417549174461276,-0.011397963901556,0.00496996373732603,0.441474101108985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,37472,0.00395905459541854,0.00515326892070739,-0.00614135248916795,0.014059461680005,0.442346181506376
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39956,-0.00351796884070909,0.00460427773873841,-0.0125423532086364,0.0055064155272182,0.444839958665751
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37557,-0.00247344321899689,0.0032461068644358,-0.00883581267329106,0.00388892623529729,0.446090303505573
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,40336,0.00413603430675446,0.00543398770131806,-0.00651458158782895,0.0147866502013379,0.446583771383081
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37557,0.00298784801237993,0.00393475899975234,-0.00472427962713465,0.0106999756518945,0.447658580559472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,37982,0.0042897081139675,0.00565513009090946,-0.00679434686421504,0.01537376309215,0.448134033647618
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37985,0.00156777708691992,0.00207374142066233,-0.00249675609757826,0.00563231027141809,0.449654093889182
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,39975,-0.00901799089353564,0.0119293108318961,-0.0323994401240521,0.0143634583369808,0.449689219468063
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,40037,-0.00677084921256255,0.00895887209655257,-0.0243302385218056,0.0107885400966805,0.449798364913644
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,37557,-0.00284219080493893,0.00376157186799778,-0.0102148716662146,0.00453049005633672,0.449911070072652
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",37536,-0.00537203325117106,0.00713259486241041,-0.0193519191814955,0.00860785267915334,0.451363272006885
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37709,-0.00468254300567698,0.00622959830991323,-0.0168925556931069,0.00752746968175296,0.452268591523928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37955,0.00204302543185509,0.00272896021171536,-0.00330573658310702,0.0073917874468172,0.454083575664918
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,37536,-0.00356904317601576,0.0047692673227886,-0.0129168071286814,0.00577872077664989,0.454267331860296
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39975,-0.0027210043746559,0.00364427510723021,-0.00986378358482711,0.00442177483551531,0.455285111802518
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37557,-0.00438693738265424,0.00588366021849426,-0.015918911410903,0.00714503664559451,0.455914206397942
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,37985,-0.00180748723363099,0.00242493671161345,-0.00656036318839335,0.00294538872113137,0.456057989814657
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,37477,0.00398902892517723,0.00535259743050184,-0.00650206203860637,0.0144801198889608,0.456133406263725
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",40039,-0.00745421158138621,0.0100197317990266,-0.0270928859074784,0.012184462744706,0.456916000270889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,37536,-0.00410981316775579,0.00555419828606624,-0.0149960418084456,0.00677641547293403,0.459345342202957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,40531,0.0034214383313477,0.00465034701455752,-0.00569324181718504,0.0125361184798804,0.461900718529536
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,37567,-0.00366623116117758,0.00501533161799625,-0.0134962811324502,0.00616381881009508,0.464789319920519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,37692,-0.00599203261102301,0.00821170498756321,-0.0220869743866469,0.0101029091646009,0.46559010250164
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,37477,-0.00435363857255975,0.00598182550121782,-0.0160780165549467,0.00737073940982718,0.466742355030688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,37982,0.00148710586505469,0.00204834408129508,-0.00252764853428366,0.00550186026439305,0.467848915786305
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,37536,-0.00476167405301759,0.00659425360402741,-0.0176864111169113,0.00816306301087613,0.47024930346982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,40037,-0.00366479786966074,0.00508164317597726,-0.0136248184945762,0.00629522275525469,0.470807360507394
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37682,-0.00304409832094571,0.0042213348456296,-0.0113179146183797,0.00522971797648832,0.470847068479857
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37557,0.00315350091311798,0.00437529842058756,-0.00542208399123364,0.0117290858174696,0.471075555925972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37955,-0.00469200741392793,0.0065174833916056,-0.0174662748614749,0.00808226003361905,0.471592309238254
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40448,0.00251001453717577,0.00348814672398906,-0.00432675304184279,0.00934678211619434,0.47179168520781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,40327,0.00251976769347339,0.00350445833692886,-0.00434897064690717,0.00938850603385396,0.472140576098796
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,40327,-0.00187839528628312,0.00261686654070626,-0.00700745370606739,0.00325066313350115,0.472889176693876
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,37955,-0.00178294077854094,0.00250183992324108,-0.00668654702809346,0.00312066547101158,0.476073550214128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37557,-0.00332531546945118,0.00467982546069833,-0.0124977733724199,0.00584714243351755,0.477367106824791
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,37557,-0.00282268605424061,0.00397689323131471,-0.0106173967876174,0.00497202467913622,0.47785838305241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37709,0.00501082887289217,0.00708047248501665,-0.00886689719774047,0.0188885549435248,0.479145904881191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,40340,-0.00182800067284,0.00258524126222249,-0.00689507354679608,0.00323907220111609,0.479520336614372
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37666,-0.00128320369400855,0.00181680523677423,-0.00484414195808604,0.00227773457006894,0.480016046261629
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37593,-0.00255991114116091,0.00363428850294118,-0.00968311660692564,0.0045632943246038,0.48121018068903
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,37993,-0.00528122260120755,0.00752681015485407,-0.0200337705047215,0.00947132530230642,0.482906515820896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37557,-0.00257125093714712,0.00367938600632652,-0.00978284750954711,0.00464034563525286,0.484673122791278
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BSND,Barttin,37477,0.00199591908674318,0.0028632788409408,-0.00361610744150078,0.00760794561498715,0.485768520684579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,37477,-0.00179686026472505,0.00258725719941309,-0.00686788437557471,0.0032741638461246,0.487378631284095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,39597,0.00161393780976136,0.00232864423553228,-0.00295020489188191,0.00617808051140463,0.488269689535639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37709,-0.00321632572845342,0.00468466586552459,-0.0123982708248816,0.00596561936797478,0.492369153179614
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37593,0.00355257638106345,0.00519857479021148,-0.00663663020775105,0.0137417829698779,0.494381920938196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37557,-0.00222459554653144,0.00327531248413025,-0.00864420801542672,0.00419501692236384,0.497022502743196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,37955,-0.00258894094859768,0.00382203205120473,-0.010080123768959,0.0049022418717636,0.498180990731802
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37593,-0.00240255369755045,0.00354947419504617,-0.00935952311984094,0.00455441572474004,0.498496582418564
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,37477,0.00444872892427537,0.00658711836105545,-0.0084620230633933,0.0173594809119441,0.499453982893331
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,40344,-0.00237651649681982,0.00354675150625548,-0.00932814944908057,0.00457511645544093,0.502832840095579
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37623,-0.00457151023376363,0.00682303878783568,-0.0179446662579216,0.00880164579039431,0.502862599697326
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40466,0.00120672267763988,0.00181315336927189,-0.00234705792613302,0.00476050328141277,0.505715958152463
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,37895,0.00205253358313115,0.00308918649077813,-0.00400227193879398,0.00810733910505628,0.506429556963395
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37593,-0.00193669539020482,0.00292194591606987,-0.00766370938570178,0.00379031860529213,0.507463781769956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,37567,0.00269553835972864,0.00407863406244022,-0.00529858440265419,0.0106896611221115,0.508692912365402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",40275,-0.00412165390443528,0.00630289216267535,-0.016475322543279,0.00823201473440841,0.513166036988839
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,40123,-0.00942110771735214,0.0145545011486861,-0.0379479299687768,0.0191057145340725,0.517448211236822
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,37666,-0.00181212767940488,0.00281709498837984,-0.00733363385662936,0.0037093784978196,0.520065841931778
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37557,-0.00258953118980695,0.00405475719787998,-0.0105368552976517,0.00535779291803781,0.523068144995793
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37557,0.00351167367209113,0.00549986269566911,-0.00726805721142032,0.0142914045556026,0.523158069953519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,37937,0.00364156142725437,0.00570872488338548,-0.00754753934418118,0.0148306621986899,0.52355350628087
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,37536,-0.00268467217639287,0.00420918122066859,-0.0109346673689033,0.00556532301611757,0.523606318667522
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37623,-0.0033589336622558,0.00527089368978262,-0.0136898852942297,0.00697201796971813,0.523966089734516
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,37477,-0.00296563688456042,0.00465967640244104,-0.0120986026333449,0.00616732886422402,0.524496324745409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,37536,-0.00387035658323414,0.00608670218286773,-0.0158002928616549,0.00805957969518661,0.524871715451887
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,40039,0.00168626184454152,0.00265732501244615,-0.00352209517985293,0.00689461886893596,0.52571744892765
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37593,-0.00295264594443507,0.00469210610751093,-0.0121491739151565,0.00624388202628636,0.529177062568714
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37557,-0.00329074708501075,0.00523809496262128,-0.0135574132117485,0.00697591904172696,0.529861891471461
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37567,-0.00344673495574639,0.00550888439658264,-0.0142441483730484,0.0073506784615556,0.531543343091227
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37593,-0.0022224762513664,0.00357885120728132,-0.0092370246176378,0.004792072114905,0.534608619597012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,40309,-0.0014503466261931,0.00235194649368813,-0.00606016175382183,0.00315946850143564,0.537469180987241
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,37452,-0.00264701469243993,0.00429283928627522,-0.0110609796935394,0.00576695030865949,0.53750170955678
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37895,-0.00332784664049053,0.00540640734274349,-0.0139244050322678,0.00726871175128671,0.538210210471525
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VIT,Vitrin,37985,0.00188201727080708,0.003061241329508,-0.00411801573502859,0.00788205027664275,0.538704459622457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,37593,0.00221499693561612,0.00361501699867661,-0.00487043638179004,0.00930043025302227,0.540071418177664
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,37477,-0.0027681319722979,0.00453766918122528,-0.0116619635674994,0.00612569962290364,0.541850001914923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37567,0.00191658700479378,0.0031451991259221,-0.00424800328201353,0.00808117729160109,0.54229040339585
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,40039,-0.00336468155926706,0.00554855108987212,-0.0142398416954164,0.00751047857688229,0.544253192487413
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37567,0.00262584608551703,0.00439190773991805,-0.00598229308472235,0.0112339852557564,0.549928462553828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,37896,0.00225523848207704,0.00377574714488184,-0.00514522592189136,0.00965570288604544,0.550319866561983
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37557,-0.00242766133156869,0.00408577663959443,-0.0104357835451738,0.00558046088203639,0.55240614740497
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,37477,0.00406880649535141,0.00685424261476365,-0.00936550902958535,0.0175031220202882,0.552777488346734
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,37536,-0.00271263749388933,0.00457224224224666,-0.0116742322886928,0.00624895730091414,0.553001458160691
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37937,0.00138940095254874,0.00234658869889304,-0.00320991289728162,0.00598871480237911,0.553797610209108
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,40300,-0.00274409121800327,0.00464260249114143,-0.0118435921006405,0.00635540966463394,0.554483657503964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37895,-0.00296958303055063,0.00503696966205111,-0.0128420435681708,0.00690287750706955,0.555497287925985
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,37424,-0.00171522453159383,0.00291551828289814,-0.00742964036607419,0.00399919130288652,0.556335404396082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,37536,0.00248220009641628,0.00422237433646975,-0.00579365360306443,0.010758053795897,0.556630829545237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,37593,-0.00234938827781187,0.00401359302199808,-0.0102160306009281,0.00551725404530437,0.558317159408445
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39956,-0.00393135570938363,0.00675305930432929,-0.017167351945869,0.00930464052710177,0.560467906818452
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37567,-0.00247113797467081,0.00425223148576032,-0.010805511686761,0.0058632357374194,0.561156695522427
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37557,0.00177712470230719,0.00307924355215437,-0.00425819265991539,0.00781244206452976,0.563861362473046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37896,-0.00615056524937814,0.0106946781342132,-0.027112134392436,0.0148110038936797,0.565229760312972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",40354,-0.00368118200641336,0.00643686708393948,-0.0162974414909348,0.00893507747810802,0.567404362868483
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37593,-0.00106313980034087,0.00186110456545623,-0.00471090474863508,0.00258462514795334,0.567845851900981
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37895,0.00404970512514236,0.00709281824275487,-0.00985221863065718,0.0179516288809419,0.568037293666402
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRL,Prolactin,40466,-0.00363671531629769,0.00637716360090353,-0.0161359559740686,0.00886252534147323,0.568501497867201
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,39942,0.00409354635307224,0.00723375593685493,-0.0100846152831634,0.0182717079893079,0.571473354581079
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,40417,-0.00487770173452893,0.00862005988913108,-0.0217730191172258,0.012017615648168,0.571500484876258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,37896,-0.0026226162070358,0.00464346098924473,-0.0117237997459555,0.00647856733188388,0.572220777536356
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37593,-0.00290271103459891,0.00514097392834076,-0.0129790199341468,0.00717359786494898,0.572339999074265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37567,0.0023238855254318,0.00413118494119182,-0.00577323695930416,0.0104210080101678,0.573769520629886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,39956,-0.00248392039759567,0.00442734378638965,-0.0111615142189194,0.00619367342372805,0.574777847689651
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39956,0.00216590373314132,0.00386622866796198,-0.00541190445606416,0.00974371192234681,0.575343635903251
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,37477,-0.00156952334422837,0.00280395677512533,-0.00706527862347401,0.00392623193501727,0.575657520550817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40466,-0.00137248927389255,0.00247129305583386,-0.00621622366332692,0.00347124511554181,0.578647359784938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,37567,-0.00323095699578107,0.00582264064378288,-0.0146433326575955,0.00818141866603337,0.57897561438271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,40204,-0.0058873837763091,0.0106234694330654,-0.0267093838651173,0.0149346163124991,0.57945905571022
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,37477,-0.00165512596665471,0.00298905417456039,-0.00751367214879308,0.00420342021548365,0.579773833298102
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",40300,0.0047356840899466,0.00859254660776159,-0.0121057072612661,0.0215770754411593,0.581546437495472
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,37477,-0.00438830769103918,0.00796629673675177,-0.0200022492950726,0.0112256339129943,0.581739659564291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,40271,-0.00152798652458844,0.00278488577564168,-0.00698636264484614,0.00393038959566926,0.58323888099466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,40325,-0.00133451518008181,0.00247103741267825,-0.00617774850893119,0.00350871814876756,0.589161357575717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37593,0.00161293723115364,0.0030074182966524,-0.00428160263028506,0.00750747709259234,0.591746798881957
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,40336,-0.0012305296626637,0.00229854072286138,-0.005735669479472,0.0032746101541446,0.592413582059975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,40336,0.00669096366611282,0.0125180004752419,-0.0178443172653613,0.0312262445975869,0.59299802446096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37955,-0.0032653209772206,0.00612513252224215,-0.0152705807208152,0.00873993876637402,0.593971682740425
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37593,-0.00202893683837781,0.00381788792470701,-0.00951199717080355,0.00545412349404793,0.595130425872509
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,40484,0.00199148008155295,0.00378208689193343,-0.00542141022663658,0.00940437038974248,0.598509323747492
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37557,-0.00422458216176198,0.00805628600828304,-0.0200149027379967,0.0115657384144728,0.600020811063948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,37536,-0.00282803714665626,0.00541920593063529,-0.0134496807707014,0.00779360647738891,0.601780455274569
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,37623,0.000965725217160737,0.00186627501036593,-0.00269217380315649,0.00462362423747796,0.604842821280243
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37557,0.00176006241312013,0.00340324452245135,-0.00491029685088452,0.00843042167712478,0.605044898878353
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39956,-0.00359969570447933,0.0069708602691689,-0.0172625818320504,0.0100631904230917,0.605588094287628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37557,0.00153240406579617,0.00297181553958288,-0.00429235439178629,0.00735716252337862,0.606110546406975
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37709,0.0025241643671902,0.00492962150505894,-0.00713789378272532,0.0121862225171057,0.608631406680231
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,37567,-0.00255398887277605,0.00498829291959269,-0.0123310429951777,0.00722306524962562,0.608662030035809
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MB,Myoglobin,40531,-0.00208285851099364,0.0040885488978471,-0.010096414350774,0.00593069732878668,0.610452865343367
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPHS2,Podocin,37593,-0.00442140325776345,0.00872794693861679,-0.0215281792574524,0.0126853727419255,0.61245805169817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,37937,0.00111021097159537,0.00219473623668528,-0.00319147205230777,0.00541189399549852,0.612969057207216
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,39804,0.00326995043998058,0.00646918654807594,-0.00940965519424827,0.0159495560742094,0.613239199552349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37593,-0.00228437556989589,0.00456764542230283,-0.0112369605976094,0.00666820945781765,0.616998227986769
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,36174,-0.00429244610939431,0.00870370852207134,-0.0213517148126541,0.0127668225938655,0.621898612969527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37567,-0.0023434003216269,0.00476895903262738,-0.0116905600255766,0.00700375938232277,0.623161595516187
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37993,0.00239085055820002,0.00488832046423427,-0.00719025755169915,0.0119719586680992,0.624782730599315
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,37477,-0.00186960697398253,0.00383385011898589,-0.00938395320719487,0.00564473925922982,0.625800444246767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37567,-0.00284856193046216,0.00585815663422109,-0.0143305489335355,0.00863342507261118,0.62679402369386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37858,0.00213516190573301,0.00442368480717404,-0.00653526031632811,0.0108055841277941,0.62934084479155
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,37593,-0.00230465659804943,0.00477947777232899,-0.0116724330318143,0.0070631198357154,0.629673035022734
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,37477,-0.00208764943397095,0.00435084706174345,-0.0106153096749881,0.0064400108070462,0.631359198226601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,40037,-0.00094344575839237,0.00196778428320742,-0.00480030295347891,0.00291341143669417,0.631628299915487
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39975,-0.00141946739799143,0.00297043902804273,-0.00724152789295518,0.00440259309697231,0.63275336980926
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,40037,-0.00197476428655214,0.00415390659551398,-0.0101164212137595,0.00616689264065526,0.634509056116909
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ESPL1,Separin,37477,0.00227454616527363,0.00478608913812669,-0.00710618854545467,0.0116552808760019,0.634623119693557
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,37557,-0.00187371392152758,0.0039668393740371,-0.00964871909464029,0.00590129125158513,0.636688928337892
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,40327,-0.000953596595527736,0.00202205911993311,-0.00491683247059663,0.00300963927954116,0.63722109764945
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,37452,0.00159846272377836,0.00339153073503381,-0.0050489375168879,0.00824586296444462,0.637427206006688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENG,Endoglin,40531,0.000667404162285724,0.00141869881178639,-0.0021132455088156,0.00344805383338705,0.638051355801838
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,40445,-0.00118715252555215,0.00252398921153412,-0.00613417138015902,0.00375986632905472,0.638113035843835
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,40336,0.00152117706466099,0.0032417103534811,-0.00483257522816197,0.00787492935748395,0.638896402711524
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39929,-0.00271319428800141,0.00578580465913395,-0.014053371419904,0.00862698284390114,0.639119246132695
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37692,-0.00393865493442752,0.00840197855350243,-0.0204065328992923,0.0125292230304372,0.639236705751632
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,40484,0.000636490410134534,0.00136235779004959,-0.00203373085836266,0.00330671167863173,0.640364796876703
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,37536,0.00251755936177051,0.00539716761927015,-0.00806088917199897,0.01309600789554,0.640894495699629
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,37896,-0.001184834855427,0.00255433435933695,-0.00619133019972742,0.00382166048887343,0.642760802586504
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,37982,-0.00277843420533438,0.00601087586928844,-0.0145597509091397,0.00900288249847096,0.643920597343417
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,37452,0.00342511072695827,0.0074417866371424,-0.0111607910818408,0.0180110125357574,0.645341742024029
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37709,-0.00226634613431629,0.00495601877480501,-0.0119801429329341,0.00744745066430152,0.647468905031167
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37955,-0.0014357081402604,0.00314199328937794,-0.00759401498744117,0.00472259870692037,0.647720212685206
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,37477,-0.00208402913041161,0.00458909694387099,-0.0110786591403988,0.00691060087957554,0.649745567832393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37937,-0.00268227932443848,0.00591432107347229,-0.0142743486284442,0.0089097899795672,0.650179642884457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",40429,-0.00277078029534558,0.00611595681300531,-0.014758055648836,0.00921649505814482,0.650525240654062
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37895,0.00215702459114406,0.00477030568671606,-0.00719277455481942,0.0115068237371075,0.651148458448737
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37593,-0.00114282442479612,0.00253048533323651,-0.00610257567793969,0.00381692682834744,0.65154832238165
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,37536,-0.0011869195532224,0.00263753250391191,-0.00635648326088974,0.00398264415444494,0.652709714664075
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,37452,0.00131736186031931,0.00293299590801703,-0.00443131011939408,0.00706603384003269,0.653329281289349
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,37536,-0.00237933544192272,0.0053062543204009,-0.0127795939099085,0.00802092302606305,0.653870470516412
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,37477,-0.00237617563074814,0.00531765342868244,-0.0127987763509657,0.00804642508946945,0.654993214299601
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39975,-0.00120528524326495,0.00270207077503996,-0.00650134396234328,0.00409077347581338,0.655560246583979
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37709,-0.00248012211900369,0.00560576060210172,-0.0134674128991231,0.00850716866111568,0.658189750168067
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,40367,0.000984688273216994,0.00222744866167563,-0.00338111110366724,0.00535048765010123,0.658444545293306
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,37593,-0.00111968442213414,0.00253535277905908,-0.00608897586908994,0.00384960702482167,0.658765215917468
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,40037,0.00233348647977776,0.00529795058104865,-0.0080504966590776,0.0127174696186331,0.659616760107082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,37937,-0.00216739886515638,0.00495507855846674,-0.0118793528397512,0.00754455510943844,0.661821337572386
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,40223,0.000443766735338173,0.00101543620938938,-0.00154648823506501,0.00243402170574136,0.662102253540302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37993,-0.00125736375240173,0.00289722738086298,-0.00693592941889317,0.00442120191408971,0.664303609270519
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,37896,0.00935949966626483,0.0215973677313757,-0.0329713410872316,0.0516903404197613,0.664758042572686
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,40037,-0.00206610675077674,0.00477952211533193,-0.0114339700968273,0.00730175659527385,0.665541632018673
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37557,-0.00144876459662851,0.00335805054380868,-0.00803054366249352,0.00513301446923649,0.666162653092228
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,37477,-0.00418977359475146,0.00975152052792702,-0.0233027538294884,0.0149232066399855,0.667454920008773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37557,0.00154770429061962,0.00360394598511543,-0.00551602984020661,0.00861143842144586,0.667604915525642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,40336,-0.00301889878558972,0.00707486255339019,-0.0168856293902345,0.010847831819055,0.669597977367351
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,39956,0.0011709403519011,0.00274634545777097,-0.00421189674533001,0.00655377744913221,0.669849207422128
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37593,0.00331640492511239,0.00780333721873055,-0.0119781360235995,0.0186109458738243,0.670844884520914
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,40374,-0.000940671221016982,0.0022187449893289,-0.00528941140010163,0.00340806895806766,0.671596737025184
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37593,-0.00167111005355622,0.00394194053006891,-0.00939731349249128,0.00605509338537883,0.671623210635053
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39956,-0.00228251750076741,0.00546680151212242,-0.0129974484645274,0.00843241346299253,0.676301400964923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37709,-0.00142055883630026,0.00340899210737557,-0.00810218336675638,0.00526106569415586,0.676897771766107
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,37567,0.00127946402917718,0.00314349944532531,-0.00488179488366044,0.0074407229420148,0.68400066915855
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,39956,-0.00177998175285551,0.00437972020344151,-0.0103642333516009,0.00680426984588985,0.684443684266882
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37567,0.00176066599447332,0.00436367959259353,-0.00679214600701,0.0103134779959566,0.686600281216215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37666,-0.0026200108730019,0.00651335114749813,-0.0153861791220982,0.0101461573760944,0.68750481748445
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39975,-0.00256286204264933,0.00639477972502468,-0.0150966303036977,0.00997090621839904,0.688591970446941
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,40352,0.00120055022245476,0.00299732405015279,-0.00467420491584471,0.00707530536075423,0.688763706552843
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,40037,-0.00184876695546562,0.00462215325933681,-0.0109081873437658,0.00721065343283452,0.689177032987605
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,37477,-0.00213173754874791,0.00535766403729146,-0.0126327590618392,0.00836928396434335,0.690721011413095
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,40037,-0.00264774840524601,0.00668323485717768,-0.0157468887253143,0.0104513919148223,0.691979387842663
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,37477,-0.000993754978791003,0.00252001507229941,-0.00593298452049786,0.00394547456291585,0.693332907264883
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40531,-0.00108270782032314,0.00274979013237855,-0.0064722964797851,0.00430688083913883,0.693776762893476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,37709,-0.00202188417414025,0.00513615149679736,-0.0120887411078631,0.00804497275958258,0.693840309042321
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,40414,-0.00109510376691202,0.00278646641093129,-0.00655657793233735,0.0043663703985133,0.694318774541503
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37623,-0.00066433937451346,0.00170032453550123,-0.00399697546409587,0.00266829671506895,0.696015501646523
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37567,0.00115450561572208,0.0029559508189513,-0.00463915798942247,0.00694816922086662,0.696121471802896
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37985,-0.000891817940999203,0.00229276225624415,-0.00538563196323774,0.00360199608123933,0.697303746732685
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,37567,-0.0029989186258256,0.00773530686958006,-0.0181601200902025,0.0121622828385513,0.698250073742074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37557,-0.00147221140485897,0.00380794869818193,-0.00893579085329555,0.00599136804357761,0.699047272133794
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,37536,0.00117272758704396,0.00303706293639711,-0.00477991576829437,0.00712537094238229,0.699400215437288
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37709,-0.00293742580102725,0.00764173745288119,-0.0179152312086744,0.0120403796066199,0.700693797984169
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,40406,-0.000774537972655901,0.00201704914742549,-0.00472795430160986,0.00317887835629805,0.700986835224764
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,37955,0.00512507104555781,0.0133653973466209,-0.0210711077538191,0.0313212498449347,0.701386103468964
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,37895,-0.00162216177337351,0.00424966482903995,-0.00995150483829181,0.0067071812915448,0.702678637841403
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,37557,-0.00116633536702468,0.00306826533215966,-0.00718013541805762,0.00484746468400827,0.703856126294851
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,40039,0.00094124998645431,0.00247630225165293,-0.00391230242678543,0.00579480239969406,0.703874116500562
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37687,0.00175055349606199,0.00464418149217265,-0.0073520422285964,0.0108531492207204,0.706228122231797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37993,0.000807254349758558,0.00214866225013223,-0.00340412366050061,0.00501863236001772,0.707145150932044
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,37955,0.00145566213870553,0.00394621581168831,-0.00627892085220356,0.00919024512961463,0.712226345368735
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37623,-0.00252893436168946,0.00685847298224161,-0.015971541406883,0.0109136726835041,0.712333866374844
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,37709,0.00166458424899764,0.00454672418454095,-0.00724699515270263,0.0105761636506979,0.71429161820781
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,40417,0.00126064472863316,0.00345476380886977,-0.00551069233675158,0.00803198179401791,0.715190582049294
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37567,-0.00127842795319073,0.00353340050016264,-0.00820389293350951,0.00564703702712805,0.717498088422588
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36969,-0.00151027601096629,0.00417670422086246,-0.00969661628385672,0.00667606426192413,0.717660689031237
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37709,-0.000866540915004955,0.00242210993729405,-0.00561387639210128,0.00388079456209138,0.720526501956491
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,37477,0.00123312153597279,0.00349425143085284,-0.00561561126849878,0.00808185434044437,0.724169077212115
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37567,0.000868009474886956,0.00246498324490916,-0.00396335768513501,0.00569937663490892,0.724741888041123
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,37536,-0.00106214260740124,0.00302421729819775,-0.00698960851186883,0.00486532329706635,0.725434665118865
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37567,-0.00186994125720774,0.00532484980025373,-0.0123066468657051,0.00856676435128957,0.72546451863481
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,40304,-0.000791278821671538,0.0022593968752313,-0.00521969669712488,0.00363713905378181,0.726180626752744
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37557,-0.00146418461448944,0.00435212094375522,-0.00999434166424968,0.0070659724352708,0.736551918596148
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,40037,0.000943281569653919,0.00281370988388704,-0.00457158980276469,0.00645815294207253,0.737444952073021
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37557,0.00114636084637937,0.0034314621636194,-0.00557930499431466,0.0078720266870734,0.738329382302928
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEO1,Neogenin,37955,-0.00058967611764796,0.00177177271779464,-0.00406235064452545,0.00288299840922953,0.739277575982119
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,40484,-0.00122190987656838,0.00375853093482986,-0.00858863050883491,0.00614481075569815,0.745107321656587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37593,-0.000956811957841563,0.00295194719051044,-0.00674262845124203,0.00482900453555891,0.74584546247936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,37477,-0.00167479620614293,0.00520021598556436,-0.0118672195378491,0.00851762712556322,0.747410275530938
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37666,0.00110328444718016,0.00348203101178424,-0.00572149633591694,0.00792806523027726,0.751361791700745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,37536,-0.00158837438301066,0.00502622699579716,-0.0114397792947731,0.00826303052875177,0.751994463341982
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37895,-0.00116757157112274,0.00369901066456947,-0.0084176324736789,0.00608248933143343,0.752277421226012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39975,-0.00157839166472518,0.00500633076735062,-0.0113907999687324,0.00823401663928204,0.752553959010145
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,37477,-0.000954661105330737,0.0030398604745328,-0.00691278763541503,0.00500346542475356,0.753489861449061
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,40419,-0.000735810729266288,0.00234386062782216,-0.00532977755979771,0.00385815610126514,0.753577475488948
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,37993,-0.00149013213352,0.00474937590925739,-0.0107989089156645,0.00781864464862448,0.753713285623166
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39975,-0.00200692331815064,0.00649909300497779,-0.0147451456079071,0.0107312989716058,0.757477415451677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,37405,-0.00112509980034824,0.00365027242509495,-0.00827963375353435,0.00602943415283786,0.757917216238886
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,37477,-0.000911613706115094,0.0029933944651505,-0.00677866685781007,0.00495543944557988,0.760720025975863
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37937,0.000657132164568721,0.00216490842667286,-0.00358608835171008,0.00490035268084752,0.761484508512591
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37937,-0.00152754769098705,0.00503682266078838,-0.0113997201061323,0.00834462472415817,0.761684173529831
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37985,0.000742684192451526,0.00245241592815439,-0.00406405102673108,0.00554941941163413,0.762018145743252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37896,0.00207093663355914,0.0068418428611128,-0.011339075374222,0.0154809486413402,0.762133117331113
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,37709,-0.004290166112418,0.0142475443828205,-0.0322153531027461,0.0236350208779101,0.763330627316023
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,40269,0.00122222228804549,0.00406515784220066,-0.00674548708266782,0.00918993165875879,0.763679238949215
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37557,0.00144447481498842,0.0048349780700717,-0.00803208220235211,0.010921031832329,0.76513157677927
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,40223,-0.00101224802711457,0.003392721051143,-0.00766198128735484,0.00563748523312571,0.765433296019042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,40311,-0.00313894059198908,0.0106316274001124,-0.0239769302962094,0.0176990491122313,0.767810179421035
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37666,-0.000916155470255462,0.00312990081937666,-0.00705076107623372,0.00521845013572279,0.769747883932302
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,37477,-0.000639359136829201,0.00221146284321377,-0.00497382630952819,0.00369510803586979,0.772500724966496
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",37477,0.00122065731806367,0.00422329915470821,-0.00705700902516442,0.00949832366129176,0.772563533972421
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37623,0.00149469974248724,0.00521865977384805,-0.00873387341425494,0.0117232728992294,0.77456518793693
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,37709,0.0014465904259454,0.00506949488176375,-0.00848961954231154,0.0113828003942023,0.775378947398408
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,37477,-0.00111718965146238,0.00392256438380416,-0.00880541584371853,0.00657103654079376,0.775793439830599
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37955,-0.000863139783970823,0.00306716531217795,-0.00687478379583961,0.00514850422789796,0.778398062444494
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37895,-0.00158815593081615,0.00568639750033436,-0.0127334950314715,0.0095571831698392,0.780026310207256
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,37477,-0.00129434315468924,0.00471335221798497,-0.0105325135019398,0.0079438271925613,0.783618688996677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,40300,0.000943857729709079,0.00345644388418141,-0.00583077228328649,0.00771848774270465,0.784801497885271
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,37536,0.00148424961504651,0.00543541456503165,-0.00916916293241551,0.0121376621625085,0.784803581167084
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,40246,-0.00128714542394115,0.0048264302775656,-0.0107469487679697,0.00817265792008742,0.789713771276801
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",40039,0.00126542187366285,0.0048310478564328,-0.00820343192494545,0.0107342756722711,0.79337480051904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,37557,-0.00113759523165561,0.00439231493396657,-0.00974653250223008,0.00747134203891886,0.795641826677477
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39975,0.000753671207570115,0.002925443164594,-0.00498019739503412,0.00648753981017435,0.796698716385686
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37567,0.000918858357973704,0.00358831088623802,-0.0061142309790528,0.00795194769500021,0.797900890893997
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37557,0.000796742615310622,0.00318978020528894,-0.00545522658705569,0.00704871181767694,0.802761568214511
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,37536,0.00112176884982629,0.0045228779448274,-0.00774307192203542,0.00998660962168799,0.804122027074538
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,40460,0.00131624623503474,0.0053174747665136,-0.0091060043073319,0.0117384967774014,0.804499548197274
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37895,0.000942172029745714,0.00388243123227503,-0.00666739318551334,0.00855173724500477,0.808260273275817
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,37365,-0.000640985647235742,0.00265602375996099,-0.00584679221675929,0.00456482092228781,0.80930102414978
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CGN,Cingulin,37567,-0.000846463705715032,0.00350890179315761,-0.00772391122030394,0.00603098380887388,0.809378130261162
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37567,0.00133623577918358,0.00557229619309974,-0.00958546475929191,0.0122579363176591,0.810489172526864
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LXN,Latexin,40178,-0.00131803217308571,0.00552150242966705,-0.0121401769352331,0.0095041125890617,0.811334369047717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,37477,0.00120294475359232,0.00509029676812337,-0.00877403691192949,0.0111799264191141,0.813187197285706
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,40531,-0.001366034335399,0.00594839594711606,-0.0130248903917465,0.0102928217209485,0.818368604498258
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37557,-0.000907216543924956,0.00404150276235281,-0.00882856195813646,0.00701412887028655,0.822391176581972
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,40354,-0.000532219555786694,0.00237189254619048,-0.00518112894632004,0.00411668983474665,0.822459821624544
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37623,-0.000795280995429845,0.00354462217195927,-0.00774274045247001,0.00615217846161032,0.822478573376773
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37557,-0.00116814684690374,0.005247226883814,-0.0114527115391792,0.0091164178453717,0.823833374268405
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,40327,-0.000617711811183381,0.00277997921530328,-0.00606647107317781,0.00483104745081104,0.824160932191798
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,37477,0.000585932202038223,0.0026511481807777,-0.00461031823228607,0.00578218263636252,0.825087540398098
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37593,-0.000534882089227155,0.00244776149859079,-0.00533249462646511,0.0042627304480108,0.827028246753785
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37683,-0.000936056415724976,0.00437684541365696,-0.00951467342649262,0.00764256059504266,0.83065520763578
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NEB,Nebulin,37557,-0.000636189846145915,0.0030359246875501,-0.00658660223374411,0.00531422254145228,0.834019123622727
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,40300,0.000346016585018199,0.00165841673813614,-0.00290448022172863,0.00359651339176502,0.834729837296717
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37593,-0.000475612262246875,0.00234374504507192,-0.00506935255058784,0.00411812802609409,0.839194194470559
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37993,0.0008989113764442,0.00446440952278904,-0.00785133128822232,0.00964915404111072,0.840427491885245
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,37477,0.000707894968663642,0.00352990087874133,-0.00621071075366936,0.00762650069099664,0.841059493427046
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37567,-0.00130188973632322,0.0065277274499448,-0.014096235538215,0.0114924560655686,0.841921692436191
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37557,0.000864975318019698,0.00434084889328131,-0.00764308851281167,0.00937303914885106,0.842059256865265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37993,0.000536472975516732,0.00273739770621149,-0.00482882652865779,0.00590177247969125,0.844629397665352
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,40039,0.00124161059366703,0.0063785446046618,-0.0112603368314701,0.0137435580188042,0.845666194113437
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,37536,-0.00121535799728525,0.00629788932059371,-0.0135592210656489,0.0111285050710784,0.846978706498074
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,37477,0.000571963686828156,0.00305406765521386,-0.00541400891739101,0.00655793629104732,0.851444560311797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,37520,-0.00148611074305182,0.0079445087824459,-0.0170573479566458,0.0140851264705421,0.851615415142889
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37709,0.000835514186179265,0.00453658025316323,-0.00805618311002066,0.00972721148237919,0.853880800571965
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39956,-0.000976109193835183,0.00532274738912576,-0.0114086940765217,0.0094564756888513,0.854498760649131
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37709,-0.00125679206455778,0.00687695376448778,-0.0147356214429538,0.0122220373138383,0.854993694538325
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,37709,-0.000662242793777421,0.00368776116404729,-0.00789025467531011,0.00656576908775527,0.85748619192266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,40300,0.00113277541733974,0.00634524315069828,-0.0113039011580289,0.0135694519927084,0.858314099506572
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37567,-0.000604723198910379,0.00358558928412678,-0.00763247819579887,0.00642303179797811,0.866071574128264
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39975,-0.00065404013177447,0.00387969724090616,-0.00825824672395055,0.00695016646040161,0.866129053148337
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,40189,0.000397727412534731,0.0023753766685255,-0.00425801085777526,0.00505346568284472,0.86702787906513
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37623,0.00056526214777505,0.00337823043386822,-0.00605606950260666,0.00718659379815676,0.867116963529004
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39956,-0.000680745339029286,0.00415490469196694,-0.00882435853528449,0.00746286785722592,0.869858147060149
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37567,0.000948245856397976,0.00586084752687622,-0.0105390152962794,0.0124355070090754,0.871471122462196
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37557,0.000426958665721863,0.00265162753996866,-0.00477023131261671,0.00562414864406044,0.872082031648548
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,37993,0.00120426729566949,0.00749397342398918,-0.0134839206153493,0.0158924552066883,0.872333582625409
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37593,0.00065304383895162,0.0040708634310999,-0.00732584848600417,0.00863193616390742,0.872553489707266
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,37477,0.000431600068965022,0.00271678551970493,-0.00489329954965663,0.00575649968758668,0.873778297586244
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37623,-0.000552753747747466,0.00351063703044747,-0.0074336023274245,0.00632809483192957,0.874891737985009
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40531,0.000336525767586757,0.00216179034714311,-0.00390058331281375,0.00457363484798726,0.87629514902904
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,40037,-0.000441736728618585,0.00284571645305606,-0.00601934097660846,0.00513586751937129,0.876643071375493
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,40352,0.00378413853145057,0.0243804523745917,-0.0440015481227492,0.0515698251856503,0.876656166351961
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,37896,0.00138147381505138,0.00917561254133211,-0.0166027267659596,0.0193656743960623,0.880325626775866
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,37536,0.000530206347785968,0.00362153523893615,-0.00656800272052888,0.00762841541610081,0.883604920886687
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,37985,-0.000312678001061596,0.00214844429112892,-0.00452362881167427,0.00389827280955108,0.884289122318291
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37557,-0.00141900622677308,0.00996164781116953,-0.0209438359366654,0.0181058234831192,0.88672917913393
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37557,-0.000852039568724063,0.00599841950979796,-0.0126089418079281,0.0109048626704799,0.887047425619476
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37557,-0.000325098417952518,0.00238365186207955,-0.00499705606762844,0.00434685923172341,0.891517680087272
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37557,-0.000579296056381734,0.00425348278388938,-0.00891612231280493,0.00775753020004146,0.891670526493324
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37593,0.000329714362416092,0.00247124178694932,-0.00451391954000458,0.00517334826483676,0.89386286145923
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,37455,-0.00053362694116251,0.00406564546222573,-0.00850229204712495,0.00743503816479993,0.895577439084893
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCIN,Adseverin,37536,0.000796874332150268,0.00612055957248303,-0.0111994224299165,0.012793171094217,0.896413107571576
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,37477,0.00037478083057047,0.00288221421387079,-0.00527435902861628,0.00602392068975722,0.89654291085705
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,37477,-0.000443788996408617,0.00341990715167119,-0.00714680701368415,0.00625922902086691,0.896753260759451
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,37593,0.000414021564231236,0.00323011792846688,-0.00591700957556385,0.00674505270402632,0.898012151663457
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,39797,-0.000360904631057063,0.00295740134868126,-0.00615741127447233,0.00543560201235821,0.902873390841135
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,40336,-0.000534241803974068,0.00439027299839826,-0.00913917688083465,0.00807069327288652,0.903147969836767
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,40147,-0.00116267898366096,0.00966489861747659,-0.0201058802739151,0.0177805223065932,0.904247725857969
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37623,0.000382723117798105,0.00324547549277663,-0.00597840884804409,0.0067438550836403,0.906128779919017
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,37623,0.00027574757470109,0.00237587510763302,-0.00438096763625962,0.0049324627856618,0.907605588572432
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37709,0.000431215829163967,0.00374992498543892,-0.00691863714229632,0.00778106880062426,0.908452262897847
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,40039,0.000848308120389143,0.00749551858192074,-0.0138429083001755,0.0155395245409538,0.909892976258628
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,37557,0.000383735707538175,0.00342857310467953,-0.00633626757763369,0.00710373899271004,0.910886284968686
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37593,0.000649256526452609,0.00581948825089505,-0.0107569404453017,0.0120554534982069,0.911169303750466
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,38008,-0.000171729687362634,0.00158073541213886,-0.00326997109515479,0.00292651172042953,0.91349034742828
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,39238,-0.000348889191878069,0.0033294891832231,-0.00687468799099535,0.00617690960723921,0.916545768313821
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,37758,-0.000546063977888828,0.00521629909696777,-0.0107700102079457,0.009677882252168,0.916627995743181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,37557,-0.000543570785119251,0.00519553908821167,-0.0107268273980141,0.00963968582777561,0.916676885468484
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,37477,-0.000521188456010162,0.00506216498592077,-0.0104430318284149,0.00940065491639456,0.917998191968677
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,37536,-0.000662639369364913,0.00651159892791612,-0.0134253732680805,0.0121000945293507,0.918946411813514
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,37477,-0.00034278519087685,0.00344397652590919,-0.00709297918165886,0.00640740879990516,0.920717570390907
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37895,0.000370401157311519,0.00376603717593665,-0.00701103170752432,0.00775183402214736,0.921653438908939
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37896,-0.000268637087145737,0.00273252854692512,-0.00562439303911897,0.0050871188648275,0.921686962490066
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,37993,-0.000355863735865669,0.00370205269367065,-0.00761188701546015,0.00690015954372881,0.923421877510396
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,39752,0.00072685986979596,0.007747088938237,-0.0144574344491486,0.0159111541887405,0.925250502981642
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39956,-0.000358137115933766,0.00382935338946569,-0.00786366975928651,0.00714739552741898,0.925488353592797
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,40349,-0.000594763155943901,0.00642420462959423,-0.0131862042299486,0.0119966779180608,0.926237127095625
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,39956,0.000366458047273447,0.00402717388955213,-0.00752680277624873,0.00825971887079562,0.927496682139593
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,37895,-0.000314830138643835,0.00382135222071293,-0.00780468049124118,0.00717502021395351,0.9343401181745
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37955,-0.000362774961211976,0.00446666436054104,-0.00911743710787241,0.00839188718544846,0.935269536625597
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37593,0.000283428993224127,0.00358886713241129,-0.006750750586302,0.00731760857275025,0.937054106935209
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37557,0.000310029662184119,0.00395643908254912,-0.00744459093961216,0.0080646502639804,0.937542265010259
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37557,0.000438728098364443,0.00560215047865369,-0.0105414868397968,0.0114189430365257,0.937579294358082
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,37477,0.000186010278559258,0.00243536235781274,-0.00458729994275371,0.00495932049987223,0.939118835359755
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37993,0.000157889978362343,0.00207394818780371,-0.00390704846973293,0.00422282842645762,0.939316681369541
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,37477,-0.000381605674396967,0.00520002871314272,-0.0105736619521567,0.00981045060336276,0.941500640701712
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37623,0.00013824407053156,0.00194917996897657,-0.00368214866866251,0.00395863680972563,0.943459143298252
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37567,0.000180058472883786,0.00278232286458772,-0.00527329434170815,0.00563341128747572,0.948401777504042
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,40374,0.000260829870715343,0.00405067515676163,-0.00767849343653746,0.00820015317796814,0.948659144908733
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TTN,Titin,37557,0.000346499394026869,0.00547232466352816,-0.0103792569464883,0.0110722557345421,0.949513849438555
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37593,0.000142895385099648,0.00231438212272034,-0.00439329357543222,0.00467908434563151,0.950768954887852
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37709,-0.000229138236979747,0.00375849232117559,-0.00759578318648391,0.00713750671252441,0.95138763077527
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,37709,0.00027150675999558,0.00460728963046864,-0.00875878091572295,0.00930179443571411,0.953008892637407
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,40039,0.000200296972333445,0.00343375241039238,-0.00652985775203562,0.00693045169670251,0.953485082515936
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,37477,0.000393742464783488,0.00675339412979834,-0.0128429100296213,0.0136303949591882,0.953508251708218
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,37593,0.000249083987793038,0.00428948258994552,-0.00815830188850018,0.00865646986408626,0.953694917110001
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,40298,-0.00010473296146011,0.00185714701388276,-0.00374474110867031,0.00353527518575009,0.955028213258587
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,40437,0.000106541165951578,0.00189092203851313,-0.00359966602953415,0.0038127483614373,0.955068870030639
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,40039,-0.000137343354204425,0.00261380774022015,-0.00526040652503592,0.00498571981662707,0.958094861432933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,40406,0.000103281487965959,0.00202682986167911,-0.0038693050409251,0.00407586801685702,0.959360297667096
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37567,0.000277264386913145,0.00561388821589042,-0.0107259565162321,0.0112804852900584,0.960610037502067
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40466,-0.000186442024534429,0.00394323271936395,-0.00791517815448778,0.00754229410541892,0.962289448561565
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37557,-0.000235267330367419,0.00499490308868218,-0.0100252773841845,0.00955474272344966,0.96243306510933
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39703,-0.000145280263170365,0.00311015149626144,-0.00624117719584279,0.00595061666950206,0.962743668261486
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37567,-0.000148833963505098,0.00324351171656181,-0.00650611692796624,0.00620844900095604,0.963401274538956
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,37536,-0.000145500175255111,0.00334934740740765,-0.0067102210937741,0.00641922074326388,0.965350378624877
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37955,7.94484732997169e-05,0.00196344093529415,-0.00376889575987681,0.00392779270647625,0.967723887085205
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",40037,-0.000261566943306562,0.00706449131200203,-0.0141079699148305,0.0135848360282174,0.97046507782224
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",40305,-0.000193091918184653,0.00565769454950997,-0.0112821732352242,0.0108959893988549,0.972774648009968
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37962,-0.000247415020659572,0.00877642303352783,-0.0174492041663741,0.016954374125055,0.977510333603181
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,37567,0.000121782563348305,0.00509266828109793,-0.00985984726760364,0.0101034123943002,0.980922120026598
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,37477,8.36180546209572e-05,0.00386790618160501,-0.00749747806132487,0.00766471417056678,0.982752664012265
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,40039,4.8848120903037e-05,0.00268973810997577,-0.00522303857464948,0.00532073481645555,0.985510710587454
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,37962,7.88470219778465e-05,0.00468538831411291,-0.00910451407368346,0.00926220811763915,0.986573858172012
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37709,-8.91758533229717e-05,0.00648084793859319,-0.0127916378129656,0.0126132861063197,0.989021737565473
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,40327,-3.94686468499121e-05,0.00295169388497685,-0.00582478866140454,0.00574585136770472,0.989331553064419
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39975,5.03826041908904e-05,0.00512334489958836,-0.0099913733990023,0.0100921386073841,0.992153913615689
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,40039,5.09638868388146e-05,0.00533503712602516,-0.0104057088801705,0.0105076366538481,0.992378304621688
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,40223,-5.54261688122924e-05,0.00581775492320854,-0.011458225818301,0.0113473734806764,0.992398732001724
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37557,-1.53971268298784e-05,0.0030170116061327,-0.00592873987484996,0.00589794562119021,0.995928142250006
NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,37477,-3.22359138080192e-05,0.00718641118932936,-0.0141176018448936,0.0140531300172775,0.996421028894424
